var title_f19_44_20160="Probiotic regimens";
var content_f19_44_20160=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Probiotic regimens",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"40%\">",
"     </colgroup>",
"     <colgroup span=\"6\" width=\"10%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Probiotic",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Study, year",
"        <br/>",
"        [reference]",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Population",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Treatment group",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Control group",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Participants,",
"        <br/>",
"        n",
"       </td>",
"       <td class=\"subtitle2\">",
"        Mean age",
"        <br/>",
"        (SD or range)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Participants,",
"        <br/>",
"        n",
"       </td>",
"       <td class=\"subtitle2\">",
"        Mean age",
"        <br/>",
"        (SD or range)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         Lactobacillus rhamnosus",
"        </em>",
"        GG 53103, 40 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day for the duration of the antibiotic course",
"       </td>",
"       <td>",
"        Arvola et al, 1999",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        5 inpatients and 114 outpatients",
"       </td>",
"       <td class=\"centered\">",
"        89",
"       </td>",
"       <td class=\"centered\">",
"        4.7 years",
"        <br/>",
"        (2 weeks to 11.8 years)",
"       </td>",
"       <td class=\"centered\">",
"        78",
"       </td>",
"       <td class=\"centered\">",
"        4.4 years",
"        <br/>",
"        (2 weeks to 12.8 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. acidophilus",
"        </em>",
"        CL1285 and",
"        <em>",
"         L. casei",
"        </em>",
"        , 25 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day for 2 days, then 50 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day for the duration of the antibiotic course",
"       </td>",
"       <td>",
"        Beausoleil et al, 2007",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        89 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        44",
"       </td>",
"       <td class=\"centered\">",
"        68.8 years",
"        <br/>",
"        (14.5 years)",
"       </td>",
"       <td class=\"centered\">",
"        45",
"       </td>",
"       <td class=\"centered\">",
"        72.9 years",
"        <br/>",
"        (13.4 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         Saccharomyces boulardii",
"        </em>",
"        , 10.2 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day for 12 days; duration of antibiotic course, 5 to 10 days",
"       </td>",
"       <td>",
"        Bravo et al, 2008",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        86 outpatients",
"       </td>",
"       <td class=\"centered\">",
"        41",
"       </td>",
"       <td class=\"centered\">",
"        49.8 years",
"        <br/>",
"        (20.5 years)",
"       </td>",
"       <td class=\"centered\">",
"        45",
"       </td>",
"       <td class=\"centered\">",
"        51.0 years",
"        <br/>",
"        (17.9 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         S. boulardii",
"        </em>",
"        , lyophilized 20 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day &le;48 hours of antibiotic start dose (duration of study drug course NS)",
"       </td>",
"       <td>",
"        Can et al, 2006",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"       <td>",
"        151 patients",
"       </td>",
"       <td class=\"centered\">",
"        73",
"       </td>",
"       <td class=\"centered\">",
"        NS*",
"       </td>",
"       <td class=\"centered\">",
"        78",
"       </td>",
"       <td class=\"centered\">",
"        NS*",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         S. boulardii",
"        </em>",
"        , 30 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day for 14 days (duration of antibiotic course, 14 days)",
"       </td>",
"       <td>",
"        Duman et al, 2005",
"        <sup>",
"         [5]",
"        </sup>",
"       </td>",
"       <td>",
"        NS (14 day triple therapy for",
"        <em>",
"         Helicobacter pylori",
"        </em>",
"        eradication)",
"       </td>",
"       <td class=\"centered\">",
"        204",
"       </td>",
"       <td class=\"centered\">",
"        45.7 years",
"        <br/>",
"        (12.7 years)",
"       </td>",
"       <td class=\"centered\">",
"        185",
"       </td>",
"       <td class=\"centered\">",
"        44.7 years",
"        <br/>",
"        (13.9 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <p>",
"         Pro1:",
"         <em>",
"          L. acidophilus",
"         </em>",
"         CL1285 and",
"         <em>",
"          L. casei",
"         </em>",
"         , LBC80R, 50 x 10",
"         <sup>",
"          9",
"         </sup>",
"         CFU/day",
"        </p>",
"        Pro2:",
"        <em>",
"         L. acidophilus",
"        </em>",
"        CL1285 and",
"        <em>",
"         L. casei",
"        </em>",
"        LBC80R, 100 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day, within 36 hours of starting antibiotic therapy until 5 days after discontinuation",
"       </td>",
"       <td>",
"        Gao et al, 2010",
"        <sup>",
"         [6]",
"        </sup>",
"       </td>",
"       <td>",
"        255 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        171",
"       </td>",
"       <td class=\"centered\">",
"        60.0 years",
"        <br/>",
"        (6.0 years)",
"       </td>",
"       <td class=\"centered\">",
"        84",
"       </td>",
"       <td class=\"centered\">",
"        60.0 years",
"        <br/>",
"        (6.0 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. casei immunitas",
"        </em>",
"        DN-114 001, 19 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day;",
"        <em>",
"         L. bulgaris",
"        </em>",
"        , 1.9 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day; and",
"        <em>",
"         S. thermophiles",
"        </em>",
"        , 19 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day within 48 hours of starting antibiotic therapy until 7 days after discontinuation",
"       </td>",
"       <td>",
"        Hickson et al, 2007",
"        <sup>",
"         [7]",
"        </sup>",
"       </td>",
"       <td>",
"        135 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        69",
"       </td>",
"       <td class=\"centered\">",
"        73.7 years",
"        <br/>",
"        (11.1 years)",
"       </td>",
"       <td class=\"centered\">",
"        66",
"       </td>",
"       <td class=\"centered\">",
"        73.9 years",
"        <br/>",
"        (10.5 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         S. boulardii",
"        </em>",
"        , 10 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day for the duration of the antibiotic course",
"       </td>",
"       <td>",
"        Kotowska et al, 2005",
"        <sup>",
"         [8]",
"        </sup>",
"       </td>",
"       <td>",
"        72 inpatients and 197 outpatients (total, 269)",
"       </td>",
"       <td class=\"centered\">",
"        132",
"       </td>",
"       <td class=\"centered\">",
"        4.9 years",
"        <br/>",
"        (6.2 months to 14.8 years)",
"       </td>",
"       <td class=\"centered\">",
"        137",
"       </td>",
"       <td class=\"centered\">",
"        4.7 years",
"        <br/>",
"        (5.2 months to 15.2 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. plantarum",
"        </em>",
"        299v, 10 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day, within 48 hours of starting antibiotic therapy until 7 days after discontinuation",
"       </td>",
"       <td>",
"        L&ouml;nnermark et al, 2010",
"        <sup>",
"         [9]",
"        </sup>",
"       </td>",
"       <td>",
"        137 inpatients and 102 outpatients, (total, 239)",
"       </td>",
"       <td class=\"centered\">",
"        118",
"       </td>",
"       <td class=\"centered\">",
"        47 years",
"       </td>",
"       <td class=\"centered\">",
"        121",
"       </td>",
"       <td class=\"centered\">",
"        43 years",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         S. boulardii",
"        </em>",
"        lyophilized, 30 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/days within 72 hours of starting antibiotic therapy until 3 days after discontinuation",
"       </td>",
"       <td>",
"        McFarland et al, 1995",
"        <sup>",
"         [10]",
"        </sup>",
"       </td>",
"       <td>",
"        193 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        97",
"       </td>",
"       <td class=\"centered\">",
"        40.7 years",
"        <br/>",
"        (16.0 years)",
"       </td>",
"       <td class=\"centered\">",
"        96",
"       </td>",
"       <td class=\"centered\">",
"        42.3 years",
"        <br/>",
"        (17.7 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. rhamnosus",
"        </em>",
"        GG, 40 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day within 72 hours of starting antibiotic therapy, then for 14 days (duration of antibiotic course &le;14 days)",
"       </td>",
"       <td>",
"        Miller et al, 2008",
"        <sup>",
"         [11]",
"        </sup>",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        189 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        95",
"       </td>",
"       <td class=\"centered\">",
"        &ge;18 years",
"       </td>",
"       <td class=\"centered\">",
"        94",
"       </td>",
"       <td class=\"centered\">",
"        &ge;18 years",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. rhamnosus",
"        </em>",
"        GG, 120 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day within 72 hours of starting antibiotic therapy, then for 14 days (duration of antibiotic course &le;14 days)",
"       </td>",
"       <td>",
"        Miller et al, 2008",
"        <sup>",
"         [11]",
"        </sup>",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        316 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        157",
"       </td>",
"       <td class=\"centered\">",
"        &ge;18 years",
"       </td>",
"       <td class=\"centered\">",
"        159",
"       </td>",
"       <td class=\"centered\">",
"        &ge;18 years",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. acidophilus",
"        </em>",
"        and",
"        <em>",
"         Bifidobacterium bifidum",
"        </em>",
"        , 20 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day within 36 hours of starting antibiotic therapy, then for 20 days",
"       </td>",
"       <td>",
"        Plummer et al, 2004",
"        <sup>",
"         [12]",
"        </sup>",
"       </td>",
"       <td>",
"        138 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        69",
"       </td>",
"       <td class=\"centered\">",
"        Elderly",
"       </td>",
"       <td class=\"centered\">",
"        69",
"       </td>",
"       <td class=\"centered\">",
"        Elderly",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. acidophilus",
"        </em>",
"        CL1285 and",
"        <em>",
"         L. casei",
"        </em>",
"        , 25 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day, for 2 days then 50 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day until 5 days after discontinuation of antibiotic",
"       </td>",
"       <td>",
"        Psaradellis et al, 2010",
"        <sup>",
"         [13]",
"        </sup>",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        248 inpatients and 189 outpatients (total, 437)",
"       </td>",
"       <td class=\"centered\">",
"        233",
"       </td>",
"       <td class=\"centered\">",
"        59.5 years",
"        <br/>",
"        (18.1 years)*",
"       </td>",
"       <td class=\"centered\">",
"        239",
"       </td>",
"       <td class=\"centered\">",
"        58.1 years",
"        <br/>",
"        (19.1 years)*",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. acidophilus",
"        </em>",
"        , 80 percent;",
"        <em>",
"         L. bulgaricus",
"        </em>",
"        , 10 percent;",
"        <em>",
"         B. bifidum",
"        </em>",
"        , 5 percent, and",
"        <em>",
"         S. thermophilus",
"        </em>",
"        , 5 percent, 3 g/day with start of antibiotic therapy until hospital discharge",
"       </td>",
"       <td>",
"        Rafiq et al, 2007",
"        <sup>",
"         [14]",
"        </sup>",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        100 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        45",
"       </td>",
"       <td class=\"centered\">",
"        NS",
"       </td>",
"       <td class=\"centered\">",
"        55",
"       </td>",
"       <td class=\"centered\">",
"        NS",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. rhamnosus",
"        </em>",
"        GG (2593, 2594, 2595), 2 x 10",
"        <sup>",
"         10",
"        </sup>",
"        CFU/day for the duration of the antibiotic course",
"       </td>",
"       <td>",
"        Ruszczy������ski et al, 2008",
"        <sup>",
"         [15]",
"        </sup>",
"       </td>",
"       <td>",
"        134 inpatients and 106 outpatients (total, 240)",
"       </td>",
"       <td class=\"centered\">",
"        120",
"       </td>",
"       <td class=\"centered\">",
"        4.5 years",
"        <br/>",
"        &nbsp;(3.7 years)",
"       </td>",
"       <td class=\"centered\">",
"        120",
"       </td>",
"       <td class=\"centered\">",
"        4.6 years",
"        <br/>",
"        (3.8 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         L. acidophilus",
"        </em>",
"        , 60 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day during and 14 days after antibiotic course",
"       </td>",
"       <td>",
"        Safdar et al, 2008",
"        <sup>",
"         [16]",
"        </sup>",
"       </td>",
"       <td>",
"        40 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        23",
"       </td>",
"       <td class=\"centered\">",
"        66.6 years",
"        <br/>",
"        (14.5 years)",
"       </td>",
"       <td class=\"centered\">",
"        17",
"       </td>",
"       <td class=\"centered\">",
"        72.5 years",
"        <br/>",
"        (11.0 years)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        VSL #3 (",
"        <em>",
"         B. breve",
"        </em>",
"        ,",
"        <em>",
"         B. longum",
"        </em>",
"        ,",
"        <em>",
"         B. infantis",
"        </em>",
"        ,",
"        <em>",
"         L. acidophilus",
"        </em>",
"        ,",
"        <em>",
"         L. plantarum",
"        </em>",
"        ,",
"        <em>",
"         L. paracasei",
"        </em>",
"        ,",
"        <em>",
"         L. bulgaricus",
"        </em>",
"        ,",
"        <em>",
"         S. thermophilus",
"        </em>",
"        ), 900 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day during and 7 days after the antibiotic course",
"       </td>",
"       <td>",
"        Selinger et al, 2011",
"        <sup>",
"         [17]",
"        </sup>",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        124 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        62",
"       </td>",
"       <td class=\"centered\">",
"        NS",
"       </td>",
"       <td class=\"centered\">",
"        62",
"       </td>",
"       <td class=\"centered\">",
"        NS",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <em>",
"         S. boulardii",
"        </em>",
"        lyophilized, 20 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/day within 48 hours of starting antibiotic therapy until 2 weeks after discontinuation",
"       </td>",
"       <td>",
"        Surawicz et al, 1989",
"        <sup>",
"         [18]",
"        </sup>",
"       </td>",
"       <td>",
"        318 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        212",
"       </td>",
"       <td class=\"centered\">",
"        48.6 years",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        106",
"       </td>",
"       <td class=\"centered\">",
"        45.4 years",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         L. rhamnosus",
"        </em>",
"        GG, 20 x 10",
"        <sup>",
"         9",
"        </sup>",
"        CFU/days within 24 hours of starting antibiotic therapy, then for 14 days",
"       </td>",
"       <td>",
"        Thomas et al, 2001",
"        <sup>",
"         [19]",
"        </sup>",
"       </td>",
"       <td>",
"        302 inpatients",
"       </td>",
"       <td class=\"centered\">",
"        152",
"       </td>",
"       <td class=\"centered\">",
"        57.2 years",
"        <br/>",
"        (18.0 years)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        150",
"       </td>",
"       <td class=\"centered\">",
"        54.4 years",
"        <br/>",
"        (17.4 years)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CFU: colony-forming units; NS: not specified; Pro1: probiotic group 1; Pro2: probiotic group 2; SD: standard deviation.",
"     <br/>",
"     * Adult population (eligibility criteria, 25 to 50 years).",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Abstract.",
"     <br/>",
"     &Delta; For complete cases.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104:e64.",
"      </li>",
"      <li>",
"       Beausoleil M, Fortier N, Gu&eacute;nette S, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21:732.",
"      </li>",
"      <li>",
"       Bravo MV, Bunout D, Leiva L, et al. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment]. Rev Med Chil 2008; 136:981.",
"      </li>",
"      <li>",
"       Can M, Be������irbellioglu BA, Avci IY, et al. Prophylactic Saccharomyces boulardii in the prevention of antibiotic associated diarrhea: a prospective study. Med Sci Monit 2006; 12:PI19.",
"      </li>",
"      <li>",
"       Duman DG, Bor S, Oz&uuml;temiz O, et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2005; 17:1357.",
"      </li>",
"      <li>",
"       Gao XW, Mubasher M, Fang CY, et al. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105:1636.",
"      </li>",
"      <li>",
"       Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335:80.",
"      </li>",
"      <li>",
"       Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005; 21:583.",
"      </li>",
"      <li>",
"       L&ouml;nnermark E, Friman V, Lappas G, et al. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol 2010; 44:106.",
"      </li>",
"      <li>",
"       McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90:439.",
"      </li>",
"      <li>",
"       Miller M, Florencio S, Eastmond J, Reynolds S. Results of 2 prospective randomized studies of Lactobacillus GG to prevent C. difficile infection in hospitalized adults receiving antibiotics [Abstract]. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 2008; 48:578.",
"      </li>",
"      <li>",
"       Plummer S, Weaver MA, Harris JC, et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 2004; 7:59.",
"      </li>",
"      <li>",
"       Psaradellis E, Sampalis J, Rampakakis E. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea&mdash;a placebo controlled double-blind randomized, multi-center study. Arch Med Sci 2010; 6:56.",
"      </li>",
"      <li>",
"       Rafiq R, Pandey D, Osman SM, et al. Prevention of Clostridium difficile (C-difficile) diarrhea with probiotic in hospitalized patients treated with antibiotics [Abstract]. Gastroenterology 2007; 132 Suppl 2:A187.",
"      </li>",
"      <li>",
"       Ruszczy������ski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 2008; 28:154.",
"      </li>",
"      <li>",
"       Safdar N, Barigala R, Said A, McKinley L. Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans. J Clin Pharm Ther 2008; 33:663.",
"      </li>",
"      <li>",
"       Selinger C, Lockett M, Bell A, et al. VSL#3 for the prevention of antibiotic associated diarrhoea (AAD) and Clostridium difficile associated diarrhoea (CDAD): an interim analysis [Abstract]. Gut 2011; 60 Suppl 1:A4.",
"      </li>",
"      <li>",
"       Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96:981.",
"      </li>",
"      <li>",
"       Thomas MR, Litin SC, Osmon DR, et al. Lack of effect of Lactobacillus GG on antibiotic associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 2001; 76:883.",
"      </li>",
"     </ol>",
"     <br/>",
"     Reproduced with permission from: Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the Prevention of Clostridium difficile&ndash;Associated Diarrhea: A Systematic Review and Meta-analysis. Ann Intern Med Nov 13 2012. Copyright &copy; 2012 American College of Physicians.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20160=[""].join("\n");
var outline_f19_44_20160=null;
var title_f19_44_20161="Flexible bronchoscopes";
var content_f19_44_20161=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flexible bronchoscopes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    From top to bottom: 6 mm outer diameter (OD) bronchoscope with a 2.8 mm diameter working channel (WC); 4.9 mm OD bronchoscope with a 2.2 mm diameter WC; 3.5 mm OD bronchoscope with a 1.2 mm diameter WC and 2.7 mm OD bronchoscope with a 1.2 mm diameter WC (Olympus prototype). A large variety of ancillary equipment, including forceps, grasping claws and baskets, can be passed through these bronchoscopes to grip various foreign bodies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles Marquette, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20161=[""].join("\n");
var outline_f19_44_20161=null;
var title_f19_44_20162="Pathogenesis of AMM";
var content_f19_44_20162=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F56172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F56172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of myelofibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 242px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the currently held opinion on the factors contributing to the pathogenesis of bone marrow fibrosis in myeloid metaplasia.",
"    <div class=\"footnotes\">",
"     TGF-&beta;: transforming growth factor; PDGF: platelet derived growth factor; EGF: epidermal growth factor; bFGF: basic fibroblast growth factor.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20162=[""].join("\n");
var outline_f19_44_20162=null;
var title_f19_44_20163="EUS hyperechoic cloud";
var content_f19_44_20163=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F57496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F57496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    EUS hyperechoic cloud",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The needle has been advanced through the gastric wall immediately lateral and beyond the anterior wall of the aorta. Injection of absolute ethanol results in an echodense cloud.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyrighted and used with permission of Mayo Foundation for Medical Education and Research.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20163=[""].join("\n");
var outline_f19_44_20163=null;
var title_f19_44_20164="Loading the wire I";
var content_f19_44_20164=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52590%7EGAST%2F64371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52590%7EGAST%2F64371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Loading the wire technique for precut sphincterotomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cartoon depicting the \"loading the wire\" technique for creating a biliary sphincterotomy (see text for details).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas A Howell, MD and David J Desilets, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Completion of precut sphincterotomy with blended current",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After an initial 2 to 3 mm incision is made with the \"loaded wire\" method, the endoscope slightly withdrawn, and the dials are adjusted as necessary to \"load the wire\" once more at the top of the freshly made incision. The cut is then continued in small increments.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas A Howell, MD and David J Desilets, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20164=[""].join("\n");
var outline_f19_44_20164=null;
var title_f19_44_20165="Encysted Trichinella larvae";
var content_f19_44_20165=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Encysted trichinella larvae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph showing encysted Trichinella larvae in skeletal muscle cells. This process occurs with all Trichinella species except T. pseudospiralis and T. papuae.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter F Weller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20165=[""].join("\n");
var outline_f19_44_20165=null;
var title_f19_44_20166="Bevacizumab: Pediatric drug information";
var content_f19_44_20166=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Bevacizumab: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"    see \"Bevacizumab: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?1/29/1494?source=see_link\">",
"    see \"Bevacizumab: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F141002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Avastin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F3422982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Avastin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1000951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Monoclonal Antibody",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Vascular Endothelial Growth Factor (VEGF) Inhibitor",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F13163443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     PMA &ge;31 weeks and PNA &ge;28 days: Intravitreal injection:",
"     <b>",
"      Retinopathy of prematurity:",
"     </b>",
"     Limited data available: 0.625 mg (0.025 mL) as a single dose in the affected eye; dosing was used in 70 premature neonates (Stage 3+ ROP) in the only prospective, randomized comparative trial with laser therapy (Mintz-Hittner, 2011); reported range: 0.4-0.75 mg in the affected eye (Micieli, 2009). Optimal dose not established; further studies are needed. Some experts recommend caution regarding use outside of a clinical trial (Quinn, 2011); systemic absorption with decreases in VEGF serum concentration have been reported in a case series of 11 neonates after intravitreal administration of doses consistent with those in reported in the literature (Sato, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1000979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"      see \"Bevacizumab: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Refer to individual protocols; details concerning dosing in combination regimens should also be consulted:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Refractory solid tumor:",
"     </b>",
"     5-15 mg/kg/dose every 2 weeks in a 28-day course (Glade-Bender, 2008)",
"     <b>",
"      or",
"     </b>",
"     5-10 mg/kg every 2-3 weeks (Benesch, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Primary CNS tumor:",
"     </b>",
"     5-15 mg/kg/dose (median: 9.5 mg/kg/dose) every 2-3 weeks (Reism&uuml;ller, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Colorectal cancer:",
"     </b>",
"     5-10 mg/kg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Non-small cell lung cancer (nonsquamous):",
"     </b>",
"     15 mg/kg every 3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Breast cancer:",
"     </b>",
"     10 mg/kg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Glioblastoma:",
"     </b>",
"     10 mg/kg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Renal cell cancer:",
"     </b>",
"     10 mg/kg every 2 weeks",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F140982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Avastin&reg;: 25 mg/mL (4 mL, 16 mL) [derived from or manufactured using Chinese hamster ovary cells]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F140970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1000983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: I.V. infusion: Dilute prescribed dose of bevacizumab in 100 mL NS; infuse the initial dose over 90 minutes; shorten infusion to 60 minutes if the initial infusion is well-tolerated. Third and subsequent infusions may be shortened to 30 minutes if the 60-minute infusion is well-tolerated. Do",
"     <b>",
"      not",
"     </b>",
"     administer via I.V. push.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intravitreal injection: Inject undiluted bevacizumab solution. The major clinical  trial for ROP used an insulin syringe (0.3 mL syringe with a 31 gauge,",
"     <sup>",
"      5",
"     </sup>",
"     /",
"     <sub>",
"      16",
"     </sub>",
"     inch needle) to accurately deliver the dose; each 1 unit on an insulin syringe is equivalent to 0.01 mL; typical bevacizumab dose of 0.625 mg would equate to 2.5 units on an insulin syringe using a 25 mg/mL solution. In this ROP trial, the injection site was anesthetized with a drop of tetracaine hydrochloride 0.5% ophthalmic solution or proparacaine hydrochloride 0.5% ophthalmic solution prior to bevacizumab administration and sterilized before and after administration with a drop of povidone-iodine 5% ophthalmic solution. Following the procedure, a topical ophthalmic antibiotic drop was also administered every 6 hours for 7 days (Mintz-Hittner, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     pH: 6.2",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F14266279\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS; do not mix or administer with dextrose solutions.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1000970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store vials at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); protect from light; do not freeze or shake.",
"     <b>",
"      Do not mix",
"     </b>",
"     with dextrose-containing solutions (concentration-dependent degradation may occur). Diluted solution is stable for up to 8 hours under refrigeration.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1000952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of metastatic colorectal cancer; treatment of unresectable, locally advanced recurrent or metastatic nonsquamous, nonsmall cell lung cancer; glioblastoma with progressive disease following prior therapy as single agent; and metastatic renal cell cancer (FDA approved in ages &ge;18 years and adults). Has also been studied for use in recurrent ovarian cancer, recurrent cervical cancer, soft tissue sarcoma (angiosarcoma or hemangiopericytoma/solitary fibrous tumor), breast cancer, refractory solid tumors (eg, neuroblastoma, astrocytoma, rhabdomyosarcoma). Has been used intravitreally  for retinopathy of prematurity (Stage 3+).",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2110715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Avastin&reg; may be confused with Astelin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Bevacizumab may be confused with brentuximab, cetuximab, ranibizumab, riTUXimab",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Avastin [U.S., Canada, and  multiple international markets] may be confused with Avaxim, a brand name for hepatitis A vaccine [Canada and multiple international markets]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F141028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reported monotherapy and as part of combination chemotherapy regimens.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arterial thrombosis, cardio-/cerebrovascular arterial thrombotic event, DVT, HF, hyper-/hypotension, intra-abdominal thrombosis, left ventricular dysfunction, syncope, thromboembolism, thromboembolic events, venous thrombus/embolus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: CNS hemorrhage, dizziness, dysphonia, fatigue, headache, pain, sensory neuropathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, alopecia, dry skin, exfoliative dermatitis, skin discoloration, skin ulcer, wound dehiscence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration, hyponatremia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, colitis, constipation, diarrhea, dry mouth, dyspepsia, fistula, flatulence, gastritis, gastrointestinal hemorrhage, gastrointestinal perforation, gastroesophageal reflux, gingival bleeding, gingival pain, gingivitis, ileus, intra-abdominal abscess, mouth ulceration, nausea, stomatitis, taste disorder, tooth abscess, vomiting,  xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Vaginal hemorrhage",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Hemorrhage, leukopenia, neutropenia, neutropenic fever, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, myalgia, neuropathy (other than sensory), weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Deafness, tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Proteinuria (median onset: 5.6 months; median time to resolution: 6.1 months)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, epistaxis, hemoptysis (nonsquamous histology), pneumonitis/pulmonary infiltrates, pulmonary embolism, rhinitis, upper respiratory infection, voice alteration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Infusion reaction, infection (pneumonia, catheter, or wound infections)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: Anaphylaxis, anastomotic ulceration, angina, antibody formation (anti-bevacizumab and neutralizing), bladder perforation, cerebral infarction; fistula (biliary, bladder, bronchopleural, duodenal, enterocutaneous, esophageal, gastrointestinal, rectal, renal, tracheoesophageal [TE] and vaginal); gastrointestinal ulcer, gall bladder perforation, hemorrhagic stroke, hypersensitivity, hypertensive crises, hypertensive encephalopathy, intestinal necrosis, intestinal obstruction, mesenteric venous occlusion, microangiopathic hemolytic anemia (when used in combination with sunitinib), MI, nasal septum perforation, nephrotic syndrome, osteonecrosis (jaw), ovarian failure, pancytopenia, polyserositis, pulmonary hemorrhage, pulmonary hypertension, renal failure, renal thrombotic microangiopathy, reversible posterior leukoencephalopathy syndrome (RPLS), sepsis, subarachnoid hemorrhage, toxic anterior segment syndrome (TASS), transient ischemic attack, ureteral stricture, wound healing complications",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Reported from unlabeled use: Eye disorders: Endophthalmitis (infectious and sterile), hemorrhage (conjunctival, retinal or vitreous), intraocular inflammation (iritis, vitritis), intraocular pressure increased, ocular hyperemia, ocular pain/discomfort, permanent vision loss, retinal detachment, visual disturbance, vitreous floaters",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1000959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to bevacizumab, murine proteins, or any component.",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F6066866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with cardiovascular disease, acquired coagulopathy, and patients with pre-existing hypertension (monitor blood pressure). Ocular inflammation has been reported with repeated intravitreal use; monitor patients for signs or symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1000960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Wound dehiscence/wound healing complications have been reported in patients (not related to treatment duration)",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; monitor patients for signs/symptoms of improper wound healing. Permanently discontinue in patients who develop these complications. The appropriate intervals between administration of bevacizumab and surgical procedures to avoid impairment in wound healing has not been established. Do not initiate therapy within 28 days of major surgery and only following complete healing of the incision. Bevacizumab should be discontinued at least 28 days prior to elective surgery and the estimated half-life (20 days) should be considered.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     May cause CHF and/or potentiate cardiotoxic effects of anthracyclines. CHF is more common with prior anthracycline exposure and/or left chest wall irradiation. Bevacizumab may cause and/or worsen hypertension significantly. Permanent discontinuation is recommended in patients who experience hypertensive crisis or encephalopathy. Temporarily discontinue in patients who develop uncontrolled hypertension. Cases of reversible posterior leukoencephalopathy syndrome (RPLS) have been reported; discontinue therapy if RPLS occurs. Symptoms such as headache, seizure, confusion, lethargy, blindness, or other vision or neurologic disturbances may occur from 16 hours to 1 year after treatment initiation. RPLS may be associated with hypertension; discontinue bevacizumab and begin management of hypertension if present.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Avoid use in patients with recent hemoptysis (&gt;2.5 mL blood) or with CNS metastases",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; severe or fatal hemorrhage has occurred, including hemoptysis, GI bleed, CNS bleeding, epistaxis, vaginal bleeding, and significant pulmonary bleeding (primarily in patients with nonsmall cell lung cancer with squamous cell histology); discontinuation of treatment is recommended in all patients with serious hemorrhage. Use with caution in patients with CNS metastases; one case of CNS hemorrhage was observed in a study of NSCLC patients with CNS metastases. Use with caution in patients at risk for thrombocytopenia. Bevacizumab may impair fertility and have adverse effects on fetal development; adequate contraception during therapy and following discontinuation is recommended. An increased risk for arterial thromboembolic events (eg, stroke, MI, TIA, angina) is associated with bevacizumab use in combination with chemotherapy. History of arterial thromboembolism or &ge;65 years of age may present an even greater risk; permanently discontinue if serious arterial thromboembolic event occurs. Although patients with cancer are at risk for venous thromboembolism, a meta-analysis of 15 controlled trials has demonstrated an increased risk for venous thromboembolism in patients who received bevacizumab.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Bevacizumab is associated with hypersensitivity reactions and/or infusion-related reactions. Interrupt therapy if patient experiences severe hypersensitivity reaction or infusion reaction which includes hypertension, hypertensive crises associated with neurologic manifestations, wheezing, oxygen desaturation, chest pain, headaches, rigors, and diaphoresis.  Proteinuria and/or nephrotic syndrome have been associated with bevacizumab; discontinue in patients with nephrotic syndrome. Microangiopathic hemolytic anemia (MAHA) has been reported when bevacizumab has been used in combination with sunitinib. Gastrointestinal perforation has been reported",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; may be complicated by fistula formation (including enterocutaneous, esophageal, duodenal, and rectal fistulas), and nongastrointestinal fistulas (including tracheoesophageal, bronchopleural, biliary, vaginal, and bladder fistulas), most commonly within the first 6 months of treatment",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; discontinue therapy in patients who develop these complications.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Infection with resultant permanent vision loss has been reported following intravitreal injection of repackaged bevacizumab; use proper aseptic technique when manipulating commercially available dosage forms. Some experts recommend caution regarding use in premature neonates for ROP outside of controlled, clinical trials (Quinn, 2011); systemic absorption after intravitreal administration with decreases in VEGF serum concentration (as low as 9% of baseline systemic concentration) have been reported in a case series of 11 neonates (Sato, 2012); short- and long-term implications of systemic exposure are unknown; monitoring is recommended.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F140976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antineoplastic Agents (Anthracycline, Systemic): Bevacizumab may enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Irinotecan: Bevacizumab may enhance the adverse/toxic effect of Irinotecan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SORAfenib: Bevacizumab may enhance the adverse/toxic effect of SORAfenib. Specifically, the risk for hand-foot skin reaction may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SUNItinib: May enhance the adverse/toxic effect of Bevacizumab. Specifically, the risk for a specific form of anemia, microangiopathic hemolytic anemia (MAHA), may be increased. Bevacizumab may enhance the hypertensive effect of SUNItinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F140978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F140991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have been observed in animal reproduction studies. Angiogenesis is of critical importance to human fetal development, and bevacizumab inhibits angiogenesis. Adequate contraception during therapy is recommended (and for &ge;6 months following last dose of bevacizumab). Patients should also be counseled regarding prolonged exposure following discontinuation of therapy due to the long half-life of bevacizumab.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Based on animal studies, bevacizumab may disrupt normal menstrual cycles and impair fertility by several effects, including reduced endometrial proliferation and follicular developmental arrest. Some parameters do not recover completely, or recover very slowly following discontinuation.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1000986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V. administration: Monitor for signs of an infusion reaction during infusion; blood pressure (continue to monitor blood pressure during and after bevacizumab has been discontinued). Monitor CBC with differential; signs/symptoms of GI perforation or abscess (abdominal pain, constipation, vomiting); signs/symptoms of bleeding including hemoptysis, GI bleeding, CNS bleeding, epistaxis. Urinalysis for proteinuria, nephrotic syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intravitreal administration: Monitor blood pressure, heart rate, respiratory rate, and oxygen saturation prior to, during, and after the procedure; monitor for signs and symptoms of infection or ocular inflammation; consider short- and long-term monitoring for sequelae of systemic absorption when used in neonates (Sato, 2012)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1000973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bevacizumab is a recombinant, humanized monoclonal antibody which binds and neutralizes vascular endothelial growth factor (VEGF), preventing its association with endothelial receptors. VEGF binding initiates angiogenesis (endothelial proliferation and the formation of new blood vessels). The inhibition of microvascular growth is believed to retard the growth of all tissues, including metastatic tissue.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1000975\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: I.V.: 20 days (range: 11-50 days); intravitreal: ~5-10 days (Bakri, 2007; Krohne, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1000990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/29/1494?source=see_link\">",
"      see \"Bevacizumab: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use adequate contraception during therapy and for 6 months following discontinuation of bevacizumab. Inform physician if unusual bleeding, high fever, rigors, sudden onset of worsening neurological function, headache, vision loss, persistent/severe abdominal pain, constipation, vomiting, or elevated blood pressure occurs.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bakri SJ, Snyder MR, Reid JM, et al, \"Pharmacokinetics of Intravitreal Bevacizumab (Avastin),\"",
"      <i>",
"       Ophthalmology",
"      </i>",
"      , 2007, 114(5):855-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/17467524/pubmed\" id=\"17467524\" target=\"_blank\">",
"        17467524",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Benesch M, Windelberg M, Sauseng W, et al, \"Compassionate Use of Bevacizumab (Avastin&reg;) in Children and Young Adults With Refractory or Recurrent Solid Tumors,\"",
"      <i>",
"       Ann Oncol",
"      </i>",
"      , 2008, 19(4):807-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/18056650/pubmed\" id=\"18056650\" target=\"_blank\">",
"        18056650",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Glade Bender JL, Adamson PC, Reid JM, et al, \"Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study,\"",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2008, 26(3):399-405.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/18202416/pubmed\" id=\"18202416\" target=\"_blank\">",
"        18202416",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Krohne TU, Eter N, Holz FG, et al, \"Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans,\"",
"      <i>",
"       Am J Ophthalmol",
"      </i>",
"      , 2008, 146(4):508-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/18635152/pubmed\" id=\"18635152\" target=\"_blank\">",
"        18635152",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Micieli JA, Surkont M, and Smith AF, \"A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity,\"",
"      <i>",
"       Am J Ophthalmol",
"      </i>",
"      , 2009, 148(4):536-543.e2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/19660736/pubmed\" id=\"19660736\" target=\"_blank\">",
"        19660736",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mintz-Hittner HA, Kennedy KA, Chuang AZ, et al, \"Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 364(7):603-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/21323540/pubmed\" id=\"21323540\" target=\"_blank\">",
"        21323540",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mintz-Hittner HA, personal communication, August 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nalluri SR, Chu D, Keresztes R, et al, \"Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients: A Meta-Analysis,\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2008, 300(19):2277-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/19017914/pubmed\" id=\"19017914\" target=\"_blank\">",
"        19017914",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Quinn GE and Rubin SE, \"Caution Urged in Using Bevacizumab Outside Clinical Trials, \"",
"      <i>",
"       AAP News",
"      </i>",
"      , 2011, 32;46.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reism&uuml;ller B, Azizi AA, Peyrl A, et al, \"Feasibility and Tolerability of Bevacizumab in Children With Primary CNS Tumors,\"",
"      <i>",
"       Pediatr Blood Cancer",
"      </i>",
"      , 2010, 54(5):681-6.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sato T, Wada K, Arahori H, et al, \"Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity,\"",
"      <i>",
"       Am J Ophthalmol",
"      </i>",
"      , 2012, 153(2):327-333.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/44/20166/abstract-text/21930258/pubmed\" id=\"21930258\" target=\"_blank\">",
"        21930258",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12917 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-71969A6E96-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20166=[""].join("\n");
var outline_f19_44_20166=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708647\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141002\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422982\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000951\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13163443\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000979\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140982\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140970\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000983\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14266279\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000970\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000952\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2110715\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141028\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000959\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6066866\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000960\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298861\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140976\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140978\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140991\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000986\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000973\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000975\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1000990\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12917\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12917|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=related_link\">",
"      Bevacizumab: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/29/1494?source=related_link\">",
"      Bevacizumab: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_44_20167="Histologic findings in GERD";
var content_f19_44_20167=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 565px\">",
"   <div class=\"ttl\">",
"    Histologic findings in GERD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 545px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Increased basal layer thickness (noncornified stratified squamous).",
"    <br>",
"     (B) Papillary elongation (noncornified stratified squamous).",
"     <div class=\"footnotes\">",
"      GERD: gastrointestinal reflux disease.",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20167=[""].join("\n");
var outline_f19_44_20167=null;
var title_f19_44_20168="Poison ivy (Toxicodendron) dermatitis";
var content_f19_44_20168=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Poison ivy (Toxicodendron) dermatitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Lori Prok, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Thomas McGovern, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Daniel F Danzl, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Joseph Fowler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20168/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/44/20168/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to plants of the Anacardiaceae family account for more allergic contact dermatitis than all other plant families combined. In the United States, the most important members of this family are those of the genus",
"    <em>",
"     Toxicodendron",
"    </em>",
"    (previously classified as in the genus",
"    <em>",
"     Rhus",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]), which include common or northern poison ivy (",
"    <em>",
"     Toxicodendron radicans",
"    </em>",
"    ), western poison ivy (",
"    <em>",
"     Toxicodendron rydbergii",
"    </em>",
"    ), eastern poison oak (",
"    <em>",
"     Toxicodendron toxicarium",
"    </em>",
"    ), western poison oak (",
"    <em>",
"     Toxicodendron diversilobum",
"    </em>",
"    ), and poison sumac (",
"    <em>",
"     Toxicodendron vernix",
"    </em>",
"    ). Toxicodendron means \"poisonous tree\", an appropriate choice for these dermatitis-provoking species. In contrast, although they often have three-leaflet configurations similar to those of Toxicodendron, members of the genus",
"    <em>",
"     Rhus",
"    </em>",
"    are non-allergenic [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Throughout this topic we refer to Toxicodendron dermatitis by the common name \"poison ivy dermatitis\".",
"   </p>",
"   <p>",
"    This topic reviews the epidemiology, prevention, and treatment of allergic contact dermatitis due to these",
"    <em>",
"     Toxicodendron",
"    </em>",
"    species. The evaluation and management of contact dermatitis from other causes is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of dermatitis\", section on 'Contact dermatitis'",
"    </a>",
"    .) Despite the prevalence of poison ivy dermatitis in the United States, there are very few well-designed published studies examining the management of this condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many people are sensitized to urushiol, the allergenic compound found in poison ivy, poison oak, and poison sumac. Fifty percent of people will react to poison ivy in nature, and approximately 75 percent will react to patch testing with urushiol. Annually, an estimated 25 to 40 million Americans require medical treatment after exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Firefighters, forestry workers, and farmers comprise a large proportion of the victims affected through occupational exposure, and this can have important occupational and economic impacts [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Poison ivy dermatitis affects all ethnicities and skin types, and most geographical regions in the United States are at risk (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Geography'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/6\">",
"     6",
"    </a>",
"    ]. Children are also affected; most children over the age of eight are sensitized [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/4\">",
"     4",
"    </a>",
"    ]. Allergic responsiveness to poison ivy appears to wane with age, especially in those with mild reactions and limited sensitizing exposures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     IDENTIFYING THE PLANT",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the common phrase \"leaves of three, let them be\" is a helpful reminder to avoid poison ivy and related plants, members of the Toxicodendron genus have varied presentations based on the season, growth cycle, region, and climate (",
"    <a class=\"graphic graphic_figure graphicRef72155 \" href=\"UTD.htm?42/4/43074\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef81173 graphicRef54814 graphicRef81397 \" href=\"UTD.htm?38/0/38922\">",
"     picture 1A-C",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Poison ivy and poison oak are often identified by three leaflets with flowering branches arising from axillary positions on a single stem. Poison sumac more often forms leaflets of five, seven, or more that angle upward toward the top of the stem. One may also find characteristic black dots on",
"    <em>",
"     Toxicodendron",
"    </em>",
"    species; this black lacquer is oxidized urushiol (due to the enzyme laccase found in the oleoresin) and can be found on plant leaves within 10 minutes of its exposure to oxygen.",
"    <em>",
"     Toxicodendron",
"    </em>",
"    species also produce a green or off-white fruit in the autumn months [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/2\">",
"     2",
"    </a>",
"    ]. Two species of Rhus possess trifoliate leaves; however, the fruiting structures are red and terminal, not off-white and axillary (",
"    <a class=\"graphic graphic_figure graphicRef72155 \" href=\"UTD.htm?42/4/43074\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GEOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Toxicodendron",
"    </em>",
"    species are ubiquitous in many environments, particularly in the United States, and can be found in various forms or as crossreacting allergenic plants throughout the world. Northern poison ivy is more common east of the Rocky Mountains, often growing as climbing vines. Poison ivy in and west of the Rocky Mountains is found as a low-growing shrub. Poison oak is found primarily west of the Rocky Mountains, and poison sumac is found in boggy, uninhabited areas of the southeastern part of the US. It is less common to find Toxicodendron species above 4000 feet of elevation or in arid, desert climates (",
"    <a class=\"graphic graphic_figure graphicRef79030 graphicRef70356 graphicRef60686 \" href=\"UTD.htm?40/29/41432\">",
"     figure 2A-C",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CROSS-REACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other members of Anacardiaceae and related families contain allergenic catechols or noncatechol phenols that cross react with components of urushiol found in",
"    <em>",
"     Toxicodendron",
"    </em>",
"    species. Mango rind, cashew nutshell, Japanese lacquer tree, Indian marking nut tree (used for laundry marking in India), Brazilian pepper tree, and ginkgo tree can all cause dermatitis in sensitized individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urushiol is the allergenic substance in poison ivy and related plants. It is a mixture of compounds that makes up 60 percent of the plant oleoresin. Those compounds with 0, 1, 2, or 3 double bonds are allergenic; the diolefin (2 double bonds) is the most allergenic. The oleoresin also contains the enzyme laccase, gum, water, and water-insoluble glycoproteins. It is a light, colorless oil present in the fruit, leaves, stem, and root of the plant. Exposure to bruised or broken plant parts allows the toxic oil to contact skin, fingernails, clothing, pets, tools, or other objects. Intact plant parts generally do not cause dermatitis. However, plants are easily damaged by rubbing, rain, or dry fall weather.",
"   </p>",
"   <p>",
"    Poison ivy dermatitis is a classic type IV hypersensitivity (cell-mediated) allergic reaction. The allergens are low molecular weight haptens that easily and quickly penetrate the epidermis where they are taken up and processed by Langerhans cells. These antigen-presenting cells then travel to regional lymph nodes where effector T-lymphocytes are activated, expand, and circulate throughout the body. Because urushiol is a powerful antigen, a single exposure can be adequate to cause clinical symptoms. Once clonally expanded T-lymphocytes exist, reexposure to poison ivy causes cytokine release and clinical symptoms in 12 to 48 hours. Patients with a history of poison ivy dermatitis may be at increased risk for dermatitis from cross-reaction with other urushiol-containing plants such as mangoes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intense pruritus and erythema are the most common presenting signs of poison ivy dermatitis. Patients then develop papules or plaques, vesicles,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bullae, often arranged in characteristic linear or streak-like configurations where a portion of a plant has made contact with the skin (",
"    <a class=\"graphic graphic_picture graphicRef69330 \" href=\"UTD.htm?11/55/12145\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Involvement of the face and genitals may cause significant edema. Clinical presentations vary with patient activity. One report found that children in New Zealand were more likely to present with facial dermatitis reflective of play under",
"    <em>",
"     Toxicodendron succedaneum",
"    </em>",
"    trees, while adults more frequently presented with upper limb symptoms acquired while gardening [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/9\">",
"     9",
"    </a>",
"    ]. Urushiol contact has also caused urticaria and erythema multiforme [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. \"Black spot\" poison ivy dermatitis occurs when urushiol is left on the skin and oxidizes, appearing as black spots that cannot be washed off (",
"    <a class=\"graphic graphic_picture graphicRef69330 \" href=\"UTD.htm?11/55/12145\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/12\">",
"     12",
"    </a>",
"    ]. The concentrated resin creates both an irritant dermatitis and an allergic dermatitis.",
"   </p>",
"   <p>",
"    Symptoms of poison ivy dermatitis in sensitized individuals generally develop within 4 to 96 hours after exposure and peak between 1 and 14 days after exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/13\">",
"     13",
"    </a>",
"    ]. New lesions can present up to 21 days after exposure in previously unexposed individuals. Lesions present in different locations at different times after exposure based upon the amount of urushiol present and the stratum corneum thickness of the involved areas. This can give the impression that the poison ivy is spreading from one region to another. Blister fluid is not antigenic, however.",
"   </p>",
"   <p>",
"    Occasionally, after the initial exposure, patients continue to come in contact with the dried, black antigenic resin on contaminated clothing, pet fur or claws, gardening tools, or in crevices under the fingernails. &nbsp;This perpetuates the patient's dermatitis and puts their contacts at risk for developing an allergic reaction. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Avoidance'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Left untreated, the dermatitis usually resolves in one to three weeks. The most common complication of poison ivy dermatitis is secondary bacterial infection of the skin with Staphylococcus aureus or beta-hemolytic group A Streptococcus. Bacterial flora does vary somewhat by site and can be polymicrobial [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postinflammatory hyperpigmentation is more common in darker skin types and, while it can persist for several months, usually resolves without treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/6\">",
"     6",
"    </a>",
"    ]. Renal and genitourinary complications are rare, although urinary retention due to penile edema and nephrosis from immune complex deposition in the kidney have both been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/6,15\">",
"     6,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of poison ivy dermatitis is typically made based on a history of exposure and a characteristic pattern of a well demarcated contact dermatitis in areas of skin that could have come in contact with plant parts, particularly when linear streaks are present (",
"    <a class=\"graphic graphic_picture graphicRef69330 \" href=\"UTD.htm?11/55/12145\">",
"     picture 2",
"    </a>",
"    ). Atypical presentations may occur when patients are exposed secondarily, such as when a pet gets urushiol on its fur and then brushes against the patient. It is impossible to diagnose poison ivy as the cause of a rash based solely on the appearance of the rash. &nbsp;",
"   </p>",
"   <p>",
"    The differential diagnosis of poison ivy dermatitis includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A different plant-induced allergic contact dermatitis &mdash; Plants other than",
"      <em>",
"       Toxicodendron",
"      </em>",
"      can cause dermatitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H12#H12\">",
"       \"Overview of dermatitis\", section on 'Allergic contact dermatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Allergic contact dermatitis not from plants &mdash; Important allergens include nickel and topical antibacterials. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H12#H12\">",
"       \"Overview of dermatitis\", section on 'Allergic contact dermatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Irritant contact dermatitis &mdash; Many substances can produce a nonallergic inflammatory skin reaction (",
"      <a class=\"graphic graphic_picture graphicRef71834 \" href=\"UTD.htm?41/28/42432\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H18#H18\">",
"       \"Overview of dermatitis\", section on 'Irritant contact dermatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nummular dermatitis &mdash; Nummular dermatitis consists of intensely pruritic, eczematous plaques. Scale, crusting, or serous drainage may be evident. Patients can present with as few as one lesion or as many as 20 to 50 lesions. Lesions tend to be circular and usually measure between 2 and 10 cm in diameter. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H25#H25\">",
"       \"Overview of dermatitis\", section on 'Nummular dermatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Phytophotodermatitis &mdash; Phytophotodermatitis is a phototoxic reaction with erythema with or without blistering in response to ultraviolet exposure in patients exposed to photosensitizing plant compounds. Unlike poison ivy dermatitis, lesions will only be seen on sun-exposed skin. Lesions often resolve with significant hyperpigmentation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=see_link&amp;anchor=H23#H23\">",
"       \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Phytophotodermatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arthropod reactions &mdash; The pruritic burrows of scabies may be mistaken for poison ivy dermatitis but do not generally appear as vesicles (",
"      <a class=\"graphic graphic_picture graphicRef51161 \" href=\"UTD.htm?4/4/4160\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link\">",
"       \"Scabies\"",
"      </a>",
"      .) Bedbug bites can be linear and pruritic, and may occasionally present as vesicles or bullae. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39286?source=see_link\">",
"       \"Bedbugs\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Avoidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important and effective treatment for poison ivy dermatitis is identification and avoidance of toxic plants and related allergens. Sap-containing plant parts are allergenic and irritant year round, and cannot be safely handled during winter months. Allergenicity can also persist years after the plant dies.",
"   </p>",
"   <p>",
"    Protective clothing is useful, but patients should be reminded that clothing, pets, and fingernails can harbor the allergenic resin for many days. The oleoresin can seep through clothing and can penetrate rubber or latex gloves, but not heavy-duty vinyl gloves [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Burning poison ivy is not a safe way to dispose of the vegetation. Urushiol is stable at high temperatures and the plant particles dispersed in the smoke are allergenic and irritant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Washing",
"    </span>",
"    &nbsp;&mdash;&nbsp;After a known exposure, patients should remove any contaminated clothing and gently wash the skin with mild soap and water as soon as possible. One study found that after approximately 10 minutes on the skin, 50 percent of the urushiol can be removed; this number falls to 10 percent after 30 minutes and zero after one hour [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/2\">",
"     2",
"    </a>",
"    ]. Despite this, washing even two hours after exposure significantly reduces the likelihood and severity of dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/16\">",
"     16",
"    </a>",
"    ]. Fingernails should be washed carefully to remove resin that may remain under the nails.",
"   </p>",
"   <p>",
"    Vigorous scrubbing is not useful and can exacerbate impending dermatitis. Washing the skin after dermatitis has become clinically apparent is futile. A study that compared a chemical inactivator intended to prevent poison ivy (Tecnu&reg;), an oil removing compound (Goop&reg;), and a topical surfactant (Dial&reg; ultra dishwashing soap) found that all three preparations significantly reduced dermatitis when used two hours after experimental exposure to poison ivy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/16\">",
"     16",
"    </a>",
"    ]. Although the authors concluded that there was no significant difference in the effectiveness of the three preparations, the point estimate of effectiveness was higher with Tecnu&reg; than with the other two preparations, and the study was inadequately powered to detect differences that patients would likely consider clinically important. Tecnu&reg; is significantly more expensive than the other preparations, and it is reasonable to recommend to patients that they wash with an inexpensive mild detergent.",
"   </p>",
"   <p>",
"    Clothing, tools or other items that may have come in contact with the oleoresin also should be washed with warm, soapy water prior to reuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Barrier creams",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of barrier creams to prevent contact dermatitis is controversial. Barrier creams are topical preparations that are applied prior to exposure to a contact allergen in an attempt to prevent the development of dermatitis. Organoclay compounds appear to be more effective barriers than other preparations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The barrier cream that has the best evidence for efficacy for the prevention of poison ivy dermatitis is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/55/13170?source=see_link\">",
"     bentoquatam",
"    </a>",
"    (5 percent quaternium-18 bentonite lotion), an organoclay compound marketed as Ivy Block&reg;. The efficacy of bentoquatam is supported by a controlled trial in 211 subjects. Among the 144 subjects who showed a reaction to urushiol, only 32 percent developed dermatitis at the site treated with bentoquatam [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, reactions that occurred at bentoquatam-treated sites were less severe than those at untreated sites.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/55/13170?source=see_link\">",
"     Bentoquatam",
"    </a>",
"    must be reapplied every four hours and leaves a clay residue on the skin.",
"   </p>",
"   <p>",
"    Other preparations that may be effective include [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Linoleic acid dimers (marketed as StokoGard Outdoor Cream&reg;). These do not prevent urushiol penetration of the skin, and thus must be rinsed off and reapplied after four to eight hours.",
"     </li>",
"     <li>",
"      Occlusive barrier ointments (such as Hollister&trade; Moisture Barrier&reg; and Hydropel&reg;)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other topical barrier creams may emerge as research continues for preparations effective in preventing dermatitis from chemical warfare agents [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Desensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of Native Americans achieving hyposensitivity to poison ivy dermatitis by chewing the leaves, the lower prevalence of mango dermatitis in indigenous Hawaiians compared with immigrants, and decreased poison ivy sensitivity of cashew nut shell oil processing in factory workers have all prompted research into commercially available hyposensitization kits [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/22-24\">",
"     22-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These programs have generally not been effective [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/23\">",
"     23",
"    </a>",
"    ], require months of low-dose antigen ingestion accompanied by side effects like pruritus ani, urticaria, and dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/25\">",
"     25",
"    </a>",
"    ], and are neither practical nor recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pretreatment with oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    , a methylxanthine TNF-inhibitor, has been shown to diminish patch-test reactivity to nickel and other forms of allergic contact dermatitis, but not to urushiol [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few controlled trials of poison ivy dermatitis treatment have been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/29\">",
"     29",
"    </a>",
"    ]. The information presented here is based mainly on clinical experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Topical symptomatic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soothing measures such as oatmeal baths and cool, wet compresses are anecdotally helpful. Topical treatment with compounds containing menthol and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/14/27875?source=see_link\">",
"     phenol",
"    </a>",
"    (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/11/33969?source=see_link\">",
"     calamine lotion",
"    </a>",
"    ) may also provide symptomatic relief. Topical astringents such as aluminum acetate (Burow's solution) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/7/127?source=see_link\">",
"     aluminum sulfate calcium acetate",
"    </a>",
"    (Domeboro",
"    <sup>",
"     &reg;",
"    </sup>",
"    ) used under occlusion may be useful to dry weeping lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/3,24\">",
"     3,24",
"    </a>",
"    ]. A soap mixture of ethoxylate and sodium lauroyl sarcosinate surfactants (marketed as Zanfel&trade;) may also be of benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Topical antihistamines, anesthetics containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=see_link\">",
"     benzocaine",
"    </a>",
"    , and antibiotics containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/57/14229?source=see_link\">",
"     neomycin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"     bacitracin",
"    </a>",
"    should be avoided because of their own allergenic potential.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/41/29332?source=see_link\">",
"     Pimecrolimus",
"    </a>",
"    , a topical calcineurin inhibitor, is ineffective for the treatment of",
"    <em>",
"     Toxicodendron",
"    </em>",
"    -induced allergic contact dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is little to no evidence to support their use, sedating and non-sedating oral antihistamines are commonly used to try to reduce pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/32\">",
"     32",
"    </a>",
"    ]. However, the itching in poison ivy dermatitis is not caused by histamine release.&nbsp;Relief that patients derive from oral antihistamines is primarily due to the sedating effects of certain antihistamines [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/33\">",
"     33",
"    </a>",
"    ]. We do not use nonsedating antihistamines at all in the management of poison ivy dermatitis, but we find sedating antihistamines occasionally beneficial for those who have difficulty sleeping due to pruritus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link&amp;anchor=H8354417#H8354417\">",
"     \"Pruritus: Overview of management\", section on 'Antihistamines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Topical corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;High potency topical corticosteroids (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    ) are most helpful early in allergic contact dermatitis. Once vesicles are established they do little to alter the natural course of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/34\">",
"     34",
"    </a>",
"    ], but many clinicians believe they are helpful in relieving symptoms. Clinical experience suggests that low potency topical corticosteroids are of little use. High potency topical corticosteroids should generally not be used on thin skin such as the face, genitals, or intertriginous areas due to the potential for these agents to cause skin atrophy and other adverse effects. However, the only topical corticosteroids that can influence the course of poison ivy dermatitis are superpotent ones such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"     clobetasol",
"    </a>",
"    propionate 0.05% cream. Use of superpotent corticosteroids, even under occlusion, for up to a week on severely involved areas pose little threat for permanent atrophy. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Systemic corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe dermatitis, particularly involving the face or genital region, may require systemic corticosteroids [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. There are no well-designed studies examining the proper dose and course of systemic corticosteroids for poison ivy dermatitis, however extensive clinical experience suggests that rebound dermatitis occurs commonly if too short a course is used (such as the six-day course in a Medrol dose pack) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/37\">",
"     37",
"    </a>",
"    ]. As in other forms of allergic contact dermatitis, circulating T-lymphocytes directed toward urushiol are able to expand and activate cytokines for a significant period after exposure to antigen, leading to rebound dermatitis when corticosteroids are stopped.",
"   </p>",
"   <p>",
"    Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    started at a dose of approximately 1",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    (maximum initial dose 60",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    can be dramatically beneficial for the miserable patient. The dose can then be tapered over two or three weeks (for instance, 60",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    the first week, 40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    the second week, 20",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    the third week would be one possible taper for a 21-day course). There are no published studies comparing 14 and 21 day courses of prednisone in poison ivy. We typically treat adults with a 21-day total course however. In clinical practice, however, 14-day courses only rarely result in rebound dermatitis and may be appropriate if there are concerns about steroid toxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although oral administration of corticosteroids offers flexibility in daily dosing, intramuscular injection of corticosteroids is a treatment option for patients who cannot tolerate or comply with administration of oral corticosteroids [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/38\">",
"     38",
"    </a>",
"    ]. In our clinical experience, we have found treatment with a mixture of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide (1",
"    <span class=\"nowrap\">",
"     mg/kg),",
"    </span>",
"    a long-acting corticosteroid, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/5/44120?source=see_link\">",
"     betamethasone",
"    </a>",
"    (0.1",
"    <span class=\"nowrap\">",
"     mg/kg),",
"    </span>",
"    a short to intermediate-acting corticosteroid, beneficial. However, published data are lacking on the optimum regimen and dose of intramuscular corticosteroids for the treatment of poison ivy.",
"   </p>",
"   <p>",
"    Intralesional injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    acetonide (4 to 5",
"    <span class=\"nowrap\">",
"     mg/mL)",
"    </span>",
"    may be useful for treatment of severe disease confined to small areas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;If secondary bacterial infection is suspected, appropriate systemic antibiotics (typically directed at gram positive organisms) should be administered. Most patients with secondary impetigo will be infected with Staphylococcus aureus or group A Streptococcus. However, given increasing rates of community acquired methicillin-resistant S. aureus, performing a skin culture is reasonable if pus is present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=see_link\">",
"     \"Impetigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=see_link\">",
"     \"Prevention and control of methicillin-resistant Staphylococcus aureus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Jewelweed extract has been used for the treatment of poison ivy dermatitis but does not appear to be effective [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20168/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/53/1874?source=see_link\">",
"       \"Patient information: Dermatitis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/3/3122?source=see_link\">",
"       \"Patient information: Poison ivy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/38/32354?source=see_link\">",
"       \"Patient information: Contact dermatitis (including latex dermatitis) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/59/6068?source=see_link\">",
"       \"Patient information: Poison ivy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Epidemiology and identification",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plants of the Anacardiaceae family account for more allergic contact dermatitis than all other plant families combined. In the United States, the most important members of this family are those of the genus",
"      <em>",
"       Toxicodendron",
"      </em>",
"      , which include poison ivy, poison oak, and poison sumac (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      While the common phrase \"leaves of three, let them be\" is a helpful reminder to avoid poison ivy and related plants, members of the",
"      <em>",
"       Toxicodendron",
"      </em>",
"      genus have varied presentations based on the season, growth cycle, region, and climate (",
"      <a class=\"graphic graphic_figure graphicRef72155 \" href=\"UTD.htm?42/4/43074\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef81173 graphicRef54814 graphicRef81397 \" href=\"UTD.htm?38/0/38922\">",
"       picture 1A-C",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"local\" href=\"#H3\">",
"       'Identifying the plant'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Pathogenesis and clinical presentation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urushiol is the allergenic substance in",
"      <em>",
"       Toxicodendron",
"      </em>",
"      . Exposure to urushiol can occur through contact with parts of the plant (eg, roots, sap, leaves, or stems), or via contact with objects that have been contaminated by the plant oleoresin (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathogenesis'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Intense pruritus and erythema are the most common presenting signs of poison ivy dermatitis. Patients then develop papules, vesicles,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bullae, often arranged in characteristic linear or streak-like configurations where a portion of a plant has made contact with the skin (",
"      <a class=\"graphic graphic_picture graphicRef69330 \" href=\"UTD.htm?11/55/12145\">",
"       picture 2",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical presentation'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The diagnosis of poison ivy dermatitis is typically made based on a history of exposure and a characteristic pattern of a well demarcated contact dermatitis in areas of skin that could have come in contact with plant parts, particularly when linear streaks are present. Atypical presentations may occur when patients are exposed secondarily, such as when a pet gets urushiol on its fur and then brushes against the patient (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Prevention and treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poison ivy dermatitis is best prevented by avoiding exposure through the use of protective clothing such as heavy-duty vinyl gloves. Washing with a detergent soap (or with special preparations designed for poison ivy) as soon as possible after exposure can reduce the risk of dermatitis, but washing even two hours after exposure can be beneficial (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Washing'",
"      </a>",
"      above). Pretreatment of exposed skin with topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/55/13170?source=see_link\">",
"       bentoquatam",
"      </a>",
"      (available as IvyBlock&reg;) is of some benefit in people who are at high risk for exposure to poison ivy (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Prevention'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Treatment for dermatitis can include topical symptomatic therapies such as oatmeal baths and cool compresses (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Topical symptomatic therapy'",
"      </a>",
"      above). High potency topical corticosteroids (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"       table 1",
"      </a>",
"      ) do little to alter the natural course of poison ivy dermatitis once vesicles have developed, but they may reduce itching, particularly if used under occlusion (see",
"      <a class=\"local\" href=\"#H18\">",
"       'Topical corticosteroids'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Systemic corticosteroids, such as a course of oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      tapered over 14 or 21 days, can be dramatically effective in reducing symptoms and is the treatment of choice for extensive poison ivy dermatitis and for significant dermatitis affecting the face or genital region. We typical use a 21-day course to minimize the risk of rebound dermatitis, but a 14-day course may be appropriate when there are concerns about steroid toxicity. Short courses of systemic corticosteroids (eg, a six-day Medrol dose pack) can result in rebound dermatitis and should be avoided (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Systemic corticosteroids'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/1\">",
"      Crawford GH, McGovern TW. Poison ivy. N Engl J Med 2002; 347:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/2\">",
"      McGovern TW, Barkley TM. Botanical dermatology. Int J Dermatol 1998; 37:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/3\">",
"      Baer RL. Poison ivy dermatitis. Cutis 1990; 46:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/4\">",
"      Epstein WL. Occupational poison ivy and oak dermatitis. Dermatol Clin 1994; 12:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/5\">",
"      Oltman J, Hensler R. Poison oak/ivy and forestry workers. Clin Dermatol 1986; 4:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/6\">",
"      Fisher AA. Poison ivy/oak/sumac. Part II: Specific features. Cutis 1996; 58:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/7\">",
"      Parkinson G. Images in clinical medicine. The many faces of poison ivy. N Engl J Med 2002; 347:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/8\">",
"      Hershko K, Weinberg I, Ingber A. Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis. Contact Dermatitis 2005; 52:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/9\">",
"      Rademaker M, Duffill MB. Allergic contact dermatitis to Toxicodendron succedaneum (rhus tree): an autumn epidemic. N Z Med J 1995; 108:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/10\">",
"      Cohen LM, Cohen JL. Erythema multiforme associated with contact dermatitis to poison ivy: three cases and a review of the literature. Cutis 1998; 62:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/11\">",
"      Shankar DS. Contact urticaria induced by Semecarpus anacardium. Contact Dermatitis 1992; 26:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/12\">",
"      Kurlan JG, Lucky AW. Black spot poison ivy: A report of 5 cases and a review of the literature. J Am Acad Dermatol 2001; 45:246.",
"     </a>",
"    </li>",
"    <li>",
"     McGovern TW. Dermatoses due to plants. In: Dermatology, Bolognia JL, Jorizzo JL, Rapini RP, et al (Eds), Mosby, New York 2003. p.274.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/14\">",
"      Brook I, Frazier EH, Yeager JK. Microbiology of infected poison ivy dermatitis. Br J Dermatol 2000; 142:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/15\">",
"      Devich KB, Lee JC, Epstein WL, et al. Renal lesions accompanying poison oak dermatitis. Clin Nephrol 1975; 3:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/16\">",
"      Stibich AS, Yagan M, Sharma V, et al. Cost-effective post-exposure prevention of poison ivy dermatitis. Int J Dermatol 2000; 39:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/17\">",
"      Epstein WL. Topical prevention of poison ivy/oak dermatitis. Arch Dermatol 1989; 125:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/18\">",
"      Marks JG Jr, Fowler JF Jr, Sheretz EF, Rietschel RL. Prevention of poison ivy and poison oak allergic contact dermatitis by quaternium-18 bentonite. J Am Acad Dermatol 1995; 33:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/19\">",
"      Grevelink SA, Murrell DF, Olsen EA. Effectiveness of various barrier preparations in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis. J Am Acad Dermatol 1992; 27:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/20\">",
"      Liu DK, Wannemacher RW, Snider TH, Hayes TL. Efficacy of the topical skin protectant in advanced development. J Appl Toxicol 1999; 19 Suppl 1:S40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/21\">",
"      Vidmar DA, Iwane MK. Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol (Rhus) antigen. Am J Contact Dermat 1999; 10:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/22\">",
"      Fisher AA. Poison ivy/oak dermatitis. Part I: Prevention--soap and water, topical barriers, hyposensitization. Cutis 1996; 57:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/23\">",
"      Marks JG Jr, Trautlein JJ, Epstein WL, et al. Oral hyposensitization to poison ivy and poison oak. Arch Dermatol 1987; 123:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/24\">",
"      Williford PM, Sheretz EF. Poison ivy dermatitis. Nuances in treatment. Arch Fam Med 1994; 3:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/25\">",
"      Epstein WL, Byers VS, Frankart W. Induction of antigen specific hyposensitization to poison oak in sensitized adults. Arch Dermatol 1982; 118:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/26\">",
"      Rietschel RL. A pilot study of pentoxifylline for the prevention of poison ivy/oak reactions. Contact Dermatitis 1995; 32:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/27\">",
"      Schwarz T, Schwarz A, Krone C, Luger TA. Pentoxifylline suppresses allergic patch test reactions in humans. Arch Dermatol 1993; 129:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/28\">",
"      Schwarz A, Krone C, Trautinger F, et al. Pentoxifylline suppresses irritant and contact hypersensitivity reactions. J Invest Dermatol 1993; 101:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/29\">",
"      KLIGMAN AM. Poison ivy (Rhus) dermatitis; an experimental study. AMA Arch Derm 1958; 77:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/30\">",
"      Davila A, Lucas J, Jacoby J, et al. A new topical agent, Zanfel, ameliorates urushiol-induced Toxicodendron allergic contact dermatitis. Ann Emerg Med 2003; 42:S98 (Abstract).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/31\">",
"      Amrol D, Keitel D, Hagaman D, Murray J. Topical pimecrolimus in the treatment of human allergic contact dermatitis. Ann Allergy Asthma Immunol 2003; 91:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/32\">",
"      Munday J, Bloomfield R, Goldman M, et al. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology 2002; 205:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/33\">",
"      Yosipovitch G, Fleischer A. Itch associated with skin disease: advances in pathophysiology and emerging therapies. Am J Clin Dermatol 2003; 4:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/34\">",
"      Vernon HJ, Olsen EA. A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis. J Am Acad Dermatol 1990; 23:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/35\">",
"      Goodall J. Oral corticosteroids for poison ivy dermatitis. CMAJ 2002; 166:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/36\">",
"      Moe JF. How much steroid for poison ivy? Postgrad Med 1999; 106:21, 24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/37\">",
"      Brodell RT, Williams L. Taking the itch out of poison ivy. Are you prescribing the right medication? Postgrad Med 1999; 106:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/38\">",
"      Dickey RF. Parenteral short-term corticosteroid therapy in moderate to severe dermatoses. A comparative multiclinic study. Cutis 1976; 17:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20168/abstract/39\">",
"      Long D, Ballentine NH, Marks JG Jr. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed. Am J Contact Dermat 1997; 8:150.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1728 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-1.234.2.38-C3DAD56939-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20168=[""].join("\n");
var outline_f19_44_20168=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      IDENTIFYING THE PLANT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GEOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CROSS-REACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Avoidance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Washing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Barrier creams",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Desensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Topical symptomatic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Antihistamines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Systemic corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Epidemiology and identification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Pathogenesis and clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Prevention and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/1728\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/1728|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/4/43074\" title=\"figure 1\">",
"      Identification poison ivy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/59/30641\" title=\"figure 2A\">",
"      Toxicodendron radicans range US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/43/29362\" title=\"figure 2B\">",
"      Toxicodendron range US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/52/20303\" title=\"figure 2C\">",
"      Toxicodendron radicans world",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/1728|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/41/7832\" title=\"picture 1A\">",
"      Poison oak",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/1/38931\" title=\"picture 1B\">",
"      Poison ivy fruit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/1/22549\" title=\"picture 1C\">",
"      Poison ivy 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/55/12145\" title=\"picture 2\">",
"      Anacardiaceae dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/28/42432\" title=\"picture 3\">",
"      Irritant contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/4/4160\" title=\"picture 4\">",
"      Interdigital scabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/1728|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 1\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39286?source=related_link\">",
"      Bedbugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=related_link\">",
"      Impetigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/38/32354?source=related_link\">",
"      Patient information: Contact dermatitis (including latex dermatitis) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/53/1874?source=related_link\">",
"      Patient information: Dermatitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/59/6068?source=related_link\">",
"      Patient information: Poison ivy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/3/3122?source=related_link\">",
"      Patient information: Poison ivy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=related_link\">",
"      Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=related_link\">",
"      Prevention and control of methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=related_link\">",
"      Pruritus: Overview of management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_44_20169="Etiology, prenatal diagnosis, obstetrical management, and recurrence of orofacial clefts";
var content_f19_44_20169=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology, prenatal diagnosis, obstetrical management, and recurrence of orofacial clefts",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/44/20169/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20169/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/44/20169/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20169/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20169/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/44/20169/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/44/20169/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/44/20169/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common craniofacial malformation identified in the newborn is the orofacial cleft, which consists of cleft lip with or without cleft palate",
"    <span class=\"nowrap\">",
"     (CL/P)",
"    </span>",
"    or isolated cleft palate (CP) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/1\">",
"     1",
"    </a>",
"    ]. They can occur as part of a syndrome involving multiple other organs or as an isolated malformation. Most studies suggest that about 70 percent of cases of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    and 50 percent of CP are nonsyndromic [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/2\">",
"     2",
"    </a>",
"    ]. Although both congenital anomalies result in malformation of the midface,",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    and CP differ with respect to embryology, etiology, candidate genes, associated abnormalities, and recurrence risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE AND EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported prevalence of orofacial clefts varies by country, method of ascertainment, and classification (eg,",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    versus CP, isolated",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    or syndromic). A well-designed study of over 600 Danish infants with orofacial clefts and no other anomalies observed that 39 percent had combined CL and CP, 34 percent had isolated CL, and 27 percent had an isolated CP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/3\">",
"     3",
"    </a>",
"    ]. The incidence of orofacial clefts was",
"    <span class=\"nowrap\">",
"     18.9/10,000",
"    </span>",
"    newborns and",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    accounted for 73 percent of cases.",
"   </p>",
"   <p>",
"    In the United States, the estimated prevalence of orofacial clefts is",
"    <span class=\"nowrap\">",
"     16.9/10,000",
"    </span>",
"    live births:",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    occurred in",
"    <span class=\"nowrap\">",
"     10.5/10,000",
"    </span>",
"    live births and isolated CP occurred in",
"    <span class=\"nowrap\">",
"     6.4/10,000",
"    </span>",
"    live births [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/4\">",
"     4",
"    </a>",
"    ]. The prevalence of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    varies by",
"    <span class=\"nowrap\">",
"     race/ethnicity:",
"    </span>",
"    lowest in American blacks, highest in Native Americans and Asians, and at an intermediate level in Caucasians [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/5\">",
"     5",
"    </a>",
"    ]. The First Nations (Amerindian) population of British Columbia, Canada, has the highest reported birth prevalence in the world of",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    nearly",
"    <span class=\"nowrap\">",
"     30/10,000",
"    </span>",
"    births [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/6\">",
"     6",
"    </a>",
"    ]. In contrast, the prevalence of isolated CP appears to be constant across races and ethnicities. CP likely has a different etiology than CL, and environmental and genetic factors (discussed below) likely affect risk of development of CL more than development of CP.",
"   </p>",
"   <p>",
"    The sex ratio among affected infants varies by type of defect:",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    occurs more often in males while CP is more common in females [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EMBRYOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Craniofacial development represents a complex interaction of cell patterning, migration, proliferation, and differentiation. Much of facial tissue originates by cell migration from the embryonic neural crest. Underlying this development are regulatory, structural, and positional genes that govern the required cell-cell interactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cleft lip",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete closure of the lip is usually accomplished by 35 days postconception as the lateral nasal, median nasal, and maxillary mesodermal processes merge. Failure of closure of any one of the three normal sites of fusion can produce unilateral, bilateral, or (rarely) median lip clefting (",
"    <a class=\"graphic graphic_figure graphicRef78946 \" href=\"UTD.htm?12/47/13047\">",
"     figure 1",
"    </a>",
"    ). Lack of fusion of the facial elements can be mild, involving only the upper lip, or can extend into the palate or the midface, thereby affecting the nose, forehead, eyes, and brain.",
"   </p>",
"   <p>",
"    CL can be unilateral or bilateral; unilateral CL on the left side is the most common presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cleft palate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated CP occurs when there is primary lack of fusion of the palatal shelves. Abnormalities in programmed cell death may contribute to lack of palatal fusion, although this mechanism remains debated. Isolated disruption of palate shelves can occur after closure of the lip because palatal closure is not completed until 56 to 58 days postconception.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The detection and study of fetal midfacial anomalies have led to important information regarding the candidate genes and environmental factors influencing fetal development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The process of midface development involves genes which control cell patterning, cell proliferation, extracellular communication, and differentiation. Gene defects in each of these developmental processes crucial to midface development are associated with cleft malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/7\">",
"     7",
"    </a>",
"    ]. Clefting usually represents a genetically complex event; single Mendelian disorders associated with clefting are less common. While at least one major gene may be operative in one-half of patients, in most cases, 2 to 20 genes are thought to interact to result in facial clefting [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are several major categories of genetic defects:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Proliferation defects, eg, sonic hedgehog gene",
"     </li>",
"     <li>",
"      Extracellular matrix defects, eg, TGF-alpha variant",
"     </li>",
"     <li>",
"      Differentiation defects, eg, TGF-beta gene",
"     </li>",
"     <li>",
"      Interferon regulatory factors, eg, IRF-6",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most of the above genes have been implicated in animal models as responsible for orofacial clefting; similar findings in humans are more limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Sonic hedgehog gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interactions between the ectoderm and the mesoderm are important in facial development. The secreted protein sonic Hedgehog (shh) mediates ectodermal functions, and mutations of this gene classically produce holoprosencephaly. Several lines of evidence support shh as an ectodermal signal that regulates the outgrowth and fusion of the facial domains [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/7,9\">",
"     7,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     TGF-alpha variant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transforming growth factor (TGF)-alpha is a receptor ligand made in the epithelia. In humans,",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    has been associated with a rare variant of TGF-alpha called Tagl. This variant has been found mostly among individuals with family histories of cleft defects [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/10\">",
"     10",
"    </a>",
"    ]. The relationship of Tagl and",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    remains speculative with studies both supporting and refuting a significant association [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. This gene variant appears to have an additive teratogenic effect with agents such as cigarette smoking and alcohol [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     TGF-beta-3 gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;TGF-beta-3 is expressed just prior to palatal fusion. In newborns, the lack of this factor results in isolated CP. Its role likely relates to its ability to cause degradation of the midline epithelial seam, thus allowing complete fusion of the palatal shelves. In humans, a rare allele of this gene has been associated with",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    particularly among familial cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     IRF 6",
"    </span>",
"    &nbsp;&mdash;&nbsp;As one of a family of transcription factors, the specific function of IRF 6 (interferon regulatory factor 6) is unknown. Most IRFs code for DNA binding motifs and as such would be expected to have a wide range of effects. Mutation in IRF 6 has been identified in autosomal dominant van der Woude syndrome of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    and lip pits. Several investigators speculate that other alterations of IRF 6 are responsible for a portion of nonsyndromic",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Environmental agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiological extension of the knowledge gained from animal teratogen studies to humans has identified several agents that are associated with an increased frequency of midfacial malformation after in-utero exposure. In addition, teratogen exposure may be a contributing factor in the genetically at-risk fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several medications which are prescribed for reproductive age females are recognized as teratogens with specificity for midfacial development. Antiseizure agents, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , sodium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/16\">",
"     16",
"    </a>",
"    ], and the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    antagonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    are examples of commonly administered drugs associated with orofacial clefts. While the relative risk of orofacial abnormality is increased, the absolute risk of clefting after drug exposure remains small.",
"   </p>",
"   <p>",
"    An association of orofacial clefts with corticosteroid use is less clear. Review of human teratology studies on glucocorticoids shows no evidence of an overall increase in malformations with use of these drugs, but a possible association with clefts cannot be excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/17-19\">",
"     17-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     Diazepam",
"    </a>",
"    increases the incidence of CP in mice, but the best evidence from human studies does not show an increase in orofacial clefts [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=see_link\">",
"     \"Risks associated with epilepsy and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=see_link\">",
"     \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Cigarette smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal cigarette smoking has been noted with increased frequency among the mothers of children with facial clefting, both",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    and CP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/21\">",
"     21",
"    </a>",
"    ]. Teratogenesis has been attributed to hypoxia, as well as a component of tobacco (cadmium). Gene-environment interactions are also under investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/2\">",
"     2",
"    </a>",
"    ]. The joint risk of cigarette smoking and a rare fetal allele at the TGF-alpha gene locus was greater than either alone in",
"    <span class=\"nowrap\">",
"     case/control",
"    </span>",
"    studies of risk factors for orofacial clefts [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27482?source=see_link\">",
"     \"Smoking and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal alcohol consumption also appears to be associated with an increased risk of facial clefting [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/23\">",
"     23",
"    </a>",
"    ]. As an example, a large",
"    <span class=\"nowrap\">",
"     case/control",
"    </span>",
"    study of 731 infants and fetuses with orofacial clefts found that women with weekly binge drinking (greater than five drinks consumed in one session) were more likely to have a child with isolated",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    with other malformations, and syndromic",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/24\">",
"     24",
"    </a>",
"    ]. Animal studies suggest the underlying impact of maternal ethanol may be either alterations in cell membrane fluidity or reduced activity of specific enzymes such as superoxide dismutase [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6346?source=see_link\">",
"     \"Overview of illicit drug use in pregnant women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41575?source=see_link\">",
"     \"Alcohol intake and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Folate deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folate is an essential component in the process of DNA methylation, and its deficiency contributes to a range of birth defects. While the most notable associations are with neural tube defects and cardiac malformations, some evidence emerged a few years ago for a possible association with the development of",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    although this remains controversial. Indeed, despite extensive study, the evidence is not converging and there is no strong evidence of an association between oral clefts and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    intake alone. Multivitamin use in early pregnancy, however, may protect against oral clefts, especially",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    although this association may be confounded by other lifestyle factors associated with multivitamin use [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The contribution of folate deficiency to development of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    can be viewed from several perspectives. First, mice models using gene knockouts for folate receptors result in fetal malformations including",
"    <span class=\"nowrap\">",
"     CL/P.",
"    </span>",
"    Delivery of folate by alternative pathways in these mice models prevents an increase in",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    as well as other malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/27\">",
"     27",
"    </a>",
"    ]. In other mouse models, the absence of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    binding protein alone resulted in malformations including",
"    <span class=\"nowrap\">",
"     CL/P.",
"    </span>",
"    In these deficient mice, genes of neurocrest differentiation were also altered, reinforcing the concept that folate plays a role in the control of a wide range of genes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In human populations, folate deficiency and the risk of a child with",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    has been studied by various approaches. Meta-analyses of controlled studies found that folate supplementation was associated with a 12 to 50 percent decrease in",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    but no significant reduction in isolated CP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/26,29\">",
"     26,29",
"    </a>",
"    ]. These studies employed variable doses of folate supplementation, but were not adjusted for potential confounding variables. The lack of significant reduction among fetuses with CP further supports the recognized etiologic and epidemiologic differences between",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    and isolated CP.",
"   </p>",
"   <p>",
"    A subsequent case control study similarly noted a 33 percent decrease in",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/30\">",
"     30",
"    </a>",
"    ]. This study was able to delineate with more specificity the source of maternal folate. The greatest reduction in",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    was noted among the women who had folate rich diets (fruit, vegetables) and who also took",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    supplementation and multivitamins (OR 0.36, 95% CI 0.17-0.77). Again the rate of CP alone was not impacted by any type of folate supplementations, supporting a differing etiology for CP defects.",
"   </p>",
"   <p>",
"    Additionally, several genetic epidemiologic studies have focused on gene polymorphisms of the enzymes of the folate pathway. These studies also support an association of folate deficiency and",
"    <span class=\"nowrap\">",
"     CL/P.",
"    </span>",
"    In particular, among fetuses who are homozygous for a polymorphism of acetyl-N-transferase (NAT-1), and in whom maternal multivitamins were not taken in early pregnancy, the risk for",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    was two-fold higher [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Polymorphisms of methyl tetrahydrofolate reductase (MTHFR), an important enzyme in the pathway of folate metabolism, have also been implicated. When the MTHFR polymorphism status was investigated in",
"    <span class=\"nowrap\">",
"     mother/father/child",
"    </span>",
"    triads, the presence of a common MTHR polymorphism (677TT) in conjunction with a low folate diet and lack of early pregnancy vitamin use identified the highest risk of a child with",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    (OR = 10.0, 95% CI 1.3-79.1). Similar findings resulted when the MTHFR 1298CC genotype was assessed (OR = 6.5, 95% CI 1.4-30.2) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/32\">",
"     32",
"    </a>",
"    ]. As these gene polymorphisms are not rare, the importance of these gene-environment interactions will have wide implications.",
"   </p>",
"   <p>",
"    Lastly, the association of folate deficiency with",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    is apparent in studies of specific medications which increase the risk of having a fetus with",
"    <span class=\"nowrap\">",
"     CL/P.",
"    </span>",
"    Several of the antiepileptic medications are folate antagonists suggesting a causal link between these agents and the higher risk of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    among exposed fetuses. In animal studies, induction of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    through exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/45/24279?source=see_link\">",
"     procarbazine",
"    </a>",
"    could be partially ameliorated through concurrent folate supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/33\">",
"     33",
"    </a>",
"    ]. Extension of this concept to human studies, however, has not established a lowered risk of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    among mothers who received multivitamins early in pregnancy and were also taking antiepileptic drugs, many of which are folate antagonists [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal obesity has been associated with a small, but statistically significant, increase in several anomalies, including orofacial clefts [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29882?source=see_link&amp;anchor=H30#H30\">",
"     \"The impact of obesity on fertility and pregnancy\", section on 'Congenital anomalies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Orofacial clefts are a component of many syndromes. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Presence of a syndrome'",
"    </a>",
"    <span class=\"nowrap\">",
"     below.)",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PRENATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;CL/P",
"    cannot be diagnosed reliably until the soft tissues of the fetal face can be clearly visualized sonographically, which is at 13 to 14 weeks by transabdominal ultrasound, but somewhat earlier by transvaginal ultrasound. Fetal ultrasound images in the coronal view and axial planes are optimal for visualization of the fetal lip and palate, respectively (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57237 \" href=\"UTD.htm?14/6/14433\">",
"     image 1",
"    </a>",
"    ). Orientation and development of other facial structures can provide useful information for distinguishing unilateral, bilateral, and midline malformations. As an example, midline forebrain abnormalities (eg, holoprosencephaly) suggest malformation of midline facial structures may also be present. The majority of infants with CL also have palatal involvement: 85 percent of bilateral CL and 70 percent of unilateral CL are associated with CP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/3\">",
"     3",
"    </a>",
"    ]. CP with an intact lip comprises 27 percent of isolated",
"    <span class=\"nowrap\">",
"     CL/P.",
"    </span>",
"   </p>",
"   <p>",
"    A",
"    systematic review reported a wide range of sensitivities for prenatal diagnosis of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    in low risk populations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/36\">",
"     36",
"    </a>",
"    ]. Better data were provided by the National Birth Defects Prevention Study, an ongoing population based case-control study in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/37\">",
"     37",
"    </a>",
"    ]. Live births, stillbirths, and abortuses are included if medical record review by a clinical geneticist ascertains eligibility criteria are met. Infants with chromosomal abnormalities and single gene disorders, as well as those with orofacial clefts secondary to another defect (eg, holoprosencephaly, amniotic band sequence), are excluded. For the years 1998 to 2004, prenatal diagnosis was made in 33.3 percent of the 978 cases of",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    20.3 percent of the 522 cases of CL only, and 0.3 percent of the 798 cases of CP only [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/37\">",
"     37",
"    </a>",
"    ]. The sensitivity of fetal ultrasound for detecting facial clefting was slightly higher when the orofacial cleft was associated with other unrelated structural anomalies (33.5 versus 28.2 percent with no other anomalies).",
"   </p>",
"   <p>",
"    Higher sensitivities have been observed in research studies and studies that included orofacial clefts related to other defects (eg, syndrome associated with a chromosomal abnormality, holoprosencephaly). A European registry reported the following frequencies of correct prenatal diagnosis: isolated",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    18 percent;",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    with multiple other malformations, 34 percent;",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    with a chromosomal abnormality, 52 percent; and",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    as part of a syndrome, 58 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three-dimensional ultrasound (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81141 graphicRef77964 \" href=\"UTD.htm?37/12/38082\">",
"     image 2A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/39-42\">",
"     39-42",
"    </a>",
"    ] and magnetic resonance imaging (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69236 \" href=\"UTD.htm?37/26/38318\">",
"     image 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/43,44\">",
"     43,44",
"    </a>",
"    ], when available, can provide a clear image of the malformation and may enhance detection of isolated cleft palate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Associated abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetuses found to have orofacial clefts should undergo careful assessment for additional structural abnormalities, as these defects are noted in as many as 50 percent of newborns with isolated CP, 20 percent of those with CL and CP, and 8 percent for those with isolated CL [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/45\">",
"     45",
"    </a>",
"    ]. The variation in rate of associated anomalies emphasizes the underlying differences in the development of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    versus CP. The location of the cleft also appears to affect the incidence of anomalies: in one study, the incidence of anomalies was 9.8 percent for unilateral",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    25 percent for bilateral",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    and 100 percent for midline",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/46\">",
"     46",
"    </a>",
"    ]. These anomalies typically involve the central nervous",
"    <span class=\"nowrap\">",
"     system/skeletal",
"    </span>",
"    system (33 percent) and cardiovascular system (24 percent), all sites of tissues with neural ectodermal origin.",
"   </p>",
"   <p>",
"    Among fetuses with a presumed isolated",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    visualized by ultrasound, even careful surveillance for additional anomalies may not be revealing. As an example, in one series of fetuses presumed to have \"isolated\"",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    after detailed ultrasound, nearly a quarter (21.6 percent) were found to have additional anomalies at birth [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chromosomal abnormalities are rare in fetuses with isolated clefts [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/46\">",
"     46",
"    </a>",
"    ], but are found in 40 to 60 percent of those with both orofacial clefts and other anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/48\">",
"     48",
"    </a>",
"    ]. The prevalence of associated anomalies is higher in fetuses with orofacial clefts than in liveborn infants with orofacial clefts; this likely reflects the high rate of pregnancy termination and stillbirth among fetuses with multiple anomalies and abnormal karyotype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OBSTETRICAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniocentesis for karyotype should be offered to women with ultrasound findings of fetal orofacial clefts and associated anomalies because of the high rate of chromosomal defects. Orofacial clefts in the absence of associated congenital abnormalities are unlikely to be associated with a chromosomal abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/46\">",
"     46",
"    </a>",
"    ]; however, the difficulty in prenatal sonographic diagnosis of some of the associated malformations supports chromosomal evaluation in all fetuses with prenatally diagnosed facial clefts [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The identification of a fetus with a craniofacial cleft will not alter antepartum or intrapartum care of the mother. Repair of orofacial clefts in surgically created animal models has been successfully performed and resulted in scar-free fetal healing and normal development of the face and skull. Whether this will also be possible in humans in whom the clefts have not been surgically created is unknown. \"In utero\" correction of a human fetal cleft had been attempted only once; the child delivered prematurely and died at two months of life [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antenatal management of the woman with an ultrasound diagnosis of a fetal craniofacial cleft should include referral to a comprehensive management team. The neonatology service that will attend the delivery should be notified in advance, and can counsel the parents about newborn management issues and planning surgical repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     POSTNATAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Care of the newborn will entail attention, not only to surgical repair, but also to more immediate needs, such as feeding and airway problems. Primary lip repairs can often be undertaken at three months of age with palatal repairs around six months. Additional surgeries, as well as speech and orthodontic therapies, are often needed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/51\">",
"     51",
"    </a>",
"    ]. The Cleft Lip and Palate Association (",
"    <a class=\"external\" href=\"file://www.clapa.com/\">",
"     www.clapa.com/",
"    </a>",
"    ) provides important support and information for parents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     RECURRENCE RISKS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    or CP in a parent, a prior child born to the couple, or in the family history requires further investigation if appropriate risk assessment is to be provided. Such assessment entails three important considerations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delineation of",
"      <span class=\"nowrap\">",
"       CL/P",
"      </span>",
"      from isolated CP",
"     </li>",
"     <li>",
"      Determination of a possible microform in the family",
"     </li>",
"     <li>",
"      Presence of a possible syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Delineation of cleft lip/palate from cleft palate",
"    </span>",
"    &nbsp;&mdash;&nbsp;While",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    and CP both represent craniofacial clefting, the recurrence of each differs, especially in the setting of a previously affected child. In general, the risk of recurrent isolated CP is higher than the risk of recurrent",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/52\">",
"     52",
"    </a>",
"    ]. The severity of recurrent defects cannot be predicted by the severity of the defect in the index case.",
"   </p>",
"   <p>",
"    The frequency of oral clefts in relatives based on the proband's phenotype is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef50466 \" href=\"UTD.htm?37/2/37931\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/53\">",
"     53",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Presence of a microform in the family",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful family history, as well as physical examination of the oral cavities of both parents, is essential prior to assigning a recurrence risk. Familial forms of both",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    and CP exist with both autosomal dominant and sex-linked recessive inheritance reported. Most notable of these is the autosomal dominant lip pit syndrome (Van der Woude syndrome). Expression can range from lip pits to",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    or CP.",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    occurs due to a dominantly inherited Van der Woude syndrome in 1 to 2 percent of individuals with what appears to be isolated CL. Other microforms can include submucosal CP or bifid uvula; both suggest a higher recurrence rate than that given for the multifactorial inheritance of isolated",
"    <span class=\"nowrap\">",
"     CL/P",
"    </span>",
"    or CP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Presence of a syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough examination of the newborn or stillborn infant is always warranted. Although orofacial clefting is noted in over 300 syndromes, four deserve additional comment due to their frequency, variable presentations, and modes of inheritance (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=see_link\">",
"     \"Syndromes with craniofacial abnormalities\"",
"    </a>",
"    ):",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Deletion of chromosome 22q11 (CP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microscopic loss of chromosomal material from chromosome 22q11 within the DiGeorge syndrome region is associated with a spectrum of findings in addition to CP: conotruncal cardiac defects, thymic hypoplasia, and velopharyngeal webs. While the majority of cases represent a new microdeletion, in up to 15 percent, a similar deletion is identified in a parent with variable, and often subtle, manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/54\">",
"     54",
"    </a>",
"    ]. In families with scattered individuals with conotruncal malformations",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cleft palate, further evaluation for microdeletion of 22q- is appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=see_link\">",
"     \"DiGeorge syndrome: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Oral-facial-digital syndrome, type I (CL/P)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is one of the few X-linked dominant syndromes. Lethality in males is suggested by a skewed female to male ratio in affected individuals and by an increase in miscarriage rate in families with affected females. Manifestations in affected females are variable and subtle, including hyperplastic frenula, cleft tongue,",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    and digital anomalies. Mutations within a specific gene on the X chromosome (CXORF5), which encodes a protein that is a core component of the centrosome [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/55\">",
"     55",
"    </a>",
"    ], are variable without specific patterns unique in either the sporadic or familial cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Treacher-Collins syndrome (CP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is an autosomal dominant disorder with characteristic facial features including downward slanting palpebral fissures, micrognathia, dysplastic ears, and deafness. Mental development is normal. Affected individuals may have varied expression. The gene for this syndrome is known (TCOF1) and mutations appear to increase cell death in the prefusion neural folds [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/57\">",
"     57",
"    </a>",
"    ]. A family history of additional members with deafness, ear abnormalities, or CP should prompt further consideration of this syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Amniotic band sequence (CL/P)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typically, amniotic band sequence (ABS) is applied to a range of birth defects often exemplified by extremity amputations and constriction rings. Abdominal wall defects such as limb-body wall complex can also be seen. Facial clefting may be significant and include CL or",
"    <span class=\"nowrap\">",
"     CL/P,",
"    </span>",
"    but not isolated CP. The clefting is often atypical in position, reflecting a disruption of orofacial development. Debate continues as to the underlying etiology of this deformation spectrum with both intrinsic and extrinsic models. While the presence of fibrous bands are considered suggestive of extrinsic deformation and disruption, other investigators have favored an intrinsic model, and possibly a single gene etiology for some cases. There may be a subset of ABS patients in whom additional minor malformations, such as polydactyly, in the same setting as traditional ABS deformations suggest an underlying intrinsic model. A human homolog of the Ds (disorganization gene) in mice has been proposed for such individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?19/44/20169/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36902?source=see_link\">",
"     \"Amniotic band sequence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Stickler syndrome (CP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary arthro-ophthalmopathy or Stickler syndrome is an autosomal dominant disorder characterized by flat facies, myopia, and spondyloepiphyseal dysplasia. Clefts of the hard",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    soft palate and uvula may occur. This syndrome should be considered in infants with CP, especially when there is a family history of CP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/36/43585?source=see_link\">",
"       \"Patient information: Cleft lip and cleft palate (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common craniofacial malformation identified in the newborn is the orofacial cleft, which consists of cleft lip with or without cleft palate",
"      <span class=\"nowrap\">",
"       (CL/P)",
"      </span>",
"      or isolated cleft palate (CP). About 70 percent of cases of",
"      <span class=\"nowrap\">",
"       CL/P",
"      </span>",
"      and 50 percent of CP are nonsyndromic. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       CL/P",
"      </span>",
"      is more common than CP alone. The prevalence of",
"      <span class=\"nowrap\">",
"       CL/P",
"      </span>",
"      varies with",
"      <span class=\"nowrap\">",
"       race/ethnicity",
"      </span>",
"      and gender. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Prevalence and epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both genetic and environmental factors influence the development of orofacial clefts. Women planning pregnancy can reduce their risk of having a child with an orofacial cleft by working with their doctor to discontinue drugs associated with this malformation. Advice on smoking cessation and not consuming alcoholic beverages should be given. Avoiding folate deficiency by diet or supplements may also be useful. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Orofacial clefts are diagnosed beginning after 12 weeks of gestation when the soft tissues of the fetal face can be clearly visualized sonographically and developmental separation of the lip and palate should no longer be present. The sensitivity of fetal ultrasound for facial clefting is highest when",
"      <span class=\"nowrap\">",
"       CL/P",
"      </span>",
"      is associated with other structural anomalies. In other situations, such as isolated",
"      <span class=\"nowrap\">",
"       CL/P",
"      </span>",
"      in a low risk population, the sensitivity may only reach 50 percent. Isolated CP is the most difficult orofacial malformation to diagnose prenatally with a low detection rate of &lt;7 percent. Three-dimensional ultrasound and magnetic resonance imaging, where available, can provide a clear image of the malformation and may enhance detection, especially of isolated CP. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fetuses found to have orofacial clefts should undergo careful assessment for additional structural abnormalities, as these defects are noted in 50 percent of newborns with isolated CP, 20 percent of those with CL and CP, and 8 percent for those with isolated CL. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Amniocentesis for karyotype should be offered to women with ultrasound findings of fetal orofacial clefts and associated anomalies because of the high rate of chromosomal defects. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Obstetrical management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The recurrence risk of cleft",
"      <span class=\"nowrap\">",
"       lip/palate",
"      </span>",
"      depends on the setting. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Recurrence risks'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/1\">",
"      Gorlin RJ, Cervenka J, Pruzansky S. Facial clefting and its syndromes. Birth Defects Orig Artic Ser 1971; 7:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/2\">",
"      Shi M, Wehby GL, Murray JC. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Res C Embryo Today 2008; 84:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/3\">",
"      Jensen BL, Kreiborg S, Dahl E, Fogh-Andersen P. Cleft lip and palate in Denmark, 1976-1981: epidemiology, variability, and early somatic development. Cleft Palate J 1988; 25:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/4\">",
"      Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 2006; 76:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/5\">",
"      Tolarov&aacute; MM, Cervenka J. Classification and birth prevalence of orofacial clefts. Am J Med Genet 1998; 75:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/6\">",
"      Lowry RB, Johnson CY, Gagnon F, Little J. Segregation analysis of cleft lip with or without cleft palate in the First Nations (Amerindian) people of British Columbia and review of isolated cleft palate etiologies. Birth Defects Res A Clin Mol Teratol 2009; 85:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/7\">",
"      Young DL, Schneider RA, Hu D, Helms JA. Genetic and teratogenic approaches to craniofacial development. Crit Rev Oral Biol Med 2000; 11:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/8\">",
"      Christensen K, Fogh-Andersen P. Cleft-twin sets in Finland 1948-1987. Cleft Palate Craniofac J 1996; 33:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/9\">",
"      Hu D, Helms JA. The role of sonic hedgehog in normal and abnormal craniofacial morphogenesis. Development 1999; 126:4873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/10\">",
"      Stoll C, Qian JF, Feingold J, et al. Genetic variation in transforming growth factor alpha: possible association of BamHI polymorphism with bilateral sporadic cleft lip and palate. Hum Genet 1993; 92:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/11\">",
"      Beaty TH, Wang H, Hetmanski JB, et al. A case-control study of nonsyndromic oral clefts in Maryland. Ann Epidemiol 2001; 11:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/12\">",
"      Etheredge AJ, Christensen K, Del Junco D, et al. Evaluation of two methods for assessing gene-environment interactions using data from the Danish case-control study of facial clefts. Birth Defects Res A Clin Mol Teratol 2005; 73:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/13\">",
"      Romitti PA, Lidral AC, Munger RG, et al. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts. Teratology 1999; 59:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/14\">",
"      Lidral AC, Romitti PA, Basart AM, et al. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet 1998; 63:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/15\">",
"      Blanton SH, Cortez A, Stal S, et al. Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A 2005; 137A:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/16\">",
"      Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008; 71:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/17\">",
"      Fraser FC, Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology 1995; 51:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/18\">",
"      Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999; 86:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/19\">",
"      Carmichael SL, Shaw GM, Ma C, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007; 197:585.e1.",
"     </a>",
"    </li>",
"    <li>",
"     www.Reprotox.org. (Accessed March 12, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/21\">",
"      Shaw GM, Wasserman CR, Lammer EJ, et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 1996; 58:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/22\">",
"      Hwang SJ, Beaty TH, Panny SR, et al. Association study of transforming growth factor alpha (TGF alpha) TaqI polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 1995; 141:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/23\">",
"      Munger RG, Romitti PA, Daack-Hirsch S, et al. Maternal alcohol use and risk of orofacial cleft birth defects. Teratology 1996; 54:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/24\">",
"      Shaw GM, Lammer EJ. Maternal periconceptional alcohol consumption and risk for orofacial clefts. J Pediatr 1999; 134:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/25\">",
"      Chen SY, Yang B, Jacobson K, Sulik KK. The membrane disordering effect of ethanol on neural crest cells in vitro and the protective role of GM1 ganglioside. Alcohol 1996; 13:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/26\">",
"      Johnson CY, Little J. Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol 2008; 37:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/27\">",
"      Antony AC. In utero physiology: role of folic acid in nutrient delivery and fetal development. Am J Clin Nutr 2007; 85:598S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/28\">",
"      Tang LS, Finnell RH. Neural and orofacial defects in Folp1 knockout mice [corrected]. Birth Defects Res A Clin Mol Teratol 2003; 67:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/29\">",
"      Badovinac RL, Werler MM, Williams PL, et al. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 2007; 79:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/30\">",
"      Wilcox AJ, Lie RT, Solvoll K, et al. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 2007; 334:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/31\">",
"      Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol 2004; 70:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/32\">",
"      van Rooij IA, Vermeij-Keers C, Kluijtmans LA, et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 2003; 157:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/33\">",
"      Bienengr&auml;ber V, Malek FA, M&ouml;ritz KU, et al. Is it possible to prevent cleft palate by prenatal administration of folic acid? An experimental study. Cleft Palate Craniofac J 2001; 38:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/34\">",
"      Hern&aacute;ndez-D&iacute;az S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/35\">",
"      Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009; 301:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/36\">",
"      Maarse W, Berg&eacute; SJ, Pistorius L, et al. Diagnostic accuracy of transabdominal ultrasound in detecting prenatal cleft lip and palate: a systematic review. Ultrasound Obstet Gynecol 2010; 35:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/37\">",
"      Johnson CY, Honein MA, Hobbs CA, et al. Prenatal diagnosis of orofacial clefts, National Birth Defects Prevention Study, 1998-2004. Prenat Diagn 2009; 29:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/38\">",
"      Clementi M, Tenconi R, Bianchi F, Stoll C. Evaluation of prenatal diagnosis of cleft lip with or without cleft palate and cleft palate by ultrasound: experience from 20 European registries. EUROSCAN study group. Prenat Diagn 2000; 20:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/39\">",
"      Platt LD, Devore GR, Pretorius DH. Improving cleft palate/cleft lip antenatal diagnosis by 3-dimensional sonography: the \"flipped face\" view. J Ultrasound Med 2006; 25:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/40\">",
"      Ramos GA, Ylagan MV, Romine LE, et al. Diagnostic evaluation of the fetal face using 3-dimensional ultrasound. Ultrasound Q 2008; 24:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/41\">",
"      McGahan MC, Ramos GA, Landry C, et al. Multislice display of the fetal face using 3-dimensional ultrasonography. J Ultrasound Med 2008; 27:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/42\">",
"      Martinez-Ten P, Adiego B, Illescas T, et al. First-trimester diagnosis of cleft lip and palate using three-dimensional ultrasound. Ultrasound Obstet Gynecol 2012; 40:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/43\">",
"      Stroustrup Smith A, Estroff JA, Barnewolt CE, et al. Prenatal diagnosis of cleft lip and cleft palate using MRI. AJR Am J Roentgenol 2004; 183:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/44\">",
"      Mail&aacute;th-Pokorny M, Worda C, Krampl-Bettelheim E, et al. What does magnetic resonance imaging add to the prenatal ultrasound diagnosis of facial clefts? Ultrasound Obstet Gynecol 2010; 36:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/45\">",
"      Milerad J, Larson O, PhD D, et al. Associated malformations in infants with cleft lip and palate: a prospective, population-based study. Pediatrics 1997; 100:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/46\">",
"      Gillham JC, Anand S, Bullen PJ. Antenatal detection of cleft lip with or without cleft palate: incidence of associated chromosomal and structural anomalies. Ultrasound Obstet Gynecol 2009; 34:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/47\">",
"      Chmait R, Pretorius D, Moore T, et al. Prenatal detection of associated anomalies in fetuses diagnosed with cleft lip with or without cleft palate in utero. Ultrasound Obstet Gynecol 2006; 27:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/48\">",
"      Perrotin F, de Poncheville LM, Marret H, et al. Chromosomal defects and associated malformations in fetal cleft lip with or without cleft palate. Eur J Obstet Gynecol Reprod Biol 2001; 99:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/49\">",
"      Offerdal K, Jebens N, Syvertsen T, et al. Prenatal ultrasound detection of facial clefts: a prospective study of 49,314 deliveries in a non-selected population in Norway. Ultrasound Obstet Gynecol 2008; 31:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/50\">",
"      Wagner W, Harrison MR. Fetal operations in the head and neck area: current state. Head Neck 2002; 24:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/51\">",
"      Cockell A, Lees M. Prenatal diagnosis and management of orofacial clefts. Prenat Diagn 2000; 20:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/52\">",
"      Sivertsen A, Wilcox AJ, Skjaerven R, et al. Familial risk of oral clefts by morphological type and severity: population based cohort study of first degree relatives. BMJ 2008; 336:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/53\">",
"      Grosen D, Chevrier C, Skytthe A, et al. A cohort study of recurrence patterns among more than 54,000 relatives of oral cleft cases in Denmark: support for the multifactorial threshold model of inheritance. J Med Genet 2010; 47:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/54\">",
"      Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/55\">",
"      Romio L, Fry AM, Winyard PJ, et al. OFD1 is a centrosomal/basal body protein expressed during mesenchymal-epithelial transition in human nephrogenesis. J Am Soc Nephrol 2004; 15:2556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/56\">",
"      Ferrante MI, Giorgio G, Feather SA, et al. Identification of the gene for oral-facial-digital type I syndrome. Am J Hum Genet 2001; 68:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/57\">",
"      Dixon J, Brakebusch C, F&auml;ssler R, Dixon MJ. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome. Hum Mol Genet 2000; 9:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/44/20169/abstract/58\">",
"      Robin NH, Franklin J, Prucka S, et al. Clefting, amniotic bands, and polydactyly: a distinct phenotype that supports an intrinsic mechanism for amniotic band sequence. Am J Med Genet A 2005; 137A:298.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6769 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-E927C15C8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20169=[""].join("\n");
var outline_f19_44_20169=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE AND EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EMBRYOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cleft lip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cleft palate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Genes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Sonic hedgehog gene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - TGF-alpha variant",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - TGF-beta-3 gene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - IRF 6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Environmental agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Cigarette smoking",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Alcohol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PRENATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Associated abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OBSTETRICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      POSTNATAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      RECURRENCE RISKS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Delineation of cleft lip/palate from cleft palate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Presence of a microform in the family",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Presence of a syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Deletion of chromosome 22q11 (CP)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Oral-facial-digital syndrome, type I (CL/P)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Treacher-Collins syndrome (CP)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Amniotic band sequence (CL/P)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Stickler syndrome (CP)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6769\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6769|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/6/14433\" title=\"diagnostic image 1\">",
"      Complete cleft lip and palate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/9/4255\" title=\"diagnostic image 2A\">",
"      3D ultrasound of normal fetal face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/0/33807\" title=\"diagnostic image 2B\">",
"      3D-ultrasound of complete cleft lip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/26/38318\" title=\"diagnostic image 3\">",
"      Magnetic resonance image of cleft soft palate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6769|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/47/13047\" title=\"figure 1\">",
"      Orofacial clefts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6769|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/2/37931\" title=\"table 1\">",
"      Frequency of oral clefts in relatives by proband phenotype",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41575?source=related_link\">",
"      Alcohol intake and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36902?source=related_link\">",
"      Amniotic band sequence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=related_link\">",
"      DiGeorge syndrome: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6346?source=related_link\">",
"      Overview of illicit drug use in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/36/43585?source=related_link\">",
"      Patient information: Cleft lip and cleft palate (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=related_link\">",
"      Risks associated with epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27482?source=related_link\">",
"      Smoking and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=related_link\">",
"      Syndromes with craniofacial abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29882?source=related_link\">",
"      The impact of obesity on fertility and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=related_link\">",
"      Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_44_20170="Glomus tumor nail dystrophy";
var content_f19_44_20170=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51899%7EDERM%2F61115%7EDERM%2F72924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51899%7EDERM%2F61115%7EDERM%2F72924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor with nail dystrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nail dystrophy caused by a subungual glomus tumor. The red subungual patch indicates the location of the tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left: Red flush of the nail bed induced by a subungual glomus tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF7AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwj4dkL4rsc4+9jmvqmzLrEZHdcKc/UV8rfD9VPiqx3H+KvqKzIjCscEcZDdK8/Ev3zrw+qNS1kCsCWk8pyVB3fMPw+nNTy2b3FqZ4CWKAblQgbSeOfwGaqGRBasUY7Qchf0/OrDu9vIIywc7gVYcbgByOetcz1OyK7GbINknm9H2BCvORg9eRjBFUpAx80Ex4f5SegBHI/Stm6V7pVcrnaxPmwt8px9OMCsudfMRTIpL4Iztx+f1rJ6HVBkdvJtYMzEuxDAg54/nWtp7n51VV6gYdto561jRiTahdQhHChjkkA1ctZWG5cYQqT8x4zmrg7Fy1LS+WJQZFIjX+6O/oKcZpoWcRR5P91uw9QKiMimV3dFkZR/AcLjpSljuHkpgEdSM7R9e9URuSSThkCMMkdcYH4VYilKwIqlgCCJAuBv8AaqalGIDf6wHJI4yfapBvEbTooGGxn/61APsS+cApAVjzyPekdXMTF2ABOQCc4qm7MzY6qTljjrTvNXC4JIB6mlzDcexdUKsIAcMO57fSmzyFnAU4PQ4+lM84AKmwbXPy1IWyA6qAD1PrRci1hI38twQrMBwfemKwEpAGMngk0pkEeW8wZP8ADiqz3GDlOT1GO1S2lqNRuW3k2lgRhMZOKjDmRSOZPpVYyPITvBfJ5yc1LGz9UG0jjBPFPmHy2Jo4vLw5Pyn8Qae8qhPlIB7joapZeQEENszgDNSzKOEC7cDkmmmSxZB8/DfM38qo3UkkJSUNjJ+Ze1aLKJmj24AC8GqV2ikMGGSD1BpSv0HHfUgN2dmXA4Hy8YFJFMm4cBT3INCBdgEu3aT+tR3dsV2/Iyck4A+9S1LsicBA5IZhuwVY9sU1yvlFyQTyBntVNgcoGYKHHTH3amSElv3mSB8u0Dg++aXNfSwnC3US4kQHbGSW42n0z2rOuI2AfGPmx0GCfr6VpxWxkby8Rh3OMscbaz5vlch/mYZJbHUY9e/NDRUWURhTMPLjJYY+mfQ1k6rloGbaCVG3O3A+oHateQqwULuBTlvp3+maxdckKadPncMKSM9PaktxtnkuS1zKeuWP8619HX9+mcjnisiE5kPHc1v6BF5l2Mnao/i7CtquxNBWR6J4fjPlBim4dSWyBmuptjNHubDcEkt3IPX8K57RlaaN23lRjBDDAauhjOZUHYAKQBxUbJD3ZYuX3iIORyduBx8uOpx1pqqcquPmZQy+oHtT1RssoMfPzZxwCOn6UDHykfcIBHzZJJPWpe5pHYXAgkBkDBshwc84PQgd6kdRLNvIO0gL0zu78VG5IlwwVniUhieOM9CfWprGEyzwIPlUth2PG0Y7/Wh66IrlS1Yki+biN2EqHBWNueQfTvVlZWzKzOwlUEcjrnrkdKay+XcKlx9zAYsRyF6YH0p6iJSyxkBdvzbTuBHYiqJ0sPQPImSzOWPzHPHT09KbGBGr4G1/4Rj7349qUMWIJ/1Z/u9+OMe9OUuOHXcv93HSmRYrAM8xLphl6gde3WrLmOTaSVWTJ7ZHtSRxqZfMUfM2PmAIOR0qCYvHvOWZScq7L145FAWuSvMhO3ALD9PrUDuUTCElcEHJ6fSmuA6dGxnJY+noadHCEU/IuQQ3Jxnnt70mLkRSEW3LbWzyTz1PvVlQEBcjt/D2PrSzIDIgy7oTjj7w560+GJsENKFXB7559DSSsxS2GufKOTtY9yPlGPWoGIRfv5B5yD09OPrVmZ1VDtQnByzA8AH2pjgJGG8oojElDkEkdB9RWhBDIuZGSRlG7+6Mhj9ajJ2gqw3K38LD+VWFCyP+8k8pcbhx0PehtiupKmSM8EMcg5HBoArpE0m4ruQxnPBGOnX9agWEgbF3Bic4P3QexGP1qxFgKzBc5+U8Y96ZdJvBUuzbRyTxuJHb3o6BfWxVEewgxFSpAIYR8Z6cVEQGmR0RckBXb0OT09jU0jGCQqQvlnlecZJNUpZkUuoG4qCTk4wB2o2HqylOGj2lJTtcEY2gBxnp+mKoiRzMWUqT8wyVAAB7D1xUty/KYba5QAqowM9h9e9UmIO0NlQFJx/dzU3L5SlcN+6QZBI7iqrqXCLnHPJC8mp5F83nack9RxgUKojbLEHtRczqKyOK+JBCwKo9qKb8SWUpGp6k0V6uG+A8OvrMwfBDbPE+nk95R/Ovqi0XFqMy/MMglj83NfJ/hh/L1yxf0lH86+sdPbzYUxjJABxyVPvXNiviNsP1NC3UxJLHIFYEbWyPv/j60DcbYAsoaN/lZuoOOn061YhBjiMW8AlSoUjIyTxmoZFy8sRQoVTbKARyQeea4m7HowGyXPl20MWRtLqpjxgD1HseM/jUFzH8qOBuO0yBFJ5G7HPvUd6/nWsLIyvJHIEHy4BQDOfXrkYpYkZZDL8v7wjPzcDpgA9uDU3udEY2VyusfG1mRQW4yc4J96LdcnZGnKnblmwOv61pNaLNlx5JQjc8aZVU69/wqC1tpL1LkxMuxPlw2TuFHw7hvsMkiEAO8pvU8Nnlcdsd6jZWkRSsmOpweN2anuLeVyIXCMSp2qxwQR6Gq80UkgDNHh9u0FjjPvgUOQ15j4vOwU2KWbGOeferStIhC4C/Lg45qnEJY2C5JK8My5+72wfWkeYbQzKVfnAx1HoafMkDQMwUNu3Ko9cc0hC4XbIMkZwKYIJJV/1YQhuDnoPpU7aY4t0kYBixOAGx+lQ7vYpW7kCzK7hWOCeQB2qykjkbkQkDjrinw2kKFPOHy9AQ3etJRCYx5TEbex6Y9c01GT3JlJIylicvmRSuelTGIlvmGNvAK8VcLctvU+WD96mBl3FSDtY56darlJuyNIsxgnCluB3NSRqfMKsFLLyD/SmfvQoO0EDIwfrT0baSwQBu46VSVhNMjkPkAqhz34HSmysBJvYE9+KSRn8wuAB6ZPSmO64YLJggfrQJLqKoeVgidhuCgdKZcAeSGYAHHzAd6bdTLCgZJCDjkDg1TRjdhfvCM/xE/wBKlyS0KjG+pVWVTMUz8gGGJBI//XWpDtlhUAOTgtnJJxUMdt/BEp7lie9CDhkRV+XJzuPHuKcboqVnoMvLbZGQoPopP9RQNxAY4UYwMfxUXbMfvOWDYyuTgH3NOgIA3OSrHgNjB+nFHUXLoNlclFBVQwG7jn/JrOnGxlbKkR8jH48H8atMyr5pcYPVCRgsfQ+lUppFZAHClS2Tgc8VMmOMTPZmTdhjtP3hj72f8nmsLxC2/SrhmIB2FsH+Ietb8svyOyjdgk8/3T2/Cud8XMyaTMhG9SmV56L2FJblNaHlluPm4rqvDK/vQecGuatlAfHUV2/haFBMm/kYOAPpxWtV62CkrRuzutKCCIqinrwxP51sxAAEqoY9VJPT8KpaaoMSRuVKxncNq4z3OSa0oNjSAup3A8Y4UcdB6nHeodxKxY2kyjLruI4PcHH+R+NR+TNsVQAp24BPcemasR4MDMgc7jtVWXqD6mo9hVlXCj+LPQL659KTQ4srOMyiSQAsw2nnv2Oe9WYE2uFlLSIAGBVuoPSlmjUuuweZGRuUuepHb2pqfKSFKhXGcZ4B9BQlY1voWJHPyl/mjUbdrE54PP5VFKMCQoQ2Tv3HipUILkElkKnPOSpxxUkcWF81gfLLYJ7jPcinuTe24xJknRmI2nACoOPoakSMyZX5wOq4Pt1P41Ecw8LmQKMYOQD70iySYRiCOflO7Oad7CtcfFv3CE7mdjjGeM+2Khld2mImZjt+8oGAMdKegk2s65AB659fSnQJGjI9wSwXIYevpzS1egWtqMMqAAPyrDPpzSvEwgLHAO7blh3PvTnhZJQqL3+TI6jHvUrhmjZzN5mCCcen19qq3chvqiFLa6MalwGQH5dhGeOR+FRyTSgSJ5ZUZJbK8E+tLJbhcbSI48AEdBtz1AqCX7RFOWWRyw4DJwGGfQ8Gi1iV7zIPOcKHiDR5z1BAz+PapnljSQtKUJc4JJyo465qaW5xCUZYi7KWyBgx5OM9fSo2s2jgUyBSrj7ijjGeDnv3NOzB26lZPKNssiRbWU/KC2en1qG9eSGU4XA4+Yj/AD0q88BMG87WXeABjOQe59PSqk8UhiETgBUYlMk9SfXtSdwTXMRKxDElmAblCeckf1NVXmdJGViVU/eU+vqBV+VV8va4DFweM5B9ajaFBHvlIGT8rddvbkdcUrNod11M2U4jDQqNwPQnDD6isuUOSN4AXpktz+Prmtt7ZTMoSTKlfmJHTGePWqrWwPMoXbgY3DBPNLlbKU4oxpfNEhKjy8dFA5P1qCRGA3MQyt1atmSNQCy4AV8Mrckcd6oSBACFTLK2cdsVPLYbncz5UCq28dOhqvGm/njA71duEwXGcY/Wq8P3eCaqJhN6HnXxHJM6joARxRUfxIbF6AT0NFexh1aCPDqP3mYvhsZ1yyA/56ivrLSnP2RVAGVUHPevkrQCRq9mQf8AlqP519XaI+YoRn5WUDH4VyYr4kb4ZbmzcsTHGyDLbdx9sdqr3Em23kUbVCZB+XGQecH1ogLvIE2khmKlcdQP88Ut9IGBCq8kW0lcnB3dAT+HpXFLU9OloMnEXlySKuSOERgcE461DbRpKkQMjRq/7sblwvuPerRkVsMzEkL9wrwpxkn60lmJGYRbE5DEhvmBPHKj+9UnSFuwiZQdwQMAQW44OOfarsNw1vLcbGBVvvN2Jx/jVO6ULkFArFtwUnkDP3SKlkKXLFdvl26AYHpj+fXvVrXchx6j54hPG3nkFiAIwUyzHPPPasy/06W3kRXKk9sYPuQfStKNZltTHvC9CwPUntT41VUaQMokcEEsMnPcn0FJxUgXumdFLIkKA524wCD09gKT55G/1ZCgZDHvWhFbxP8AMAdoGBn1/vfSmIFiQrkZz0Hc/wCFKz2C66DImmyuBk5PJ/U1PkPIMbhtPXGc1JD8m4yRgMwxj+6D3FM27QEBDAA89yKtKwtGwVI5Swl6qflGMc0ks24bXUMDxjoMU4rsh84GM+ozy34VE6syBmTaM5PHSm2FkKQJCUHXPFPXYmCGPX5s9qhSZss3yrg9cY49KZJctlmHK/dxUtj5WyzjLEgnGTg+1V2dEdh3PamSSu4VI8behz6UnkB4yegPVfSlzt6IOTuMmcsnyphseopkIwwBYuvcmrMSRrEygD2NO2JswMDB/GjlvuO9tEUzbKcGQgge/I9qUW7Hk4Qqvyj1xUk6q27GcA5JBz+dQy+mWwOMf1pKw9x7TSE843Kcg9xUAZ3fqWbBBbpRGX81+ANo4B6mi4Zy7HyvLYDPzHqPSm2UlqIzq8ZwGwpBOR3/AMKhUKrOQ7eWBlQBjnPNJNJvXEy9FIUj+RNIpKj5WwvGQO1ArWEm27w2VILEhiMD259az9p+RcM3ykDAzj3q3P8AOo5JLDj/AGc9KrFgYxkM0g3bcNwp78fTpUsa0K8kjQ/vGY5CckYHJ4xj0rlfFjhdMdecY6E11U5URLLGAybtuxucA9jXH+LX22LkgHIx+tLqJnn1sMykYyc13vh6L5ULKWPQY4xXC2ZPmggcg16b4VkaJI9uBu4YFA2fpWk9ZWGnaOh1thmKIFwrOyksSfyGK1LddzKJAE2c8epHBrLsQxOQuF3fMCOxrWVgjNtYEqScr1z9akgmUlg+FA38gEDJ9MH86YyCML5uMknkYb8Kk84kRpHl2TgD+6TknjuKbwqEggKxBOF/LB9aLjTJE2gMW+Z9uW4z096gJOyQCMjnIPcDtx3FSFVEa4UqWJ5A+X65p0SYdV+ZCRksw6kUblrYWGMAlWVVGOVHOO+asJ8yKpkVI2wDkfpUGSJJC4WKQDHcg09XIVFZAQRt+U5z3zVImQsccTMVl2lVBGORuFQ4YIQCFJwT74pzMTkhcB+wOcf4UpkBMewdPlw3P40WGKGdRjKMccgDoCeaZISeGIyOMMeMep9Kc0wijZGyQe49+1Ug7orFurHbxk5A9aBpN7GjHNsVIJWLp1G4cj6e1E1uvfAgYYQg8E5/xquoY3EWdwj2ggbeR6fhThczjCxGRQW3KuPlY1Rm4NbCwsBIzqu4lRkHkEHikcNHeRgxqxUAnPc+maVWeNTK6qAWyVB/h+nbFEkDEDbucYBVh3z3OO9Mluz1Ipdm1VXl1bLPgkDJ+6TRDCSr5Lb42zw2DgdT+ANNICQpIrLy+ZIhwSM5zT5JQwDFPnQkHDYyp/zimS0KGTzvMDoDkM5RQN3uD+VRPKMu8kQ3A7djc4B/i9+tWEJb53wcj5cDJJHt+fNQvPG0uJIWYKMRt/eGeSabM+ogjUBkhfIzkRsASD6/THbvVcDzDIYo87W5jGSSB6Hqe/FWA25gyFdgJX5jtx9f5UwuyOxP7sxDJdD0JBHB/HFHkJsxXUyPI2QEJYLtO0fSnShFVDAQoXOAByPpT22qQrEGNuQoHJOOtVyoWRlZvlPXByefSpRZRYCRZZGJLEkgEd6z5VKycEbjxW0yZj+UMMYLZ6fWse4jJduQeeMdsVEuhUWUL5trFOM9zUC/dGePSpp23896hHMu04PTmiO5nUdonnHxHQC6B4zn0oqT4ljF1H6UV6+H+A8abtI5jSH8vUbVvSRf519U6KTLZQFehUV8o2TBbqFj0Dqf1r6r0KRJdMtyuNjIBkdRXNilqmb4Z6s3YndRLt+YHA3Efd96L6MiQiR1aIKjIec4z1A9Mjmi2VJSylmUhCQQM9PUUTMJreJVdVABbYcnv93Pp3rgkepDcIWke3uCZMgbQRjAY/T0p5ZIfLKhwTkYA4HYYPcUyMqPPVAWLONpRcHuMD2zVq5iMIVIVLZIJLgg8jOCPpSVzXmV7FVrkAglAUjGVJ5LfjVo+ZCwmiOYuWDYHUjpT2jdofljYRynYGHOWznp2FMjt1ijZhE+xTjdkkAk8ZP4U1cLrcq28lw8UihUKScO7rkhvY09LbBY79xPABJqQuYz++Jb+6FO0Dnt60XTPK0e5oyoX7qkEKPr3pFK/QdGC5kX7RHEi4DZPUf3cVLDFDF8z/PGc8gY/KoM28hG/ACkYBH3x/8ArqVFSLPmAZ5BDHnNUgeqF3ANII1cKRx5nPHaow/3HYruVvmGMDFSE/vN0nyvgAA80zYokKjcE/jzzn/CqElYQtGzEEAKerY4HtUhSSRW+U7M9fSlSPdjCgdDk96kA3gKm7aeeT1osS2U0i3BEYjA5Of0pZINiPIDkdNvepJA2PlUjAHI6UEnySxICg4O71/xqbIpNsihUBHKZzjGD3pu4EAIMEHHJ71Nhgx3BdvUYHAqMsBI2HBfOckdPemitxUkblW4Td+FPmP7wlAuegPb6UhPmo5UhRng96rSbgs2wbnxz6CmTy3YwGMBtjFCykEDkZpICN6hgdrdDUbPsVQp5JznHXipEkCrDvcbjxgdvxrNIpp2Ipo23YX5Wz3Paq0plTcpBbnjBzjH9KsmNCiyb0BJIBzk4HrVWR3eV5EypbAIx1FNoaVyPeysuAJAhJKse9LJsLL5QJO35ie56jA9KXzFluGJVVAGwKg6Y6H60g+eQERZk68d8Dp7UgbRXlAkceXuIwGOR90+tQTsQ6MhzLjksRyBxx/jU1wwT52JBGAc9PrkdqgkzE7LtDJkqpccr/s/lzSGV2jLpIsYBwDtU8kiuO8ZMrWkhACjH612CiPeEiZlB4UnjgdM+9cZ40Ui2kJHO35u3ehEnF6aAJVzg5Nen6CkSWSSM4MhYgJnnPb8K8y0vPmxnA+9/WvUNBC+WfNiDA/hVTfvFNe6dNAzM+CBtU/cZsDp0rRh2FRlic/dUjOfy/nWZDtKEttjQ4YF/vH8a0N5UqA+AMuoJ/PH4etSQ0aEQ+RAMLHgqCuAevT61Gu5EYbjiM52gEknp9MimbioVipXcFbd7+noKR1Doo+VCxPK5BIzx17n27UAiXzPMZ3CYDcHaOg44qT90SyuDxxwfmyOn60sCyAEqeEG4vjOOep/lS5lPluFVWY/Lgj7xPp2FUl1FcdKFmlzGWdTgsDnkd+evFLK0RMyxrFu3YDDIBUDqKa8ksURYlcwyfPkjvx27UgxwCVDbeeOvvRsPURSqlVTIRs5OaiMm1C+RsPHXrUxXBLbQGA5A/mKg3bpCVUhOchQBgD0zTuXEMGYrFsIJbCntnsailQoGw5JHyEAdTnmpFDxrIqSH5l78c9vxqKXc/zyRuXVtpOeCPcetBeq9CSKfc0hzskA/i7gc4qeOF2O8xs6c7QDg59qrI6RMWClmA3Ke5/D6VJbSl4hHebpHLAllbG1aaM536E32cMMkMsjZU54GfekxEgZYn2CRQzsM/KRxz7Gn72FmYSCyklwS3UehPrUPmHy1VgF5O8k8569PTAq7GLu0Q2jqG8u4kVd4I3MvfnaPYValWMndIUJ2AqAeVx/jzzWc8Vvam8CFpvPcTIznmPP93tVuK7kPnRwszEjdC5AJU46c/w+nuKaaW5Mk37yLJR45/Kkj3KsfAU8hPY1VQKmSyjaRn5WBK5PA596lM+bnzpo2S4bJQhsB/U4PQ5B4qSdIllCQSrKjpkhl+cr1IwDx9RRa5in3M/axkbygTGQW7Zx6j8qqm6nRdsiiSPkDHGMn0+vNaTW4bc7K6BUyNxXHTJ+gqtcfZ/LVn2sXHDISvzf0z6mjlZSkiAAMy7XC7sKVZe/1PTjtT7uKNYlCgqyDDMTkH3Bpl1Gp2hpFG75sgEk8Zz9aikklIdEOxACA7DgjHp70l5g03qjLbEe5GGFY7hkfdrNnX7xGcdcitG5I3bSzbhWZMykkA9etZMtaGdKMN7d6bCvzHj6VJcYI+XoO+KWAFRkjqacdyKux5l8Tv8Aj9TPrRU3xRXFyvPfjNFevh/gPHqfEcPGSGBPPI7V9Q+B5DJ4ctD/ALGM18vLk8Dqa+k/hpMZfDFrvBAUdK58WtjbDPU7WI5iMwL5jGPlHX61MkymSMspz5WCPRwfvVXRuGwoKyKVY9QDnijzGO5eAQuAWz+NefLY9aGpOHdPL3kySYUrnjIJ4B/GrU29l3Rf62PqFPpz/KqayieMKQpBTBYnG0AjGamWcm1dHAGdwMhJ59Rj1pI15bFyPJZ1SNvmUEbuMMPr65waclyuyOESsEJDBdudp9T9Kq29xJPI6bCzhsHb0/H9KdjY6NHIRtzvLDbtA68Vd+xPJrZk99BFJdSm2fMCNtLO2Cxx1Htn0qpOjRskcqJ8yg7l4PPrU8biQgspABORkcDFRmSSCXzGYqzD92A3f3H0pS11LguXRlR2VuCWOTgHHOKcCg3SZUZ4AJyau3cDTILiQD96x4xjnsBUdxaxskOzcjsnzM33cjqalJo0uhizpvVEBlUtyzcfjUyvjOdu4cDd9e9RC3UImAFLAZ/+sKc8Aib94E+XGCp3A09RNIZLdPvzja3bHIpYLjB3bicchSKnaCH5ZFDOJAGDHj6ipLmG2E85hiZY+wJ56U9SXy7WK8k28EnC7RkY9aiEgMeXQ56knrmnrAm1fNI3Zzwaf5YIly+GT5vXd2xRqGiK5lYMeN3zZ470wyIQXK888elW5ogqB0+7weeaiaHaHEZB3H73p7Uncakmhsc6lNix8HgH0NKwbzA0Y5PBC0oiAjDKcY6981HG5BJbO5TlSBRcXmiGUEZYID/DyM01jsjRFQZJ5bGcip53JBDMoyQNoPUZpkSb1IwBg7sk8AdOKa7lXK4VGykWExn6H61EE24jADMSM9jippFQv8uBjqOlNUllbcdrMPTJznjFLcE7FZ8mJWBI7AH72e/1qLftIwTtI+ZD0z2NWLkp5e1JS6DB3KuMHH+NUgwEDALlmUrj+6e9IErojmH8JDLlh9D61FcMmCcsCzfOCO46H8al2871POBkdTkjJNKCoYsyluOvTb0AxUg9CrMoCMjLkg5yO49q4zxuwbT5QF+h9RXazysxO7Gwt1Uduua4rxoQbCQJjGaaIWrOS0NN9wuRlepr07RwiwKZc7s9O49DXm2gKDOnHGea9L0aNADvRiT37n2py3NHsjbt43l+Z8orc73HUH9M1pWxVX3B8klQp6nGO9UbKExoGHO1DnDZzn0FaUSGMjLJ0yxLZPTjH50jO9y221BCruGZvvbR+mKCo2liyh1J3JgjGD0z+dMQkk4zzyMDBZs5zT0aVpUYsGeTLAj5umc5pivcejpJkpuBGVYZAz/jS4EcgAIkc/MpUcYxzSwlHKrglNvG0c9fT9KTysRuwjIUfKxB/SrS0EtRxz/rTsIddhGc578ilCOwBVsNsLLnHIHalhXc6rvCZOGbbwvuTRGrAYPOwlQVGcjPaiwXK7Z2Ku8nAz9DUYXn59oLd2HAqW4+UcDDAbWx/KotwUkZPUHBHGMVL3No3H+WcLG5+Yrvzxg02IYnICksoycHgjGKiY7lfbjAbKhvp0p8JkjmG/lSOCBgeuKaHbQfJCkZYOVDYOMc9qjKFPLKDMuMAHucU5fnXMvzAk8dOewqs7eSB5jZxjYueM5+7mq0RnrsXZo/kUE/NIwwo6scZJ+lRXEqRgu8IYgguqnBORjIP9KgkkeRlNvHtdWIG4cjH+TUaPJuMhZd5OOO/wBKOYnk7kkUxkuAAOV4+ZcMFx0I6U5mVHXylKAuWQq27BHXI+valw+NyKfMdAyseScHvS3VuJHJk3q24sEA7nGef6U+lzN2uMZVmZGY7gmXfI4Ukfnjv7ZqvE4YHytyurfKR12+mfSpjIgm2GX0AXONxx0Pt2qNWMc+UQRckDDbhyPumi9xJDSJY4ZmS48tHGHjQ5yv0qKV5iCxO7tjg8joankmdfKzt8pgVQMO/Jyf5VReZ0kwVUKygEZwM/8A1vWk3YcVckEsbw+VkoB03D36UyXcoZkYhNu3rnAPUUy4CGOMoAf4s9Qf8KrXErE9cjaBnvS5u4uXqipK3ykKV644qhNjaMADHateZFRiFz8wz05rPl+WRX2g47H+dTbUdzMlU7gAeeuKkCjOcEZ/SiZSZcjgg06Ife+Y596qC1MKr0PMfidn7SmeeaKPicD9qTIyM9feivWw/wAJ5NT4jiRxk+lfSHwzmD+GrRozggYb8q+b04Ir6B+EZX/hFYsseCfxrLFbIvD/ABHo0D4ikwBnryeDRcqyCNnIKOA6sOgHQ/lSW5VShOSCQygDoelTXEgaCKQjIVzHjdyD2x7V5sj2KbK0f7pt6McqmAR0Jz0NPth5yoq/8tEJ5HIIPXmgOwuw24FlZQob+HI5yPzp9vLscJE5ij3YBBzz/TrUHT0LNq+y5cP91QJNoPDHrjinvG0aB5UZXCnaNncAE5/OoYZTCdh2OzAKHbk4Bzx6YxinK3mSeU87YMhcBzgZIyT9TirQa3uXYj5brkLGSpzgfeGeCfrTJiBCwzucfMGx0OKqD95dCRgET5Tzk7R/j14q4bkK25FJDHMa45GD3HvVi5dbiCVQqlvuoAAM5O71HrmkjILoM/K3Qt2HrSSqjSlmJMznLEtxnrikdtjoBHngYAP16ntSLSJzcRpCUjcSOBlgwIGfaoD8gQsmBnnHTmmW4OwPg8dQxwSc9qlJyGVtmBnauMZ9aBWJJgpZQOYzxvA5PqaQbACFZd2PvE5+g+tRhM5Vc46LuOAvHOKU7hAxIVHUgkY60xWECBkVuhBAOOTS4dAGZRnGRwTkU420hjErqwjJPJ6UschaTn5iAAoAIGP60hNkYdnJLDHTPpj2oWJSB87DGck9QKV0yH8wEZPy02fBjfYowABgdancn0IHZ414JMZ4z7+9GZJEwADvOCB39cUOv71cMWULjaOhP/1qczvGMIWyQVHfH0p2KZWkjDsREjGQkKBjOBj17UkyOUTzPlDKApByTipiolDOrEOCApPftVaRTvaIglVOCcdMmhjWo+2hVpjFcuEwCSw6/nVMllUBOMZwc9T2FPKkMUcMMMVyR2pL2Ny5/d7MPhkHyjPGPzFHQdtSvM+6U+eMg5OFz8pqveSZXLfOyptJHDKR3xVp/naVzGVUnJI+vGRVbzI8yCVQ+5+p6qM9v161D1GiNAdnmHPlgAE56HgEfr0qukhEoB+VgQG4+99D3NTPuaR4gGUEAflzyOnpTU+6E3KrPjDP1BxwV9qQNEEr4O1UD4zlTyCc9q5HxqmNOY5Uds4xmusMnzOzMA23INcZ42ZzaOHyM880ELcwfDUWbhT6HnPevStMxHsbLI2PvA52k9q898IbRMWZdwBHBr0m03NaK7keXuLKB1Hb8RT6l1OxqW5kA8rbgqSAwHT61bhbc6sjMVYEZboMdv8A69VEISQsDxwTgcnI5HvVuNWaIlVO5FJ3D69SO1Igtq58lDuZskjCHIBwP096cy4T5v4s/PwSPTOOmelQwkZYYJwCGXIGe/6dfwqwj4cjqSdqttxnpnI7VUREiys4Chjzn5jyOf5Yp6Kruqu5QqWYIG4eq20Rt+9VwSOWPHOPappAU3qxbdgEDnaRj165q0KxMJlRpGDMG2/IT1U96S3GLjqE2qXCtj0qP97Ir7csVVSQQOee/wCFDbVYqgLFcbeev5UBayCckuWKr8y8MR+tMGwLGzMHx/CeQakVd0nl43lV4Ut0XrVZz3YME64HapaNIjlRMlFZNo+bI+tN80rOdylosAA/56UkUIlkkRVz5uBGT2470wkqXhVVGOGbPUD0oSKHPN5cittbac5Qt3HQ1A6yCJiFGwt36jv1p7FkxL8wBxyRjjNNyXiIIUqM7ec8560MVtLjmnkaNxF80a4fcp5JJ9aWU5VV8t8I2N2eo64NLAFeI7yyYydw4zzzQAphJJ3L/C2OvOOvrVK5k2rjUKvEBGQIwpwWzkH09QKZHO/mSxqsgTGSmcZ9cZ9DUkZXcBES8eQDkYqn5gRcN8xwVz3HNDItfQnufKVIgA65ZsFwAxI6HjnOeKhknBhzCzCZ8ZjI6+pB9QaSSWOe53szHdgllHIZcdR70+QFhIuzCl9xU9Oe4NG4mrEKrKdquQ4YZ+mf60yYIsgVsBH5RixHcA4qS4kXY8aPhAOGzyT0+vSqRVXuGBAzyAT0+oo2Ki76kskJEHmRuSgO1mJ4z2H5UQsqQMmAMn5XI4A7imsxkcfOSCFyDz+lNlfer4AAGN2Ty309aPMhroyu+T5cmdw5PQAgjiqF2cuecnrnuc0+Y4Zth+VRwB35quZAwdj1yCc1LYNFXBEhBIyOfrSopUnjn19KFH7zp70+Vl8oY5I7VUTCq9Dy74oNmdT3zRUXxLb/AEpB6HpRXqYf4Dy6nxHFqea95+DU4PhxkIztbpXgy17R8E5caVcKBzu7dqjEr3blUPjPVIpCyFSOV4/OnAM8U3z7sKrFfTB/nUcalRkuo3c59CKWR2EgKdMfN9TXmSPbpLsSjc8UbyHksqse/wBKtoqByQy7QwIPTg+o9aoLJvt2SXcXRuMdGGf51LBKdrBjlyccDAJ6/wAqSRvqzQjUTL5W3c6gyD5QMYPOc9c5FJFMocebzsCt1xg5PFGUSAB3kV2yExzwT9w0XMkDqohUKSzbTyTt27QMn3zTSBahGrbG3OmNyseRk+ox+NTCQiZCv7tQCV9SPWoIyhZMyIVB+fjG7GOPr71ObcTZKyK52kMM4CnJ6/hVB11FZwvyyhS7YUDHPTrTo3hMKLsJdnIb/Z7VDc2/lwo6OjYAcPn5QvYf0p8EIhuES4YlnXfJz0G3gfj0/CjUtWsWoLafyWVY1DBh945AOKW2UQeZMoDGMArxnJPBqlBLIgzFhFDcR5OAMcg1b+0l0ZyNqEgeyj2oJd2hsscpXfhsDPUc4H+RSbWCqzNuRh360KxkmLksQBgBzx/nim7GiGIgxLZxzngdaYtR7PLIiREl1HaqplGIghYkcN7c1MPMQoejMcgD0plsMynIUA98d6QWLIflAxyDkbsdv6mmOIoiBEZGVupzgk+mKSPYThnyS3GRxjvTpZMhmyxfdndtFBnaxXjXfMwY7QD2HfFRzhjFhugTC4OMHtUudwZ8HI5PNNbaZGIyFUdG7igoa7IQQOG4XHv2qG8UQyu3PBG4E4560S+ZFMrllLDa2PUZ5p+oPFPczNsKbmDYB6AdqTHazIbosssiZBYlSMc7jUdyWLTByRko5B75xU+oRmBtr4xsVlB4OCO1Vo1meCeQn7jKWJOeDlV4+tMFrqVp98bsY1+/K3HcAk9faqE8SKAEXKuR836YrWv1LeXNHkCZtqhT0IABNZrTtHBcQsBtUsVJGDgcEVDNI36FaQGYxY5QgnzAecdOR7cU75miL/KFZeTjkd+PaneWhlLw5YYDFQMYLcYA9KY6BVOzO0cbT3OehH0pA+xHIjHIjUhc4xjgcdq4jxtcF7eQBfkXgZ5NdqzbZXyzYyCBXn3jIkRquScnofrQRFe8N8GYNwCq55+bNek2yxbCwyqAkY7ge341534KTDs56Z5HrXo1rsVQCodG7sfftTXUKi1LsTDMzkEp8qlenbv71MjrEu2Jzyo3KDyy981CpwJEQBwy4XcOg7H6iprdiGcqFAztIZRk54GDSFa6LOGLo64cbTt7k44x+Gc1KknmIVCB3IOWbjHv71WUMZYxlUfBHBx6dfep4NvnGLClDjOBkrnn+VNCZPDIQ8bSR52jHPrTYZo0uQZI2IBbaMnPTjn8aaIiPLKYZDhceo5xSwnC/ON8fmfOF+9tXGcVaBWJyXmeaSQ5Y/fUnpxwfzpy+WSQrbYgoJOMndjpRDD+/cqCy7GcKGALAd/rzTXVWhU4AbcQQOmMcflTFpsNVsldoZSy4fB54qMRvK4RDukPuOlSuuFjZzgFSCY+rYPNRHaXzIPmGCOcgmk1cpMSQtIZ5VYJswAOKbcqpkBDiSNcAEcc9aVHkCP5gASTp3wBUcr4wiqRu5A9CKNim9QuJXmcJ8xVM4zjj2FQ26GIZeINkEjDfzqYIVU7m/egYK9P1pu5Vgy2w84IIPSiwr9EMllHlNudcMAQhOSPpVdQzAgDKYxsyQBn+I0sscglEp+UvgLx8uOhFTMGVJXiBZvu7gMg0lqJ2SGXMq8RRsJolA+cHB6c4/GorYNcI0bht2N4AxzjoM+tNeMF1ZTuK8gfw/8A6qGXKAwNtaP5sDgk/wD6s0X1FayFmMUABDK0p5yBxz3z9KbBJtkVAwjU8BmXP/6qS3kWMIy5+ZSCD/Ep7U1o2/d5PyMM9e3+NGnQzYAptZd2fLYo7AZJz3qu7gbVGwj+AjgHnirOcB1BDYAOeBkdfzqKQoxLFQoJwcDgfT6cUPUSZBIx2sytyPlUEVCHKMrBiXC7c1LL87uMgllOD3z2zVF3ackLxIqhiPcUmNK4248o7WhVsnk/X6elVNu+AZ4bqPfnmrDMCzKW2nOTUSuY5QScjFCWonsRucc9DjpUDNujOODVm43bRhcLiqr7QmBknvWi3OapqeVfEdy9+N3GKKh+IZzqWByB15or0qN+RHlT+JnLKeK9T+Cl3tvLi3JPzc8V5WCfWu7+Eswj8R7cgblpYhXgx0XaaPf4jviIwu3OcHtT3ICIVbc2Sp59sVAiMrssZ69KlVUKqsgBLAgDNeZLU9ymOTbhjyCjAOoP3h2qMuDcMVG2PqR7jin3L4uckYUgb8dM4xmq9qGdndAc5wMevU/yrNo6obXNNS/lwNIrFTIFCngEn+f/ANamSFFmgdsksADzxx05p80jO8fnDacHAJ/HinuyEgkMqLtKrxwQP5c1bQotpiJMfNcSMW468AnnmrMk0cdwohP7tO5H3uev1qCDcmCwUqOCCc8Z54qELl5Nj8nB2nkkg00WtWW0k3xkvvPVmHJGB0x2BqS0KLO+JVjLAKzMN2cik2KyA8rkbCir8wPXP60skIaNdjtlF5ygUZ6cf407BpYsOIRlSscbMCMFSQBjrn8qqqyzJKhcfKANuec+w9KRYbmdws77UAOwnk4zwTV+1RLeZ9678jaZD296S1JVoobbb5vKUNHGjHlic/kPwpkbBMmNmeNSRuPepBMvlj7NEUEKtlsjJB4qg00gVY2woH3gOjfWncFeTL4/1Y2YEu3JbHTPpTGtizxtHOACPmI9KgtJXkPzDOeOvQVO86rGiKQW2gjA4pqzIldbDJpA0kbKQuMLjr16U8kNkENhT1bgD1NMYBm3MpBY8HPenfIs7FhvXbkDOMGhIW+gyYxiTDkhSDtxTC9t5LE8yKBheuSepqt5eZUxj5jkBs0rQOJEbbgA9uhouOyHToNy4ySEDDA4x1xUcsRVjtwSFDE9jkVDKvlqhZic5CkGp7uV4omKPgiNQFxywI9KVivQhkTdHlid2RjPYYqJo9sc+9gNoyQRkn5h09OOa0NQAt4g6Bdrxo21TyMd81m3M6hSQW3ykq6Meox7e9D0FFtojYzuFj5ZLfMi46LlgarvtuZnZAwceYxQ/Xge9K3ytOFy0ZQH5s9yP600LteXacEnGV9zWe5paxFCrfaH2lc7cbivv09utRzgb5yUGc5IP9atS/LEWiJVyCT7EYH9Kq3LMiFMffJ2nPPbg+1PoRe5UvUfy1XfmTkY74HQ1wXjR2ldAykEdSTXb3GGkUMdi8EHPTArhPF7GSXLHcRxn8akqK1LXgyNmUFVyV5HvXpOnpsCLIFBYkbH6KPb8a868IBvs4K9e3NehWaKRGHYlsBsjvntTiTVLcD4kH3vLLFSqj5sev54qcRNHAd4BIJBLHqQeSB7VATGkRCq7K/zbmbBBzz0qeNpJYcSAEgDB6gc5yP60W1Juh7HCkMztuAJPrnp+HSn+afPOASrcEZ645OPbvQdsiXKlFJz5hfGGGDyF/w9KSINGfMeQqUGCCOTz2/Ok0VoS2zMysy5dABkDgH0qcDHUqgK/dUg4OeePSoUKLKwXGC2M5OcdKDH5JKSrtDBjg9wfetIrQhsm8yTEmAgDHDAEDbx19ulL0HzjYUAUMP4vUk0rpvklMELOvmBFVueccfX1pyti3Xbna4yDjhiB09uauwdBxkR0QbcMFwpHJJ7nPpikLJG8TKSxwSu09+1Q4IQ7M4CgE5/GpcvyHGC4Kk9AR/SkD8iOT9xIq4LuIznB6E/WoX8tGZo1OzgblOfrip/OtwrvKjkbuB/s471X3BkAQPtGRnpxSGhhcABWGUJzyenNDqBDIhJKMADjGfb6USpl2+Vs7gFOfugdqgeKNfLbdj5jhR1+v6UgLW0vbux3AIQAB0Kgd6o7ycsgIQcnr/Kp7gtFGN5ZmbAAHPy9fwqAtvKiQY2rgY/nQJA7RlceWN2MKAO3vUTKzPhXYhflCjse2DSgu+TnG85Y7scfWm5CFjswAwOQTx/9fNIGQiQpuVDgEZHGSDTlb5CQGBAwT6mnlVaAbsjBwRjFMCsT5e3Yy/NtJGAPrQiLpgqggswB2Hkg8kGiaVJN4XGOACT19cfX+lV7hiWIAKhSVIz29Ki8wnqx2kgLjqM/wCTSJt1FkAxhTnAycDPIqtKqo7sPlk4PJxx3zUplC9ycEqwz1B71WkZd2CMEcdzxQCvcRlVpX6BTyfYVHKWMvynnhQdvBx3pUcyxglgWK7W98U4fM7ByVjAIUiqihTZFOvzyB2wR61nmbbHtH5+tW58n5d+c9M96qzoqo2DnAzVM5pOyPJPiAd+qNzn2opnjx86owHrRXqUGlBXPLqP3mc0K6f4fXAt/EluT/FxiuYFanh2Uw6xauOzetFRXixQdpI+orZjIyttAGBin+X8rksPT6VU0iTfbRtkk7Qa0CSz73ZQMDr7V5Mme3SZGyiQuBnO4Dk9BiptPQgsyhflXoRz17VFJ8js/BHymnj7ybDwuQcHHeoSOu+g52DBcDIUj5vYc1IWb5lGCB1b1z2qFFUKAGORkE9qfv8AndmyWOOB0FV1Ki9CwZAzsQSqswBG7qfSmwOAOePm2naP6ioY33Bg6suPm/Trmp7dYpJGEZLMcSYY985H5U7lbK5e3IZBLEFjccqoYngeppsFwJ5FjCtwMFwM5Y8/zqC1EVxOJCWiR2dQ3XsMcdq0JI4xbIkGd4IztUjA7ufx4GaN9SXZaD47xVjaKURvLubCqDwfX8KS8vvPREVE2AbyechfT6VCsos5t0M5k3gEs/DY6YB7VXuLlrpDsVl+bG09OfU96LiULu4+3jjkllZfMYIGYnPBX+gqIzecSQAEUADavBPvTBPIwYmMgcrgLhSMdqklkGQgAZU28DvxSbLsOVvNtUBAA5zs4qSNA0fzjlfuKB39zUKqQkOJOqltoH6VJGqFcE7QRzk96qJDdtiU4IUuTlhgfX3pzRMeinzflBHbkVHcSN5G7A2H5S47+n8qfJcPtml5ySu327CqI6lWSImblsqM4HtnmjzWghZYtxViCCRnHBqW7lRLlJFUNwTnOOvaorQiaSziaTbGcxn/ABNBfS4jqViIk+fZkcDG7/INRRPJc3UZjBGxCihjnjHrVpN7KzKuWAyWzj7uQcfhiop2A06z2IvLusZX+L6igEypcTvcQADpHFjrjIUnNRTxxpKNrExyKjBgMFcjn9ac3yCULCYyVDKCckqT1U+nWo45C9uC4UrEUAI/hG6oK21RCUMmI1LMqKcNu44Y54+lOthG7T5XCkKM5x1cHr2qSaENfTRo3lI8hADDkc+v0oaPzY5nAG9QHwDtDDP9P60JEyZWmk+RhBjL78gjpgnAz9Kp3LRxLHgeYXC7iB2wD19jmr0uyRWeR1VnLAZGR1wcgdOtZssXlzzR5IdQRtPQDbSYo+ZQuHKRksMZJP0U9K4PxYE8wbScE9DxXcy/MiuAduNjZ7kCuC8Vv5l1GM/KvrUouO+h0PgobYUJJI549OK7a1AUA7XyrADvgetcR4QkEcMWxSxJB56V3emq/kqz58pdwznAPOTihE1FrdmokIJDIST2TGRj3pzQskxfjy2wXGQuR3B/SgpEq7BI5GCy/LgmnSZLAvuyRhypySOOPrVsxjcUw+RK0ZK43KuV6E+x+lI21ogsTA8hSQ33vXNRofMWIvuAUfQ8Z/WpYIQIWfYsiKFKqDxknoc+lK3Yu9txBESjhSWD8li3GTyP07Vdkjke1Z4wGiYMuTzhEA7fWqRgcGHzJFKSKHA7kZwDVpFniaRHbZIEYEZ5GSOPxqoibGOwBh8rCyBgSo4Ax3zUM0ki2yhhjdnJOMjcc1YJ2mR4SAyIJBxksTxx7Z/Co0Yb/KkQEBSd6c855J/lVFp9WPhj24i3fOGJZ/THQ1Mrh4JnjTczAqgwTznr+VUJsxwBtpwfnyvOQTgCq8k8q2cMRU/PlU244z1JPtRzWFa6uWZXmurkQQlVKR7S3QY6kmnx3AmUNGMLK+xFHQKO/wCPWqU9yIopZFKMjKIcgdQOT79O9ZtndyCF3TLBnyy5+6pNZOVmFtDcmmDx3SbiZQQuV9BR5pS4VZFA2qByORkcCqFqWBO7IJO4ge3rTlkBidlQsd4CnqT3z/SnzCH70ZyCjZBx65Ip84DxyOibSqhT83JqKPMztNhUYEsy+3saUzYETMEwFJWMZ+8T1NNGbYyWSKMHfgAqCFxndmoNxYsvOd2QrNkE+v5UQWM0kiK7sshPQjBA9fpWibK3t9NSV5QSWOzaRyScfnmmk2TOpFGbcSZYFzwByB1xnimTyupBG5GOdhI5x6GnzRMzYyzvkgAcfMO/T8KrSrI04EhPmISCCeSeOM+lJ6EqSYsewMT0zwST0PpUMyYX3B2kDueeaknXy+mDjknsKhkkDsD1OApwehHepduo1IrFfm8wjcnGR7elMLMJAfvIh+b1xnmmyMRw3cc4HHHGaUNmIsDtYjAAHtz/ACpItvQiZBuIQYJJU8+lTeYWG58k8gj05qEnY6sQTuwygdOaURNJHI7OQ2RnFaRRlJ3K90v7wHBxjIBqrOwwTkk4/KrcxKOQxDfj1qLV7YWtwlvc3EEJdR5jZJEWf73vVMxkeK+M3D6s4Bzgmin+Pvtg8T3CaiyvOiqAyY2smPlIx2xiivTpxtFHlS+JmCAM59qsWbmO5iYHBDDBquKkU7eapog+mPC0hk0u3kYcBAOv6Vu/eifPRjjDf0rjPh5OJtDiZSxLYLEsT24HtXaIyrHg4Hy8V5Elqe1Rd0iUbcCNiDlNvzDGBmo45B867TnHGOh9ahOZELDqeDTEwMPt2nlSf6VDZ3wWmpbR965GCvXI7+1KGHmMG+bjr0P1FMgCiPjBABzz+tObak3zEhAoH6dqfQpPUYZG8mRXz82AV3HgCpIBiPcPlJAVSV6+pzVWZsAdjjJ9atAgtbpyWQEsScdvT6VCZrfQswdCjlgincdgGc9O/erMNxcQKvlTqSGOQw7dvY1RcFwiAkPjHOOQR3q5EjQblcBscq2eMcYIP0NMzloJGsrJt6RFs42nOaf5ZMBGE+Rhuw2Aasx27ylpFDYUDaTwvPQH/GoWX5vKnkUYz8qjv/hTStqCkV5VIZyuHyOvYZ9KiKgszHCkfw4I59qkcCOH92VPJQfNj9O/1qhIzLGBuYMffpSbLWpbV/LuAgC9MjB6CrZYAA7ScA/h71n2pYFiRnKcY5q0LlflSRlDEjKkdRRGRnKLvoWcKExIpUAgjB9BwTUtmpleaMNkR5Yd845FUZJxIZcBtkYwcH0/+tUqTbRI6FRtTAA4JHSrUieVj5xhy8YLALkHA6kZqAukaLlFATDEt3yecD171YiBR4hz+8GCO2BVq/g3WUTudvksEVtvboc/nVp3EnpZker262E7O5EcMmWUBs4VlznH4GsuUNAqI4ZJEYbkPOAeQ2fxrckt5bqza33JcjarIwXDBdxGM+oIPHvUXkrFaWb3UjGSV2R3JyShTp7Yxik7smM1b3jBeX7Rb2ZO7zIA0IweSM561BGhDSoAAik7uhyFPGD0zzWjdaakFmj2shmjdmCIPXAxn3xzVKHy/tMZCAI7KWQnHzLyenY1NjRSTVlsIH8xZHcHDFnCg5I/GprhgbmNYY/K8xNjBTkfdGcflSWgU28quFYmLGQdoAHPT9KS4k8y4VEUCQSZUg9PlHAp20M762Kd24KMh+VoY3+UDOOehrLmlEURZifMclduegHrVy6dpoJJCwKup3HuW/yKoMFMUxYZ2YJJ5+9xx+NZs2iu5RvGES4XDgsXxnjnv9a878QuTeAHtz9K9A1QoiEAgNuGR745Neda6wbUGJ9h9aFuUlZXOy8IKotVeRSQMFTnHNdzbEtuMp4Dbdp6DPeuI8KhmtYduNo7HtXc2zlV3qEJU5Jxksc44pxM6mrNeFGG1JsuwGzj6dqd5KooWRihPKEnHy9/x4qGCV2klbO85G4n1zzUyzsJId7knLCPAz+H61RhZplQRhhIwd9io7oWGOTjA96sBmY7SyhA7EDoCVAH55ohEaySSjI24xlc4XncT34OPzpzlIXdSrB8gZ4zyMkfXmmjTW43zlMUbMpZ49y4z37H1/CpwjtbymdWkbcBuPTGD+pNR2wMjzQlU8wFShB6sW6/lVqWQ/ZlRCfLY7+vBJOAfwpoTl0KNwChZEHPlLGOSDnFIC2zB5b7owenrjHrUijddSEgBsgj3yOKhBML7UxujySSeOmP0NBonpYrahcyW0Syxgnc2CMYJZeMfSqkNyxd4XRVVjjbuyU9Tn1PFXtRjXdGPMUxjd854yq9evcmsQeaNRhaFFaS4bgAYA9h9PWs5PULrlL9+YyzWhZWTYAsinoerDP1psccaQr5Sny1UhWfue2TSIYJ44o4cq+0iR/xJ/IDvVhSZZ1RsJE5BI6cduPWp6mbnYahn2pCxVz/AHl7/U1aWNnykIBK9FU8YHv9aliikjmMyMMqNuM5Ge+KsPAURgoLy4YNg8D2H860jFnNOulsVY4EFtPOv3WwA3Tdz1A9fWnyRLuE+PJiK52HnHbA9auIrPaW9qm4xxDO31Yn7x9D2q4yJNbxhAMEknByBt4H9a1VM5p4gpwRtJcKpJTz0+9wCM8f0pq2QWaSCRl2QjchYYAY9/rkYrTt0gDh/MEgCgEn5RwDj8jWeJM5MdzBGzbZPMZvmJXjArRQMHW7DWtWnOY1QSH75OQRx/LrWTe2/mySS4wFGWkweVHJNbqoZlwlzEzL+9JwSZCfXJ6YrL1G6aOFoSpLFto+Xaqrjn5aUojhWuzn5dyS+WWz5g3dccHpUVyiEh02qGXJHuKkZWjuAc72HUnPQ4quwLRxhcgenr1rBrudSmiOd1aAY6AluvYjkfnUL8Rx55ddysM8eo/nT5Ew0qSYLZI4/OoGdgHbG4byc/1qbGsZXGrKWZgxwqH5Qeg9qlgnIhlYj5hgDd24qH5REEbO7lqkaQeW5TBHAJIqohLXYgX5tz7iHxwSOh9asaxHa38Ul3c2WqCR1zItvHuWQ46g9s1UX/WlmGVJBxnrWh4wi1Sczy2WoRxxOo2ILtU2DHTrWkVcwqux4J41u5r3xFcST2z2hULHHA4OUjUYUHPtRVXxHFdx6vOuozie5AUtIJhKCMcDd34or1YJWszynuUQacD70xacvWkxHt/wluRJo20HBWvRUJ+Vj0b+VeR/B64xFJESeScc16xA+QozyeleVVVps9bDO8EPf5iRn5RxgUQqTkNyuTmmlcBSdvJ9O9SwuscUqFSJGbg+nrWPXU9GLaQqkoCRtJ6KD39qJAVnZHH8W7PXHHSn7QEiLHOeM1HKwErAgZLdSO2KXQtPUZGc7RIcbgOe/pTXyuSRndweeemKexwpZQpGABxUSkhMMDx0GevPeoZoi3bkBFPJAPTqc+lW7Wbs7KF3EMGOR+IrO3KFKJtDD5hkYNSW8kgk4TcCM/dGP/r9KaZMlc21QRxFvtI8rqDu4wewB6tmqLyPDNI5ZGJGACvU/TtUDsc52qg65Q/L+VK0IkLFuScAfNQ5XIWm5FFM6qquSWPb0pCxWfc5wAQDjmnXDD5QowcelV8u3y/NuzySai5qrNFwyp6ABMnOcHbUX2jzCVIw24AZ6mqkkW+RNxOAe38Jqby+rLlu3PelcE0i3bu4lWQAEMqsR7/5NSwkRXP711O5dpKrx71VhfamOQFH161NbxGRw7YfYckbsEj1rRakSkbAikmVQFztBz68Hn+lXYbXzdLdbiTYksoBfIOFJHb61SlnkhRGRNqht3QAh8YYf1q9Nc20um7slIcbdu7d5ZP8WB+eDW8TllJ9C7pK4uLxTGsvlR7nRmx8+7a+CO+Rn2zWXqUkRtLmOHDqpSbDnDBWBz9TkYqaKOWXUJJ0wYbpPmcPtAPRip9CR+tUdVctpkMu9RJDCVbBBb5W5+vXv2q2Zx+K9ypd7ZrWKZUKOo2ZXlWYDjHueeaqSTuyI4WMNv5RR95Qp+X6Yzmi5d7aC2MUxODtO7Ix3X9CaLvaJrgxSblU7F2ndkheQD36nms2zqWhDbFRFJlQHKjbg8n5f8Ka7eVLFLnbIQ5Kt2OOtL92BUhjwseW3N/EvcHvn2qvqjM8kjNIGKl2LE8ngCh7AlqZkjlbYx7Ttkwc9sdSKhlkwxlYAJjGD3wKtSjMJAzsKjk9MHvVPAMbHlcLjPswrN7mxk6hhnHPO0fN6159q2Gv3weM9a7q+ykOCB2PTqK4G+Gb9seuKI7lWsrHe+GWC2GAoHIwfauv09WWPBGN4BBzxj/69croUZaziXAGBkjua6yzIZgxBPA4B259KEZNmnEpjtMupBLb+eSp+tSXG5pWeF/9HUrITjI3Edh9aqpcSsGXJEjMrn3IyMVORL5ELqJBC27Y+OG+Xkc9eaq5KWos+y3u2U5ygALA8SHOD/hTm2qrOVYujKSCOhOMde2MCobl/OhQzsoYgISGJOcd/fr+NTxhpGaSXJPyYGP4Qvyj9OlNMbWiJiPMuo2jJVlDbi3TIPQe+O1RSSp5VwzY3+aFj47c54pygedIiF9xz5RKj7wAzx6ZzUSxlGRNzFBN8zev0poVkTxGQpduY/mwgAUZ6gc/gKqXU5YXsjHB2qqEgZwD+mafCrM0q7iHDDDL0PB/TiqOoOq2hiV8mZkAGRyVPeiT0DRSKn2kSEqwALAqm488/wBKghnaK/LWzt5sG5FJIO1QME+nWle3lVQsEReQjaqrySa6HT7JdOhxLHDP5+Q4UZy3qG7bc4x61nGDmZVasaei6mRb20kkaxAIZ5SAfVcdv610VrYoib5GB45Qcknp16CoYEjgYm3iLMRhS4zgeuBVzeqKWlkaIDAVIud1bwgupx1ajlohi+TaySAlWUjCjrg8fgana9VgQq7uAFVVzt/z/Wm20Mk7b7eDZEBzJIdqqfUk9a0pbwJbxRaf5cW7/Wzhc7z/ALIPQV0QizjqMypxc4XEb5YcHBBJ6A59aeNNvbhQ6QSbCPmO4KD/APXqR7fzCRJPNI3YmT5T7VG6orMmH3bdoTdkD3zWih3Mm+wsHhi8jmY3EscMeNx+YNx6VlXNlbxsqRXJlKkg4Qrirs8UTLgsQ20t8xzk05p7N40MttJ5gTDOrAbmx1FP2aJUpLfUxNmFDRXKgDPqP/r1Gv2hZCxbepGOWJ7cZrWmNhc2YdJTaOoJ2vGXMmONoK8VkTW5D4UJvxnhsY9qPZlqRnmdwyu1vJuXIO3kAD1HcUge3mQJFIwd22/MPun14/zxVyaO7ttrl1ZAAAVw6EnqDVaSWJZ1FxZyRjaSHiOMH+9hv6Vm4FqRWlQwEGTDsCGIVu2P51QRMEBgxZjwrdMVuSWUEVxbCS7gW1uSQJccqPXHX9aqXlvD9qlNnLLLbfwyOm0sR7dqylSNqde+hksGErHgbRjr/KmT4UAKT0yc09gDKARyeOvvUc6kzOCMCsDuTLNlPbQBvtNr9oyMKC5XH5VjeKdU0qGxk83Q1dfTz2FXnkARVAxj+9xmuQ8dNssGyc5yeK1p6tI5q+x5rqtxb3F7JLY2Ys7dsBYQ5faR1OT69aKdqNiloqlL60uScFlhJyuRnuBn0OOhor1DyyqOKcKaelKKTEejfCSRlu5FDEZYGvZ84QYPPavCvhfc+TrOw9GOa9wBOMjuOBXm4hWkz0sG/dJncFcfxd/YU8ANuXP3ffnFV0ybhQeVZefSrUB/eNkKWI61yrU9WJOJcxQgYOMYP40XP/HwQrEZPBx14pkI/duVVcJxk05iRPyMr0Huab2GtyORcuQVBGBjHfmnNbySJ8h+UcHcO/bFWLaEOUK84BJx61pRwRKmPlDjBcD7uD6Hv9KIw5jKrW5TMXTX8yNSdjlfus2PwzVq2sp/K3GJMKMso6gE8YPerbRSMRJLPHbQsRw7Yzj685qSC4hjB8q5knJBAIjwCPbNa+xRzutKWwtrpiknzFuSScYVhtx9fWpf7IfezqrsuAcCLj8SP51Il3MYlVLZRtIdS7cg/hWjBc6ugOJcDIyNvGPY5qlTSMnOe9znrvTkUKhl8tR8pZ165PaqgsWDsI5I5Bu7HJBx0xXQXUlwuBdbchvu7QCcf/XqqXDoB5OZGOSyn/EUeyT6Gkas7GbDp81wzRhAscfzO7DCj/Glks4xblbWTzWjXLDaQxOccdsfWrRSONfL3zIrZRyy5wp7U+O2kWFktnLByTvj5yPcdRS9iuwOrLuZMiPEzARlXAxsPG71pIT5JdNoxjkHv6frWgt3LBCsLOHQ5D7+oOe3ekYwzFPPVFkPO5Rt3Y9fas3RS1TNVVdtURiacowR8DIfBPXH/wBYmh5g8aHlcHaSg7jlWP1GQRVmK3SQKYZkYEZeJhhlPtnrUF3ayRQN98uoAbaOAOxz9afI0L2i2Hx6j9kS5gjJiIY+S4UEMpOQD7VUTUy1vKrQxmMllYAckEHIA9Oc1TPzAYYbh7ep7VGzPtKnagzkqO3rUuTNkohG2bJQx3sileTnp0x70l3cJsyGyWBxg4HIH5VCku07WRHU+px0757GnSHdEjMTwM47gdQKaZqSxq5llXAGwHLDuao3WEjKLjgE9Mknir6SBnuV2lWDEkt6Yqu6r5qEk4OMAcDOOQab2GtGVLpwiKjjgxhdoOccVnztshK8nBHJ6ECtG5iHnBT8rmP5c+pFUboBYoVYgrgtjHOc1DRovIwNRfKsS3Y1w0mXvyO26u21IgoxIwcVxS86io/2v61MdxyPSNDYBUZVJIAUit+2+WCPcASSy9OeORWDoxZYYSpycgkVvxoJGeP+LAkQ+mDTMluXo8PGk23GWPmHHIJ6AU+NjJBGrMybZfuMT8ozn8KrwSs7vGMsjMCx7n0NXog1wzPGcCJtrB/7pGNx96aKaCXdJFtd2d0ZlXjkg5P86kjAkR2Rm80ZO3sTnnH0FMsn3ssapgkIGB6Z2kZP6VBHIWtpAz5OSqsfZhT2YrXRo2r4klAKkupj3HPy8g/40qTll2OiHClsqCDnHXP9KZE7LccH59+7nHHHT9ajcCIPgsUZtgZ+vX198VaM2tRF/dRK7IflkLsvboMKPU45NU3t/PKl2G6FdysOcEt/QdqsRiWadlAxuhMmP7v/ANfpVmRFa8SGCLZBEMu7EHGTzn1Y00rmdSfLsVreBbWZfsxaecsfLO0/JxgjPr1rSlWCxj8iaR5bl0ysVuuNvpuY/wAhTLSdGnUQIFjbKrtxlz7+g9+9bVvHZ2aO0p8+6aTecHhfcn9BW0Ipqx51SbT1RUsNLvZpcPHFCV27gpyy5GQMn65rQl0qCwjDSsk9y7bdj/wn1bHWrF3qN3N5pkaCOOQE4hX/AFgPr3J7ZrNEgRpG24ccjBxjHQ89a1UUjC85eQ6aV5QsNwW+VjhVO1U+ijjNMjBkQFVx8/HbnPemrKDMsxm5eTnch/PFV5mG/eJWyWOUC/e+lXcHHUW5Dxx5JXcrYbBzg+9V1KMiNI5V2JJIGePX61ErEkhS64/ipuFJy0hDHjJXJNCYnDuLKyPLlEZUH3QT2qEuryszxocjhQMAUOR5jcnaBye/4VGCoRhllGPY4q0xcpXuWYJtVVUHkuowW9vb8KoSu+CGDqw5Of05q7NNgKQcEdMjp9KzpGIZ23Hc3Oeu7/Ci44xYi3c9szNGXQMP4MfMfWkE8M8EqXEm25Jys7gtuHoagi3zEwIRncGwfXpxVaZTFMcsCUYjK9OKm+gcmp1uhWEi2kkKywz2u0PwQwRiegBqmloILa6Sdsuspkjbd/yzPaqXh28W0mnlaTYGTaQF5z1BrQ1UB9PNwmN+0MOM55p6cvMY2kp2fU5kW6vraxoCkeS4HXAxVG6Y+dKFyQGIzW5p/wC8unldjuWNu2OtYygG5dpDwST+dcE9D1YPoytIuXGMLnHJrO8c29hp8WpXNxaNcwWKpDHDKxxPM3fjtjsK0bgFpCF9cD3rB+JG+CyRp9Yu2n0y4h3oqApCW7jPLMorSgryMMS9DzLxZYwafrTQ20bRRPFHMImOTEXUMUz7E0VH4ntZrXW7lbm6a7aTbOtwesquNysfwPSivRPNM8c04U0f5xSjNMDoPBU/ka/bnO1Sea+hrbLQRvn7yjANfM+jy+TqVs+ejCvo7RrjzdPgLAcjGPpXDiV7x34N6M00QjPH3RU8MZAUkDngdqZENynGMj0q0QVAX5enWuSx6iloDMNjoRwTg4quSxlUHO0HIHbNWMA5xnOfwzVtIVJLHOAMtu4/Kko3Kc1FEkFrK5Hkqd7HAXuTWl4nj/sq001LNozdSZjdSMshA5NR6BNbwam7zMfLhjMgAJ+b2qrptudUuL/V7ncDNKTEO4Hp7VtFaWXU4Jv37z2X4jLeNRIsl2WuZQedzEmrScs2G2g4xu6AelRpHO33IG2E/Lnj8frUk8bRXCpIHB4OAegx0rXYq9zV08WzxE3BlLdzGQNp9feuggltpo42aC4Dqd24ldrY56e9czZrHICZAWYJgjGOc8YxV23gAUuAygEjBk4J9cH+tUYThcdqlzGF3xFXdTuZzHkYJ6EHrzWTe3LXKxBjGqxZYKibefw9quSM5AZwGOMtgYZiB19qozunmIyr8vPzcnPvRc1pxSCPl18kEswOF6547D1qJ2RrhsqflA+ZRgkn6U1kABK/NuGTzgj6UgcquVJWTGMn0ouXbsW5DmZInfaQoVhJ83PXn0qEwwtu2JtJyDg5XH0NMHk42hC0hGN+SB09KvxmJ2jja5IKDd5bDhRjqD0/rQ0mZv3Si2nLMuIni3AA4b5WNMktLy3V8RzEHqY33DHv1z+NasUIkRglzAqkkfMxBJ9eajubWOGGJBcrJu+c+SfkA+vXNL2YvaNOxipOsTj7Rao2TjOwA5+h+lULpYbqbFtJscnGJDzuPY/41rTRTCQNGfPyMlZDncP89qppJBFeK0tuLeXJ2nkx7umT6Vk4aWZqpPdbmdfW0VjKQxaWTI2sVAU/3ic9QKjQZQkh+Dtxgcn0Fbo8tJRbXySSy3jkhmYblIGMD+961i6lALK6byMiBzjh92CBx74qJQS1R0Ua3N7r3HRwus9zG/3xuyMdB700lfNj3LwvUd/u9aksEkZ3REXb1OeORk80y5JAlCELwSxbg+9Qb3d9TIumZp92T8oAXnn6VR1EETbCegwePzrWmh2m0Z+GPzk8HAHQ1m35EhMmMsuFPvnvWbNkzm9UASBgMsTyPYVxlvltRTBJ+b+tdjr3ETsvGB3rjtOBOpRkn+LNOImz03RlOYwcDIyBmujhUJcROPlAypB9SK5/TcsAzDLY4z0rdBzArclSdwHTBHUUEPcltmEYVOqlQDJt7g5GKvo6/Z4yirmQFJSPxINUI5CTleBnjaOnpVuAGKYcEHBXGcDd/jQi3qTWSiQKY5AsgkVwAeCFXP8ASq8Uax+btBzwcccEn9asLH+/SZOS2MbjjB28j86SzISKcSjLAI3KknrRYV9Lk1vHskViQoBGOD+JqM7mVVGc5JA7bv8AJqSMBUGcAgHB7H8PzqIhjgIOf4WB5HHWtFsZtlu2VY4bmZ5AkcYCM2DyeuB6ms/VhJbXMWnLKsbzZmmbj5ATgD6461o2ZX5FdY3jjVpyHOFCx/MzMfTp+JFN8I2ZubiTxPrrqsEoN0qMozMQ2AoXtzwPpVpc1kjknUUbyfT8za0rRlsLaKRJop5jFwq5JRM84/Tmp7K0jt0ndoTJcn/Vbsn8SPT+dUoddulvrm6WNY57tDG+eQqZ4C+mOK0tLiKRsySAfKPmcEMBx8wPqK6NOhwOM9XN7j4bXGcgEqMvtywAxkEAdxWVdAGSTafu91rpdrpHIfNJCL8oJBAyO/1z1rnLp2LSHONygkUwjuZrFvMDDLYY8k9KQ7sAs2cfdFLIF42qQM5/OhOhXByMZNFzW2hBNuLEnd7f1xTV3BCxwMDOWqVicsx4BPaoQozySccgHv8AhQhW0sIVJBJHUde9RFCVb09DVhSWdu3bFCoWjLHBXOSR0+lWmTymdNGCCAADWXMudwHJ9K2JhsQlgPwPXn9KyrjIDnIHX8PrQ2VGJmxSCOXKlgQcZBpZv4cIAACPTP8A9eohgOWx+VSlg0ZVuRjI9Qai45wsRq5EgO3AU5yfStC4v2SCCMfdcZJ/lWXKePmxzjtippGBtrfeRvGTxUybsRGCck2amnptsrp22lQn5d651gWQsfvE8VotMVtGTON5x9frVaaPYYkP3h+tc8tbHRFWuUpgAmVJ3ccj1rn/ABZIb17qPUPDesTPcsjzG3GEkZM4PTK5zzW3eOMtu+6OSBxXH+NLbVtW8QG90fVoRYDHlsbwRiAADhlJzkfjmt8MveOXEvQ4nxSdRm1FrzUdPmsVkASGN0KqqqMKoJ64Aoro9d1GC507xBIb5J7SZoYoFL5MlwoG+VF/hXrz70V3nCcP+FOFNXmloAlhOyVWHUEV7/4In87SYGJzgV8+g/nXt3wsl8zSFDckD1rlxMdEzqwkrSPRYBuj6Y6Zq1zn0HoKqwrgqG5Jx36VabJfHGPWuNo9NSJ7ePzZvu8HtVlYW8xtoJIUk9+fWo4nCkENtJGMgVMLjynMq/xDB9+1OOiFNtkXhyaG78QXNvJGWeaAojZ4XPU1vahcWmnabBa2RV5Fb7uMg47GuY8ISwxa/qTSMq4hYKQeVPtUk0gYgZHqGNVRlaNzOvSvUt0Raubya7bfPITyWCg8L7D0pxLSEyOeuCSx61UhPT8KtwjJboT2+lNMvlSWiNOzJUHjquCcds8VsOqmZ8oHZju5AOfbBrJteDlvuFcEGrkkjKm1SADz3/OtLmLVyLUZAqBIyc7sFsd+nXrmsieRiyli/wAo7/WtO8cNHgsxzy2fWsmcEykDgn8PwpXNqasrEZKlhjJA96sNK7IA7AgnBHUAVAuVOfl/OnuMDOORRcpoAQx/exqzZx8oxxU8QIADERpuJx1OcGoYyflPc8CpFDKwPzZ6daZL0NG2SMbPMdkzznaCR7ilmiR0Jg3Rg4IDHLZ9MfrSQq7IcKC3XH/16J8HIZQjoe2cj05/Cncwe5kamcNtIKlc7Vzn16GqN0qz+b5ikKRnA/hNX72dldAyrIo67wDk1Qu1j+9A5KAZYdx7Gpb7mkE1sWLGNtR0mO0y32hMyW0h6pKO341gR6lPfyOJ0Md0CY7hQpAEinjHsfauj8OyKMqgDSZOzk44/wDrVz+vWosvErzAMrXS+YyDj5gcH61nUWiaLo29o4P5E9t5TDzCuI5RypHp71DKGDMvGT370qg7l6sgPTrkEUyUEyr8xx0zWTR2R1Yx5POuSFwQi7RkfhWDPkFkwTgnI9RW/jJmdmACLt4HWsO8LBzt+8w5JrORpF2OW15iIHOeSOa5TSv+QhGe2fyrp/EeViYHuK5rR8f2lHu6A0RCbPTtJH7hDnKk9fSttG2FVQ7lJyM+tYemkKsfHLDnFbkYDOpxgKMZzSRKeupdtoCWbO0B8IVxzn1+lWLdd8Blk2kQurMD0Kk4z+eKgZhEQUYliAAR6/5NTQgMY4lYlf4h68/rVWBO+pYThJCoAIcSKOTjr6+lQ3YIkUu+5SpGOgH+TV6QqQjIoDrEFcE5BYEjj8Ofwqm31ztJGCPXtTYoyESUZBdnLKRhQcduo9aeCuPmcRsx2k9sHtUPlksoIPJwWYcVN5RM22M7mUbiSc4weTjpVR2Jm0iDVGENg2nWYkLau4RsLhmhXO8Y7ZcgDHBArd1yb7LpsdmCvnNsCwheY4UB259CW596ytE1QXnjibWFCfZLOMrECDtEaLjB+pz+NV7m4lvrh57hmknkO8t/d/wA7CtIysm11OOVNuai+mr9S3ZZeZOMrkYHvXe6bAxgk8+EiLkrnuccn3HHSuF01Q08YjGeeP8AGvSUtmk0kPHvR+TzxuJ/n0rSOxhXdjn5pvMWYuqB3VfUZOe3tWPPJl5t2ASeOOmKvXWcSqrAqDlcDGM9ay5jhWXoDzj3qwiiux4Bbp2+tCnAyTg96aoJwOhAzilKMFxyRnPSkakTt95jgk8YoQnPy9MYPNDKATnJJbqaYgHTkDNMVh6AHd6HHXvVhEAhGARx0NRQA9QvHOM1okYVFIz8nbqD1polowrtMwE8gs4GK5+7fIfJzk10Woo3kxnozSdunQk/jXOXYG3PaolI2pwuZ5A3EflUhG3r1xio1yWJx71ODheD0x/OpTHViV7pcRqxxg8fjU8ybrSAjBYZzjvVO6J7Z61oyMHs7dVI3AYJobujn2kiIbW8tXPfOKqahN5kjt0HQYq6sOWJD8Z2jjoO9Ub5QWwnYioexrG1zCvXIjfkqDgZz0rnddbR7W811B4ftZjpZiy0rNulRiAzH8xitrXn2WMndmBAHrXL3ksemayTe+KHGoQRC2kX7F5qBeuw54bHvXRhVucWKepzXjGGOHXpPs0EUFtJDFLDHGuMIyAjPvzz70VV8RXAu9XnnW+e+D7SZ2i8vJx0C9gOlFdhxlFelOFIOAPelFADlr1X4QXfyvDkceteUg12Xw0vvsuseWW4bFY11eBrRdpo+goBuKkjK4A6dq0ET92M429iKo2TBogVIzjgjrV+Abxt3HB5OOlcNj00x0cRRWO7BIp1xmGGJgCR60PxjBGRz68d6iu2MiMvOMcGjZGkXdlHR7ZjPe3eRgYTB9+9XJQA5HVh2qDRUIinckj5xgVO6ne4OOSenapp6RKqNubJoh8oG3pwcmrcRw5wPbnsKrQLzgDgirsS/vOMggZz0rREsvWuOMYIZSAetSsVCBeDjr349hTIUbYnbnjFOO4SbmBY5wAx6CrMkV7gHywWIYAc44zVRxyrAcY6DtVyRRtJBBABOBVZmUrnGOg5pSNYsr8GTp+AFS7TsB4YHIFN24YfeOMYwPu/41Nxs5I3dQPWkhtkUfyyKRg475zWhhShkBzxz9aqIDuAz8w7561MAdjlsY6AVRnIt25ZIAd2FOcCpLhZHt2BYbUbjIwWBA4/CpIIUFsJA5JI+YY5HpmmsxbnI7Ltz1x3pmN0znL/AI+bA69u/pWVcuwJK8Yrb1EDIyNxxz+dZV6u2IDGWqZbHRFjZblLVpki3CF0DLjg5I6g+xqr4nuhdaZpM9yCl3AFXfnJZemSabgSwtsADx9yc5B46U5gl3pF2LuZR5UOyNSOetRL3k0aKKhJSCxdlUojAhuOR0Pap0QPOSxxjoAKy9FufNhi3j5ioB/xrYceW24HOemKyWsbm0tJNFaWLZZTucDLYAz1Fc1ej5WVhn+6a6a94t15IcsSRXO3xAyFHzdzUSQ4PqzkfEZ3I/oK5nSv+QmmB3rpteTCOH4IPBrmNMbbqcZ7g5oj1Lm7I9P04howwBUBR161uIyskQUsDgbh6n2rA01i8Yz6VtoWypUAbR3qCVqXQVEzLklVO769KtlAAZUxtUZ3E9G//VVBF+Vpxt4O3A64xVy3P3LfKGOY7jzwBirTuV6FiKVsIXBJXGM8AZ5/yadNu3AKwdWxIw6HvinJ8z+ScgAFFBPbt/Omsod1B5PdsYOOw46fSqIbI4WzIoVX5zx972xVXxPLJp+lGOVQk90QxQZzGo6DPqT1HtWxpywvEzOQERS2Sdik+ma57VJptT1Kws40j27zMV28Y6L/ACJpz0j6kwd53eyNnT4IdL8Gog2tcXjkSYyCqAA4x9R+tUIRjBJw2OmDVi/PS3iIaOMn5lOd2eW/CoNvzZKj64q3bZGML6t9Tb8Pqsl0m4Ekc9a73ULiSOBcMygAn5Rjg8A4rk/CMKPdDcDwD0A4P+FdHr7sFDRyZAUYKtwCf8a1WxxVfenY5i8fZvznAOOemR0rPkY87s5IyD6n6VYvHLfXPTqB6mqfOzJwM9xTNkh8I3v6AHpSScggZwDinwg7y2MqO5pjnCkkA+4pjK7BsMM8k5NCLwpbODnPPOKWXgj5ucZNORCxwABgAYP9aZXQtWkRZnAIJ28A89ePwrTntyAdqZKIRtIyV47kUml25eRY1DMcqQc1sSGWL7SZAeIAAMc5HbPv0pmM5a2OI1PAt7cgYJduP+A//XrmL1SIhnGD2FdVrJfy0diFJjbC46AkCuWuziM4znoTWMjromdGvHuBgc8CpWHBAbAOM8U2IcAgZ/GnuByMY57ClHYKyKNyo2gjoOKlh3lVXA2j3qO7J4B6jkcVedP3dvs4460znvZl23h/cSZUAqAAc9aw7hwDI3XOeO9bryBLVlHpg1z2oEFPu4APFEyIs4rxpcrHZMrHaGOCw7CsPxNf6fBqrxTeHhflUQLeSTOGuBtGHO0YOfWtHxRarqM7w/b7SyEYBzcPtDHPaq/n62Bj/hNtMwOB+96f+O114eNo3OKu7yOI1OWGe9d7ayWxiIAECszBeOTlueetFWPEbzvq8pvL+LUZii7riJsqwxwAcDp0orcwKFKOtJSigAFafh+4+zarbyE8BwKzBUkb7JFYE5U54qWuZWBaO59ReHbgz2kTZ+8Bk10CIVOR1zmvOfhtqYvNKjBOCPfrXosb72Uj0FefbWx6cXezJ2YLGSoBYckVWugfs4fpnjirF0CrJtGCevvRdKoRYmXpyc9xSaNYStYrWCBbdefmY9KaxDSZA69vWpyNpAGAoGRxVNSfM5A4NS3ZI0j7zbNC3ByOh9s1dizlgTkkYBJrPgJz2H1rQgXaAMg5pockacX3Y8jOBg80p7MMbj0yKijOAu4E5OMZ7UEl35ByOOlXcwCRvkIA2j0zjNVnyF6AkHqeTVib7ucYI6gnrUTHnJPft9KTZcSMg7uuBnj1o52AYYHPehsbgevFPONhyBtPBNJDY2NSCuOpPHYVOhOxkymN2SMc1Hgk4BH0HapyDg9uR+HrVohs0bMJ5ADcnHABqKdNjFSvTkMTnBPpTYMEYB+Tnp/Wgkshbt2Gf1pmNrMxtSyR8uSMkN25rFvGOxgTitu+UKp5XcAQOKwrpsKQ3APrUSOqmZ5fbOrHbgYyAeDSFS4uEGPnQqMj+VMkIb0Jqe0+d1AGGOc1kndnRLRXMnRMxTyKeFIyAa6swq0SH7hHXPTNYXlRb0a3YbgNxHpz0rcsy8tv8hDg/eBopq2gVZ83vFa7USuiKc46n1rB1MAk9sV0k4O/KgAKCOOtYF4uSxIzk4pTREJHD+IV+Usx6jIFcZFIItRjb/artPEWVRwTnHevOr6byruEju/NFKPM2isRU5IXPY9IlDwJ0GR+Vb0f3WG4bz1PpXMaDLvsopD94gdK6SI5c5wWPbNZMuDuixBFIyeUTywyR9Ku2gMkshdeNoA/n/8AWqBFInMnKqq8ge9W4yNqbcA7cEjuf/1U4luRdAMjWzMTjPOeRz0/XinyJlZWyCpO0MOOenAqS1RWMaMT5TgjJHT8fzqKdzEoGcB5OARyuK0MW7uxIWUW8iyAmJeNm7aDxzmqsUEiC5v7hVilnAWLGM7e3HbjtUkSm7nWNwREZNpYDOVxuY/0qO9vxeuZ1iKqgZDwPmbPP4AYH501JGUk/hXzK0wTeQq4HQAdgaWMDzMepx9KXBkdRj2JHU1JEgaRQnbJx6ile7KZ2PguPF2SwIU4UuD90mpvEssQlcQ/eJHK+noaj8P4jtJXMiouMfN6d6oahMCx2qqhiTgDse9bp2Rx8rdS5nXALFcnB2846GouMKoB4p0mQfX5eaYoORtOD2FK5qTRnAAORyeaZtwOQD3BqVEJjfI5BAzTXQHPc9frWiFcjZD+JqxawF2P8v6Uuzlcjp0J6ZrSs4CZ9uQMDO4dSfSmglLQvabD++ZNpwGGBkdcZwafqUpa3ZSmQzD7p6Ec8/jgVraFAuZcAMWc/Me3Axx+NV9UtI4oxJuVSrZG0DJycCmczleWp594kKrJsUkYVU444/8A11yt6xBfcPYGup1/aL5oy2SMA56njn+dcneLn2x6VjI9KjsVoemQATTtu1epOc5p0WNp5zgdf/rUvOOMg+melStiar1M+6zkZ59AK0XRkto2XkYyazpx84yM1tmQf2WkW3LkdaqPU5ZuzRXVh9kb1Pese9I8gk57nithFHl7T9a5zxFOsFnN83QEg03qkRzWPKPENveatq8wsbWa58r7wiQtj0zisr/hHNY7aRff9+G/wpst9dpfytaXE0LSsAfLkK7jnjOK7OaxsLWO9W88Sa40tg0aXTRMdqs/deckA8V3QXKkcEndnA3VrPZzNBdQyQTKATHIu1hnkcUVpeLbdbXXp4UmubhAqFZrh9zSAqCGB9COntRVkmWelIDxS0UALSg8cU2nUAeh/CrVvs141s7YDHIr3rSZCUDMMccZ5r5U0K8NjqUMwPAIBH419IeFtTF5ZRMp7DmuKrG0rs66MrxsdZIrbldSCgOQT3pb6VHjEkhG48D25qDcWQoPu561X1Q+T5MeMkn1rKTsdMdR4z8+7rt4x6VWjGXOT09atYEeeeq1BEect0rOWyN6Tui3CRjPbse9Xoc554GOtUoQB7D+dXouCcj5T2poqZbjzsXIOKfuJPXFRx8DJ6088DcDye3pVXMQmY7R1FQNg7cdcGp3yy9uOfrUGAHX1z09KCkKxG7djnqMU4AFSfzpJM7sH8jTk+70NANixjlefYYqU5IcDrxznjrTRksvUnOafkYcsTnrgduaaZmyeJv3eRw4J59vpTljZkDqoY8gjOOtQQ/xAkleWx1q3b/8e7c42ctzzntx3qyHoZGsLtXG4AD7pA5YfWucuhuHGScda6vWkIgGR8wJBHbPsa5i5GE+XnoPqKiZ00mY8px6596ktdzShVYKx6E0lwp55/8ArUkLYdS33Rwcd6w2Z1X0JrCzCGJ2wQ7MrYrSSFrO5aHquNwx2HvUelv80sWcDGVz2rS8trzTzOhJkTKMfUVpFK2hyTnJSsyncN+7G3AzwB6msHUsR7lU5bvWrcZXyw3O3uOlY2sf644ICnkClPYuG5w/iXlHOevNeWa3J/pYAGdozivT/EjARSsOF9K8nv5TLeSEduBxWmFV5NmGPn7qiev+Cp/O0qA5HQD6V2cLZIQAEE5yK8w+Gt3vszCSCVPSvS7EHaijoehrmqx5ZtHRh580EasBbY+W4OAw6jjpVxxueRgRtJGceuOKpQFim0D5gxPXPFaCuMAj+JuvvUo2bL9uGERV8uhwmF7HtnFMkhnvL6OG3ZXuEVnbc20EDrgnvT458XEaq4Cu43MMjGCf8auGOz+zzXd0HE1sCI5OgKnPX+X41skmc7bi7kaSQW8l6VnE8cFoBngAO4+7x+FYMSNb2tuhwGx8wB4J65q35SpooeVQhuJBJtA4YDgVXLb+QNq9s/zrOTHT3bHQjnJ64zn0q9axkygDoRxzxVW2UKNxxjI/+tWnZ7Y9xx1OOMZqoBNmvbt5NtkOpZD8o7D396zpn3sSxILH15NWnOyMqX59CSQM1WDqch1ySep7jsK2uZW6lds7+FPHagjLEADcD+VSAHcSc7j1/wA+tIi8j8DmgCfb+6+Tp19+vemFctt549asSNuWNSeuM9u9MhRhMCOoHWrRA+0h3ygNywOeenTrXQabbFWjcoWbyzIFxyfQVjQhvP4IIXLg+h9a3dLuUt5Ul2E+WMHJ6j2/OqRnUb6G/pNlFBahmjxKp+ZmOct71Q8QjfJHBD/yzO91UdAB/UkfrUkmrqtookjIfePlPHpknGawdT1WRZ5JXyfn3ZX7o2jge/amc8IScrnEeIATqdySoLK5XGfTj+lctdkyEEjBY8AHiti9dmUliWd2MhJ7knNZMo+bk45zjFc82ezTVkRquFOCM4xTTkKcfrVggbVIBHeoW5Un3prYxm7lEjdKoycMeprWh27Wjbr3FZiDNymTkFsn3rb1CNVkRkH3uMU4rqcVadmU59qQkgYNec+Pr/ybFlBHzcYrvdWuESArjHFeJ+Pb7z7zylIwprWC5p2MnK0bnItnJbOCTkEV2j3l4dcjh1XS7ZW1e2jS4hM/leac5WQn/lm3A/ya4sMVdXHJUgjPtXVasuh67qEupPrX2JrjDzW81u7urY5CkcEenSu45TK8Vz3M+uT/AGy0FnJCFhFvnPloq4UZ78d+9FN8TajDqerPNbLILZI0giMn32VFChm9ziigDNBpQc02lBxQIcOppaQUUDHgnHFevfCrVmkt/ILZYYWvIK6n4faibHWo0YgJIfXHNY1480TSnJxkfSWlyh2XLZzT9T2yX0Q647VjWUxiCyq2UYZ4rQs5BNfo27PPeuJv3bHUnZ3NO7XahA4+UYBqjD97+lT6hMWl+Y4A4HNVk65zxWU3dnTh3oaEPRcnirsY+Y56D1qhA/ccdjV5GBznJoTNpFyJvlIAxmn/AHiduB61XjPofbr3qUSAHnII7Yq0zKxKegJBxjp2qHaeCoJ56g1MCBkkkZ7HpUeAfunpxxQ2CAqWIyOPTNPHIyVb8KRtpxg8j2pVPA28nP0polsTGOTkfWnvyG+nSmnAIwue/WlkyoJHBx3FMkdabjI+QRn0OCK07ZSYnJQ5HI55x7Vlwn5iCBnNbFhPEtrcKwTH+0f1xVJkz0MvU1AsCTtPbHfGetcxdACPrxjHFdXqEu+1fcxLEgkAcGucnUCBSdvIxUy1NqTsYciAEA9O2e9Qxjc+QODVqfqcnAHTioYhgnr7VizpvZF2xj3yhg2GHH4VoS3TWlrNbQgBnYZPt3rHicpcAk43DGKt37lJoGK/JJxmqiznlrJJigGSLzV+6cjmuc1U5wFIPqK6aSaNWEYwVHFc7e27G7dEBIXnNOeqHCVtWebeNLjyrVwc8npXlu7cxY9TzXffEefbIYgSCTivPxxXVhY2jc4cXPmnY634e3n2fV/KPR8AE9q9n00grySVNfO+k3JtdRglHRW5+le+aFOtxBE2cgjg9qwxcbSv3N8FL3bdjpLYlsFQWbGPpV2P5oYye3XNUrSRd6ZB6EFs1Ytm3w+XwvX865TuuW7VGeRoFyzMMKe3NVr0vdXsFkjyNHnMy4yF+taVpOtknnSg4VDuHrkY/Sk8M2ole4vpDvyQN2OVGeaqzdkZyqezjKfb8xuunybi2hOCka5UDt7VTt23IMnPUc+gqbWJfMv5ZcAmQ8cdqghwHU8HAOTU83vDp3UFcvRfKE4BPp6VdtxgDHXHNVcbZMjBU4AwcYNXAu1cnjB+9n9K0iTuEjktlT09OtImRnaPeonOQxQjA6kcc1NEMKM9Tye2asLWQ5AoyD1zjj6VJChEirjv0NPjRcM2MnpTlXDZHVfXmrMmxr8yuQMr78n6VPbsNu4nnoB6VEqk5OeoJx3/AAqRSVQE56Z54q0SyeDaBIq43YGCeDnP+FWFvAQdx8ra3L5xxnpVFZWTzDuGe3tVKSZwC2dqknmqEo3N2a8WWBTIxLZJZFPYd/x4/Kuf1O4L27pnP8RKn7xPFMuJz5ewk7aoSSArkAlRyPX3zSbLhCzMq9KlmXPC8AVnsfn4+6T0q9cdWOOeO/FUXGTlcHv1rB7nXeyFcAFeccZxUEh2rzz9Km7/AF71BcEbSv51ZzSZWg/4+UIH8Xeta6Dvtb5sjt0rHtjtukJzjtW+ku5GecAL6GnTjzM4a7OR8SXCxQyt02jua8J1i4NxfyuTkZNes/E7UI4bWRY8ZYkADivGXJLHPeumhDVyMZyukieC8mgtriCJwsNxt80FQc7Tkc9Rz6V6FPNq9tNHBceLNGimdVIR4ACARxn5OPxrzVWKsrDGQQRn1rtpbKw8RPJrEllrsbS4edLa282N2xglHPQHHfOK6TIo+LdH1BZrq/ur60v5YCkdz5A2tFkYUlcDg+oopupeIba5ttW2QSx3V55dskbfdhgjxjJ6lzjFFAHMiilznvSUCHA0tNp1ACipIJDFIsiHDKcg+hqKl70mM9w8Ca22paeisSXUetd9pcJSYOmcng5HWvnrwHqx03VEVz+6cgc9jXv2j6gkipIjfIy8VxTp2ZvGppoaOpyf6RluOKbEQwxlQfWn3bLcIZB6dQahtWOO5H1rinudtGWhcgbaxDY59KvxOAeOfTms+PJQfKCenpViN8Pjhe2BTOpO5oREE8cf1qXKgnkj1qpE2DzjAOetTM+GyvI9etUiGXg2QcE5788Gmk4Ubsjio0IYAcE1G77T3z3x2qiEWicgAFSD+dAbOcfTiq+4cZxj1xT1ddnT3FO4miVs43A59qaz9MHOOtRSScjHXvz0pGYMBzjt7GncXKTRth9pJAAznH9KsDqAGJbtwKooQQu084xyakLqwwMMfY9KYNMmuAVjYOuw4yffPSsuSPhlO05yVx0+v1q/IcsxJY4XrjFZjMASykBcnHqKHsNGTcISegIHGTUJUBhgEAeprQlUszdC2M1WJ/eYIyxxjNYyRpzaFaUYkUg459KuTmSWxDKcmMgiqsy5fb2PWtXTdp2oRwB/nNKC1Mpy2MHc6KJG6g9PWrTP5OnXN2f4hgA07VJVJfpgHjFcj4q1t7PSJY2IVMHGa2WjJm3JXR4743vTdau+GJGa5w1Pezme6lkY9TUBxXoQjyxSPOnLmdxQfT869g+HOoi50xEY/OnHWvHlPNdV4B1MWWqCFziOTv71liIc0DXDT5ZnvVtKAFXA4OcnrVy2Xc+Cy5yCD+PQ1h2s/mQjJznoa17NwJYs8qrDJxXl9T109GalxEGCRblLHgKW6VuafENO0bYd29+Bk8isXUEWWIvCSxA3FcdR3rcvZmlWALt8sRKDj1rRqxy1pcyjHzMO8U+YhY89v/11FEpzwAAT+dXdSjHDgNnpjtVdI8MSq9PSsram8JpxLERVx057H3+lTq4CEDHPUDuRVWFRuXk4PJq1jg5I9M5rVAMdumO/OD3qzHkpjkDqO9V15fufwqwg7DPsKpDlsWY8FeOM8nP9KnUHymYccd+KrKQOM++aljkAjYL0xjgVaZgxygYX5fvev0qZsg8Zxngen4VC7Fee9EkmeQxLAYya0RNh23ERIY7sfUfQ1m3AH8Q5Pqat3EuY22g8gZx61QmZQw+9jgZPJzQ2XErysRsBYZ7Z44qvKwy4OOeMjvRLLmbb3FVJ25I645z61k5G6RXnwwyP4jVJjgsPbpVi5kAY4zx6Cs+NyWLHr/So5tS3sSZYYz29arXTZGeOeuamYjcdqjpVa5bYpycn+tU3oc03YSyQPdKC2B+VWNQn8pDlvlUdjVSHdHBuyc5ya5Xxnrn2KwkGRvcYArWltY4KruzhfiBqYvdRMaE7EPPNcj3/ABqW4maaZpHJLMc5JqHFd0Fyqxzyd2KMZG4EqCCQO49K7zXbLX9R1ZbzQppJdNKp9lkt5wscKADCkZG0jvmuDpjEhWClgD6EjNWI3fG00Nx4iuHhkjmYJGs0sf3ZJQoDsPXJzzRTPF1tBaawsdtEsUf2WB9qDA3GNST+JooAx+lKKTtSigQo60ZIH40maOtADgaUZoAxSAnNAEsbFXBUkEcgjsa9I8EeKsIttcn5h0JNead+KlhkaORXj4YHrUThzoqLsfVGjS/aLM8hgRmpImCSlWxjpXCfCvxIl/ZNbSvidO2a72SLzMuv3x29a8yrA6qdSzsW0+76gGppE+ZXAyRVS2fgqc46c96uRlTnkEH17VmjsjPsTwNg/MMjP5VKzHPGPqKrqpDZxtB5ApxfPXkjvVo0vcuRuNgx96o3kGcFiB7VB5gwOSDnPFRtJ83tSY0i2JPlGfzpyv1xyKoiU7CAcD6UscuOD8ufc0XDlRaLfN/OnlgFHPX1qmJMt0yfWpA52YPrTuS4krnavXoeh70Qz7lBwoB7jtUUso8oKeD1qBSwQIpOCMg002PS2pekkCjGTz09qpltwIIGQetS5yAeC3Tk9Khk2428Z9qpszuiGZzkEZwOuepqvKdkiMOg5OalkBAPXPeq8ymRlUDP07VnuQ5EiKrFmP15pGcRQOd2BU+3y12nkkVRufmiYDoaErMx5zOu7uM252kZHX3NeR/EnVtzeQGySecV2nibUotPt5CWAx0968R1W9e/vHmc5BPFdNGHNK7CtPljZdSoevSijPrSCu44Ralt5TDMsiZDKc5FRUoOPrQCPbvCGrLe2cTow3qMEV2MblmQg+3FeDeCdXOnaisTsRFJxz2Ne26HdI/l7/mY9OK8mrT5JWPVoVVKNzsLIfKrs24DBAPp3rWgkB3/AHdoY7cdh1FYSnbbCZJMzI24pjIK96v2typi81FOxvv55Lehz2o6Ez95XLkyLLwVJPtxWaAVJJwWHbPStkxl4eWJ44A7+9Zl3C8ZD557nHU1kwpTtoMVcA9SB71MrgbgMY7DNQ/KYyO+ecH+VCkAdMZ6A01odCdyYArJuGcY6VPG24lcHGfzqE/MgxkH9adGxHOf1q+or3RaOOWwS2MA5/lTw/zDjkA9uar7lKjBPJwc+1PV8gsfpirTMyViQR69iaikkAcZbJzg49abu6nB/Gq7zYIUDr3/AKVQWHSy/MTznuKpzTck559c8013wSc8jrVKabDAMRnJxx14qJSsbQiKZBulP4Z9Saqu/wA2RnAp0km2JBjqdxNVGYlH9WO0emKzcjYr3MpZDk4ZiagVsAZ696W5bLhRwFGAPSotwzk9+1THUmbsiQMQCcVVc+bKoBz71JISRjufzqKUiJCwPPetYq7PPqz7D9VuYbPTXeUqFArwjxPqzalfuwb92DhRXTfEDxG0rfY4H+Ufewa8/wCM8+lehSp21OFsMYptKTmkPTtW5JoaRrV9ozStp0yxNKAHzGrZx06itP8A4TfxB/z+R/8AfhP8KpeH7CzuIr+91R5hZWSKzJDgPIzHCqCen1qfUNJs7nS5dT8PyTPBDxc2sxBlt/RuPvJ79qAMvU9QudUvWu76QSXDgKWCgcAYHAoq74qsINN1g21oGEXkQyfM2TlkDH9TRQBk0Ug6CloELijHFJ3oFACnP8PWnA44P6U2igB+cHmlByOKZnFOFAGroGqTaTqMV3ExG0/Mueor6P8ACmtQazYQ3Nu4bIBb618uA/rXSeDfFF14f1BXjJaAkb0rCtT5tUNOx9PyWvmL5kQIbHQiq1vcfvGSTIcHGKreFfEFprNmlzbyqR3XdyDW7e6atx+8j+SXuD3rglDsdVOtbRkKFvOUY+X65xT5IwGyG75Aqm8j28yJID7HFW5Jd4DAg59KlaHTGpqMA28bunbFRMg37uPrSuSsv17VHcklCQcADvQzZSbFYbVIJzj06UxX25Bzis3SL+S5Mwfqj7QPatRNrbskcVJXNYUSYYlSSR2A61ICdvXimKgzwaerAgg4K+lMlzTEUk9ev1qVcIBkA++agDYk2noOMUEHaB15p3Jcrk0r/NjHAqBzj72Bn3olkCAk4yPU1RnuS+FQdTgDuKL3M7liWUEALyc+nWrVsmxfMYUyztTGBJMST1waW9nAYbfukYAq4o55z6EVy3zDbnFYeuXqWVk7yOFX1rUeQAHsOwzXm3xj1E22kxQxyEPK/GDggVahzOxjzo878aa4dRunihY+WOp6Zrls0Fmbk5z70ZPeu+EFBWREpczuFGeaM0VZIZpc0maKAHo5VgQcEdDXqngDXTcQosjkyxcDnrXlIq5pd9Jp92s8XUEZHqKxrU/aRsaUp8krn1Do93G5Ekrna67XAq3aTLYTvaFlNu/Qn0rz/wAI67FqFsoVlyw5B9a7KLZO3lSnDFflYnOD6V5mqdj0FZ69zqLO4WOdIy+QeQCeK1JYFnjYAZDDv3ri7K4YN5UvLxnHPGK6zTLoPEY2Yb+du4Z4o3MJx5HdGZMhhcqwAYnKn2oLFuAfmFa+o2iywfugCy/MpFYQbOc8Nn8valY3p1OZFgORwSTmn9Fzzg9hVYONpJOMHrUquCpzygHFFy2TbuTwcelSB8DrgZquJFOM9PUClLYUZ4H1zxWqEJNJu6Ek9uarPIDzz2AwPeknkOen/wCqq0rlV4OSOlJysaRWglw7ANkD04NUXds4Gct+lOlfDAVVlkPJIyRwPasXI3SHTSlnbHyg8AVVlcIwyQAo7etNL5O7PA5OarSvuPzdDyfWpWopOw0vvYk9RTS2WAxluwFRNMOAmckdakRhCu4tlsVrCFzjrVuhIyiJQz456kmuG8a+JlsoWhhcGQjGAelP8X+JVs42SNyZTxgHpXlN7dveTvLKxZie56V2UaSer2OGciOeV5pGeQ5ZjyajNHekNduxiFIevXrQKO5oA0dD1SbTJpitul3bzp5c8EqlkkXORnHIIPINM0y+vNMvxdWSMj8qUZCysh6ow7j2qx4Y1648P6iLiFmMD4WeIHG9f6Edj61cufF+uCeQ2+q332fcfLMqgNtzxnjGaAM/xBqbaxqbXklulszIieUmcAKoHGfpRVXUL651G6a6vp2nnYAM7dSAMCigCvS0lGaBC0UlHWgBxopKB1oAU8nNKDSUUAOBpwORUdOU80AbOga9faFciewm28/Mh+6wr3fwL8UbDVvLttSxa3Q4+Y4DfQ184K2DjvTgemT05HtWcqSkM+13ihv4Efcjq3IIOapX+ntHHmBiAB0NfNfhL4i614d2RJMLm1GP3UnXHsa908FfEXS/EsIj3GG6UfNE5wa5J0Wio1HE0TccBZlYMBRJKjpjcv8AQ1vNDbTDB2kjkDGP1rOutMgkUiPK8fr9KxcGdEayOa0q2W3vbojjzWyMmtZAQBtBzVP+zZ7eRtuWT1NAW6UsSDjtxWVjb2nMaAzkE8DninhkUDPT3FY7vOo+YncelS2qytIBITzQPm0NPcMbicgd6qS3XMiIPm7Y70wW8xn2qSy1qW2lxRXAdyWYjkVcYXMpVVHcz4bSa5bJ4BGQDWlb2EVsQzgM3r1q6G2HAGBjiq9xKAjA8EnIrXksc0qzlsQ3WTHIqnJzkZrLmJOGOOTV66mVIyzEDjrmvOPGnja00iDbDKst0QQqKc4PvVKLexHOzp9U1Wz060kmuZFRVB+8etfPfjTXm17V3nBYW65WNT6etUdX1m91WdnvZmYE8IPugVmE5zXVTpcurAXNITmkorYApcUlBoAWjPOaQUUAOBzSjg03NLnjnigDX0DWZtIuhIpLR/xLXtfhjxFbatbxuknz+ma+fh2q9pWp3GmXImtnxg8j1rmrUOfWO5tSq8uj2Pp+7uY5jFj5ZQuN3rirlndBlXzCwIPysp5U15d4W8UQ6mFBl2y91JxXbRXPmIMKCyj5j3Irgd07SR1pprQ7qxvpHPlS4MuPlwcK/wCNR6lp+QZYG+oPaudh1FZLUBmHHKODgoa6DQtVF7AY5mH2mMfNkfe9CKqyehk7w95GcZynG4KR1BFSRy7yOmDzWlqGnx3e3YSsnXI71gXSS2UxEittHcdKylFo3hUUkXEc4y4I6qCeM0skg2jkD2FUVvF2gMABnripFnjIJY5PYU0yuaw7cWKlgMkVVlbJyD9akmuEIJB+b0PSqkjqzMEKe57Zp6lKdiKR2JOcnPOMVXfJUr0I5pXmUPght2OPSq7SyuxCjGf4jUtDdUbPKqL83T+dZE9w8jYTIB7ipJ3UufNJJHpWPqeuWWmLvlcbhxjuauNNs551r7G4oWKPzHOMd64fxd4ujtg0NnhpCOorm/EHjG61DdFbny4unHeuSZizFiSSepNdsKN/iOOUyW8uZbudpZm3Mx6+lQDGOTR357UhPpXUkjPcCQDj1ozR3opgFFJS0AdJ4LjZjqUlnbw3OrRQhrSKUBh9752VTwWA6CrsOqeNnuFjEF5IxOPKkswVPsQVxisXw/YW9z9rvL65mt7OxVXdoBmRmY4VV9CT3rS1cXcujnUNF1nUbvTkOyeGWQiW3J6bgDgqfUUDKHjKG2g8RTx2qRRjahljiOUjlKguq+wbNFQ+J9Oi0rVha25dozDFLlzk5ZAx/U0UCMukopaBCgcUhoooABRmikHv1oAdn1opDSjpQAtFJSigBQcHNCnC/Nz70h+7zQDnANAEgbjirFrdTWs4mtpXikXoyHBqpnHFKTRYD1Lw/wDFm+s1SPUohMo4LqcGu1sfixo88eJpGiY9d1fPIbHQmgH6Vm6SYrH1Pp3jnQrhQPt8ZY9MsBWgfEWikDN9C30cV8lZHoKXeQOp/Os3h0x3fQ+tDrOkMoYXcHH+1TJfEOjWysxvYAMZ+8K+UPMcfxMPoTTWYkAEsfcsan6sh80up9IN8VPDkdyyCQkqcZA4p9z8VNChUSLdh884XtXzVnigNz0FUsPFCep7rqXxnswXFrbSyHtnpXD618T9cvnb7MUtYz0xya4Msaaa0VKKFY277xVrV3GVuNRnZD1CnFYzsWO5mYt1JJyTTetJ+daWsMTPakoooASiiigA/Giij1oAOaUUlFAC0UmeaM0AKCRTvoPrTc0oOBQBNBNJFKHico46EGu58O+O57cCK/BI6eYP61wHRiaAeuaidOM9yoycdj3yz8TWOoIjWsyCUAZXOM/Wtqx1c29zHMg2f3l9RXzbHK8b7o3Kt1yDit6w8Vala4DTmVR03c1yTwrTvFnQq6krSR9ZabqsE8IdZMluQQe1W38t0YnaVbnnmvmzSPiP9nYedE6LjkKa67T/AIoWbKsbybU9HFS4S2aMtn7rPR73SllkLRNtA444FVjphQDdIQw71yY+I2nSEg3SD3JqhdeP9Odm828BUd1NQqavsa+0kdsbWFSdzksDgnNRXRtoF2Ky5PBya84b4h6XbvJhpJP1rB1b4kecf9EgYH1atFR8iXUb3Z6tNcQRjAxjqawNZ1qzsSzT3KgEZAB/SvItQ8Y6rdg5mKL2CmsO5uZ7hi08ryH3NbRw6IdQ7PxH42aVjFpwIT++fSuLuLmW5lLzyM59zUB9qO3tW0acY7EcwE8UmaKQirELTVPXilNIelAC0Uho60CFpM/jRRQBpaJqv9mNcJNbR3dncoI57dyQHAOQQRyCD0NN0jVLjSr43NqF2uCkkMg3JIh6ow7ipNA06O+lllufN+ywBdyRffldjhI19CT37AGtaOG1mvb2xm0S0RbRSZPstyxmAH3ipJIcgckY7UDMfxHqi6xqbXiW4t1MaRiINuC7VC8H8KKg1eyOnX8luJBNGArxyqMCRGAKsPqDRQIqUtN7Gg0AL3xS0LTRQA6ikNLQAUopKO1AC0UgpaADj3o7ik70o60ALmjrSUL0oAX8qcMUw0tADifegHjmmmgUAPJ7ZpAc0g6UlAD6Qnjim0UALnpQc0lFACjNHY0lFABx2pKPSigAFBopO9AC9KKUfepO340AFA70UUAFFFFACnpx0pM0DpR2oAWge1JQO9ADx0OR9KNx/GmnpRQA/caA2R75pg60rUAOyOc9aQ+wzSdqBQA7NHemUDrQMU9aQmjtSL0oEFFAoPagAFJSikoASgdaWkFAB2o70tI33qADuPajilpq8g5oA3vC12kTy2zTRwSvJFcW8kpwgmjJKqx7AgkZ7cVtw6WLW8lvLfTL2zlKtiS7mQW1vuBBYP1cAE4H864bsaQkkbSSVHQE8CgLmlr11DdaiPshY2sESW8LMMFlRcbj9Tk/jRWee1FAH//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bluish-red flush of the nail induced by a glomus tumor of the nail bed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20170=[""].join("\n");
var outline_f19_44_20170=null;
var title_f19_44_20171="Classification of pancreatic fistulas";
var content_f19_44_20171=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of pancreatic fistulas",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td rowspan=\"2\">",
"        1. External",
"       </td>",
"       <td>",
"        High output (&gt;200 mL/day)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low output (&lt;200 mL/day)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Internal",
"       </td>",
"       <td>",
"        Pancreatic ascites, pleural effusion, communication with other viscera or retroperitoneum or mediastinum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        2. Based on underlying disease process",
"       </td>",
"       <td>",
"        Acute pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic cancer and other pancreatic neoplasms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal pancreas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        3. Based on the immediate predisposing cause",
"       </td>",
"       <td>",
"        Postoperative (pancreatoduodenectomy, distal pancreatectomy, surgery on organs adjacent to pancreas)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percutaneous drainage of pancreatic fluid collections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trauma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dia T Simmons, MD, Santhi Swaroop Vege, MD, and Suresh T Chari, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20171=[""].join("\n");
var outline_f19_44_20171=null;
var title_f19_44_20172="Imatinib Rx advanced GIST";
var content_f19_44_20172=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F78415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F78415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Results of imatinib therapy for metastatic gastrointestinal stromal tumor",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       Trial",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       Phase",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       No. of patients",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       Dose in, mg/day",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       Follow-up, months",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"4\" rowspan=\"1\">",
"       Best response, percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       CR",
"      </td>",
"      <td class=\"subtitle2\">",
"       PR",
"      </td>",
"      <td class=\"subtitle2\">",
"       SD",
"      </td>",
"      <td class=\"subtitle2\">",
"       PFS, months",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       US Multicenter Blanke, C; 2008",
"      </td>",
"      <td rowspan=\"2\">",
"       II",
"      </td>",
"      <td>",
"       73",
"      </td>",
"      <td>",
"       400",
"      </td>",
"      <td rowspan=\"2\">",
"       63",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       61",
"      </td>",
"      <td rowspan=\"2\">",
"       16",
"      </td>",
"      <td>",
"       20*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       74",
"      </td>",
"      <td>",
"       600",
"      </td>",
"      <td>",
"       3",
"      </td>",
"      <td>",
"       65",
"      </td>",
"      <td>",
"       26*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       EORTC Verweij, J; 2004",
"      </td>",
"      <td rowspan=\"2\">",
"       III",
"      </td>",
"      <td>",
"       470",
"      </td>",
"      <td>",
"       400",
"      </td>",
"      <td rowspan=\"2\">",
"       25",
"      </td>",
"      <td rowspan=\"2\">",
"       5",
"      </td>",
"      <td rowspan=\"2\">",
"       45",
"      </td>",
"      <td rowspan=\"2\">",
"       32",
"      </td>",
"      <td>",
"       2-year PFS 50%",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       472",
"      </td>",
"      <td>",
"       800",
"      </td>",
"      <td>",
"       2-year PFS 56%",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       US Intergroup Blanke, C; 2008",
"      </td>",
"      <td rowspan=\"2\">",
"       III",
"      </td>",
"      <td>",
"       361",
"      </td>",
"      <td>",
"       400",
"      </td>",
"      <td rowspan=\"2\">",
"       54",
"      </td>",
"      <td rowspan=\"2\">",
"       -",
"      </td>",
"      <td rowspan=\"2\">",
"       43",
"      </td>",
"      <td rowspan=\"2\">",
"       32",
"      </td>",
"      <td>",
"       18",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       360",
"      </td>",
"      <td>",
"       800",
"      </td>",
"      <td>",
"       20",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    * Median time to tumor progression in months (TTP).",
"    <div class=\"footnotes\">",
"     CR: complete response; PR: partial response; SD: stable disease; PFS: progression-free survival; EORTC: European Organization for the Research and Treatment of Cancer.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20172=[""].join("\n");
var outline_f19_44_20172=null;
var title_f19_44_20173="APL induction regimens";
var content_f19_44_20173=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F51345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F51345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chemotherapy induction regimens for acute promyelocytic leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drugs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dosing",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        ATRA",
"        <strong>",
"         plus",
"        </strong>",
"        idarubicin",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        <strong>",
"         ATRA:",
"        </strong>",
"        45 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day in two divided doses until complete response.",
"       </td>",
"       <td rowspan=\"2\">",
"        This is the AIDA protocol that yields a 94 percent remission rate. After three intensive consolidation courses plus maintenance therapy, the event-free survival at 12 years was 69 percent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Idarubicin:",
"        </strong>",
"        12 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        intravenous push days 2, 4, 6, and 8.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        ATRA",
"        <strong>",
"         plus",
"        </strong>",
"        daunorubicin",
"        <strong>",
"         plus",
"        </strong>",
"        cytarabine",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        <strong>",
"         ATRA:",
"        </strong>",
"        45 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day in two divided doses until complete response.",
"       </td>",
"       <td rowspan=\"3\">",
"        This North American Intergroup regimen had a high complete remission rate of 90 percent. When followed by arsenic trioxide for consolidation, the event-free survival was 80 percent and overall survival 86 percent at three years. Disease-free survival was 90 percent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Daunorubicin:",
"        </strong>",
"        50 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        intravenous push on each of days 3 through 6 (four doses).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cytarabine:",
"        </strong>",
"        200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        daily as a continuous infusion for days 3 through 9 (seven days).",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        ATRA",
"        <strong>",
"         plus",
"        </strong>",
"        arsenic trioxide",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        <strong>",
"         ATRA:",
"        </strong>",
"        45 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day in two divided doses until complete response.",
"       </td>",
"       <td rowspan=\"2\">",
"        Initial studies demonstrate good results with short follow-up. Yields a &gt;85 percent remission rate. May be an excellent option for patients who are not able to tolerate anthracycline-based therapy. Hydroxyurea, daunorubicin, or gemtuzumab ozogamicin have been added if the WBC count rises dramatically.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Arsenic trioxide:",
"        </strong>",
"        0.15 mg/kg per day beginning 10 days after initiation of ATRA and continuing until complete response.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        ATRA",
"        <strong>",
"         plus",
"        </strong>",
"        arsenic trioxide",
"        <strong>",
"         plus",
"        </strong>",
"        gemtuzumab ozogamicin",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"       <td>",
"        <strong>",
"         ATRA:",
"        </strong>",
"        45 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day in two divided doses until complete response.",
"       </td>",
"       <td rowspan=\"3\">",
"        Initial study demonstrated a response rate of 92 percent. At a median follow-up of 24 months, the estimated three-year survival rate was 85 percent. Disease-related complications resulted in an early death rate of 8 percent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Arsenic trioxide:",
"        </strong>",
"        0.15 mg/kg per day beginning on day 1 with the ATRA and continuing until complete response.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Gemtuzumab ozogamicin:",
"        </strong>",
"        9 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        on day 1 for high risk patients (defined as white count &ge;10x10",
"        <sup>",
"         9",
"        </sup>",
"        /L).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ATRA: all-trans retinoic acid (tretinoin).",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Avvisati G, Lo-Coco F, Paoloni FP, et al. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance. Blood 2011; 117:4716.",
"       </li>",
"       <li>",
"        Powell BL, Moser B, Stock W, et al. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood 2010; 116:3751.",
"       </li>",
"       <li>",
"        Estey E, Garcia-Manero G, Ferrajoli A, et al. Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood 2006; 107:3469.",
"       </li>",
"       <li>",
"        Ravandi F, Estey E, Jones D, et al. Effective treatment of acute promyelocytic leukemia with All-Trans-Retinoic Acid, arsenic trioxide, and gemtuzumab ozogamicin. J Clin Oncol 2009; 27:504.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20173=[""].join("\n");
var outline_f19_44_20173=null;
var title_f19_44_20174="Down screening test performance";
var content_f19_44_20174=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Performance of maternal age and various second trimester maternal serum combinations in screening for Down syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 346px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The bar graphs describe the detection rate (DR) attained at a fixed 5 percent false positive rate (FPR) for each of the screening tests. In addition, the risk in positives is given for each of the tests.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data adapted from: Wald, NJ, Kennard, A, Hackshaw, A, et al. J Med Screen1997; 4:181.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20174=[""].join("\n");
var outline_f19_44_20174=null;
var title_f19_44_20175="Severity obstructive dz";
var content_f19_44_20175=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72469%7EPULM%2F59123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72469%7EPULM%2F59123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 574px\">",
"   <div class=\"ttl\">",
"    Interpretation of office spirometry: obstructive pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 554px; height: 331px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The FEV1/FVC ratio decreases with age, so the lower limit of normal (LLN), as calculated by most spirometers, should be used to detect airway obstruction rather than the absolute value of the FEV1/FVC ratio.",
"    <br>",
"     If the FEV1/FVC ratio is normal AND the FEV1 is greater than 80 percent of predicted, then the spirometry is normal.",
"     <br>",
"      If the FEV1/FVC ratio is normal, but the FVC is mildly reduced (70 to 80 percent of predicted), the cause is often abdominal obesity or poor technique.",
"      <br>",
"       If the FEV1/FVC ratio is normal, but the FVC is below 70 percent of predicted, consider referring the patient to a Pulmonary Function Laboratory for measurement of lung volumes and diffusing capacity (DLCO) to assess for a possible restrictive ventilatory defect (eg, interstitial lung disease or respiratory muscle weakness).",
"       <div class=\"footnotes\">",
"        FVC: forced vital capacity; FEV1: forced expiratory volume in one second.",
"       </div>",
"       <div class=\"reference\">",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Interpretation of office spirometry: Restrictive pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 308px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Spirometry interpretation flow chart for the detection of a restrictive ventilatory defect.",
"    <div class=\"footnotes\">",
"     * The fifth percentile lower limit of normal (LLN), as calculated by most spirometers, should be used to detect airway obstruction, rather than the absolute value of the FEV1/FVC ratio.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_44_20175=[""].join("\n");
var outline_f19_44_20175=null;
